Mahul Amin Academic CV 5-4-2015

Curriculum Vitae
MAHUL B. AMIN, MD
Professor, Medical Director & Chairman
Department of Pathology and Laboratory Medicine Cedars-Sinai Health System
8700 Beverly Blvd. Suite 8707 | Los Angeles, CA, 90048 USA
Citizenship: USA
Office: (310) 423-6627 Fax: (310) 423-0170 Email: mahul.amin@cshs.org
EDUCATION:
1979 - 1983
1983 - 1984
1985 - 1986
1986 - 1987
1987 - 1988
1988 - 1988
1988 - 1990
1990 - 1992
1992 - 1992
1992 - 1993
G.S. Medical College and King Edward Memorial Hospital, Bombay, India, Bombay
University - MBBS
King Edward Memorial Hospital, Bombay, India - Clinical Internship
G.S. Medical College, Bombay, India - House Officer, Pathology
G.S. Medical College and King Edward Memorial Hospital, Bombay, India - Registrar,
Pathology
G.S. Medical College and King Edward Memorial Hospital, Bombay, India - Lecturer,
Pathology
Bombay University, Bombay, India - M.D., Pathology
Residency Training, Henry Ford Hospital, Department of Pathology, Detroit, Michigan
Chief Resident, Henry Ford Hospital, Department of Pathology, Detroit, Michigan
Visiting Clinician, Mayo Clinic, Bone and Joint Pathology and Oncology, Rochester,
Minnesota
Fellowship in Surgical Pathology, University of Texas, M.D. Anderson Cancer Center,
Houston, Texas
LICENSURE:
State of Michigan (#4301052820), (1990 - 1999)
State of Georgia (#045696), expiration date: 08/31/15
State of California (#C52183), expiration date: 08/31/15
Drug Enforcement Adminiatration (#BA9680821), expiration date 06/30/2015
BOARD CERTIFICATION:
Diplomate, American Board of Pathology, May 1996 (Anatomic Pathology exam,
June 1993; Clinical Pathology Exam, May 1996).
Diplomate, Pathology Boards, University of Bombay, India, February 1988.
PROFESSIONAL EXPERIENCE:
Hospital and Departmental Appointments - Present:
2006 - present
2006 - present
2006 - present
Chairman, Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center

Vice Chairman, Department of Pathology and Laboratory Medicine, David Geffen School of
Medicine at UCLA, Los Angeles, CA
Medical Director, Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical
Center
Academic Affiliations present:

2007 - present
2009 - present
Professor of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine
(in Residence, Step V)
Professor of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center Professorial
Series
Hospital and Departmental Appointments - Previous:

1993 - 1998
Senior Staff Pathologist, Department of Pathology, Henry Ford Hospital, Detroit, MI

MAHUL B. AMIN, MD Page 1
1994 - 1998
1995 - 1998
1996 - 1998
1998 - 2006
1998 - 2006
1998 - 2006
1998 - 2006
2003 - 2006
2003 - 2006
Senior Staff, Bone and Joint Center, Henry Ford Hospital, Detroit, MI
Associate Director, Immunohistochemistry Laboratory, Department of Pathology, Henry
Ford Hospital, Detroit, MI
Section Chief, Anatomic Pathology Education, Department of Pathology, Henry Ford
Hospital, Detroit, MI
Medical Staff with privileges, Wesley Woods Center (Geriatric Hospital,
Long-Term Hospital and Long-Term Care) of Emory University, Atlanta, GA
Pathology, Henry Ford Hospital, Detroit, MI
Medical Staff with privileges, Crawford Long Hospital, Atlanta, GA
Medical Staff with privileges, Emory University Hospital and The Emory
Clinic and Satellites, Atlanta, GA
Director of Surgical Pathology, Emory University Hospital, Atlanta, GA
Associate Director, Winship Cancer Institute, Cancer Pathogenomics,
Emory University, Atlanta, GA
Medical Staff with privileges, Grady Memorial Hospital, Atlanta, GA
Academic Affiliations - Previous:

1987 - 1988
Lecturer, Pathology, G.S. Medical College and K.E.M. Hospital, Bombay, India
1990 - 1991
Visiting Instructor, Wayne State University, Detroit, MI
1993 - 1998
1994 - 1998
Clinical Assistant Professor of Pathology, Wayne State University, Detroit, MI

Assistant Professor of Pathology, Henry Ford Health Care System, Case Western Reserve
University, Cleveland, OH
Associate Professor of Pathology and Laboratory Medicine, Emory University School of
Medicine, Atlanta, GA clinical track
Associate Professor of Urology, Emory University School of Medicine, Atlanta, GA
Professor of Pathology and Laboratory Medicine, Emory University School of Medicine,
Atlanta, GA; tenured position
Professor of Urology, Emory University School of Medicine, Atlanta, GA
Professor of Hematology and Oncology, Emory University School of Medicine
1998 - 2003
1999 - 2003
2003 - 2006
2003 - 2006
2003 - 2006
Subspecialty Interests:
General Surgical Pathology with emphasis on oncologic diseases

Genitourinary Pathology
Precision Medicine & Translational Research
Immunohistochemistry
PROFESSIONAL ACTIVITIES:
Committee Service and Administrative Experience - Institutional:
2011 Member, CS-Link Steering Committee, Cedars-Sinai Medical Center
2011 Member, CS-Medicine Committee, Cedars-Sinai Medical Center
2011 Member, Personalized Medicine Committee, Cedars-Sinai Medical Center
2010 Member, Information Sciences Committee, Cedars-Sinai Medical Center
2009 Chair, Biorepository Executive Committee, Cedars-Sinai Medical Center,
Department of Academic Affiars
2008 Graduate Program Governance Council, Cedars-Sinai Medical Center, Department of
Biomedical Sciences
2007 Advisory Board Member, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center
2007 - 2008
Chair of Chairs (Co-Chair), Cedars-Sinai Medical Center Academic Chairmans Group
2006 Clinical Improvement Committee, Quality Improvement Committee, Significant
Adverse Events Committee, Cedars-Sinai Medical Center
2006 Medical Executive Committee, Medical Leadership Group, Executive Medical
Committee, Cedars-Sinai Medical Center
2002 - 2006
Promotions Committee, Department of Pathology and Laboratory Medicine, Emory University
School of Medicine
2002 - 2006
2002 - 2004
2001 - 2006
2001 - 2006
2000 - 2006
1998 - 1996
1998 - 2006
1998 - 2003
1998 - 2006
1997 - 1998
1996 - 1998
1995 - 1998
1993 - 1998
1990 - 1992
Chairman, Billing Committee, Dept. Physician Liaison to Emory Clinic Management group:
Revenue cycleimprovement initiative
Outreach Steering Committee, Emory Medical Laboratories
Residency Committee, Department of Pathology and Laboratory Medicine,
Emory University School of Medicine
Director of Anatomic Pathology Translational Laboratory, Emory University
School of Medicine
Junior Faculty Mentoring Committee, Department of Pathology and Laboratory
Medicine (Anatomic Pathology), Emory University School of Medicine
Residency Committee: Department of Pathology, Henry Ford Hospital, Detroit, MI
Director of Surgical Pathology, Emory University Hospital
Executive Committee of the Department of Pathology and Laboratory
Medicine, Emory University School of Medicine
Director of Surgical Pathology Fellowship and Genitourinary Pathology
Fellowship programs, Emory University Hospital, Atlanta, GA
Director of Genitourinary Pathology Fellowship program, Henry Ford Hospital,
Detroit, MI
Section Chief, Anatomic Pathology Education, Henry Ford Hospital, Detroit, MI
Co-Director, Immunohistochemistry Laboratory, Department of Pathology, Henry Ford
Hospital, Detroit, MI
Anatomic Pathology Quality Assurance Committee, Department of Pathology,
Henry Ford Hospital, Detroit, MI
Chief Resident, Department of Pathology, Henry Ford Hospital, Detroit, MI
Committee Service - Local and National:

2015
Award Committee Member, International Society of Urological Pathologists (ISUP) Excellence
in Genitourinary Pathology Awards
2013 - 2015
Finance Committee, United States and Canadian Academy of Pathology
2012 - 2014
North American Representative to the International Society of Urological Pathology (ISUP)
2011 Prostate AP3 Committee, College of American Pathologists
2009 - 2010
Personalized Healthcare Committee, College of American Pathologist
2009 - 2011
Council on Scientific Affairs Committee, College of American Pathologists
2009 Member, College of American Pathologists Genitourinary Cancer Protocol Review Panel for
the Cancer Committee
2007 - 2009
Member: Benjamin Castle Awards Committee, U.S. and Canadian Academy of Pathology
2006 - 2009
Member, American College of Surgeons, Commission on Cancer (ACS, CoC)
2006 - 2009
Committee of Approvals, American College of Surgeons, Commission on Cancer (ACS, CoC)
2005 - 2009
Chairman: Cancer Committee, College of American Pathologists
2003 - 2011
Executive Committee, American Joint Committee on Cancer (AJCC)
2003 - 2006
Council Member: Association of Directors of Anatomic and Surgical Pathology
2002 - 2008
Chairman, Pathology Committee: Radiation Therapy Oncology Group (NCI-funded
multidisciplinary cancer research group with 260 institutions and greater than 90% of NCIdesignated comprehensive centers as members)
2002 - 2007
Commission on Cancer, Urology Disease Site Team: American College of Surgeons,
Commission on Cancer
2002 - 2007
Member, Executive Committee of the Radiation Therapy Oncology Group
(RTOG) (NCI-funded multidisciplinary Cancer Research Organization)
2002 - 2007
Member, Corporate Relations Committee of the Radiation Therapy Oncology
Group (RTOG) (NCI-funded multidisciplinary Cancer Research Organization)
2001 - 2004
Vice Chairman, Cancer Committee: College of American Pathologists
2001 - 2004
Publications Committee: College of American Pathologists
2001 - 2003
NCI-sponsored Prostate Cancer Pathology Committee for Common Data Elements
2000 2000 - 2002

1998 - 2009
1998 - 1999
Pathology Committee: Radiation Therapy Oncology Group (RTOG) (NCIfunded multi-disciplinary Cancer Research Organization
F. Stephen Vogel Award Committee: U.S. and Canadian Academy of Pathology
Member, Cancer Committee: College of American Pathologists
Membership Committee: Michigan Society of Pathologists
Organization/Participation in Major International Consensus Conferences & Meetings:

2015
2015
2015
2014
2013
2013
2013
2011
2009
2005
2004, 2008
2005
2002
2000
1999
1998
1997
1997
Co-Chair, Surveillance after Focal Therapy (Prostate). Society of International Urology

International Consortium of Urologic Diseases Consultation (SIU-ICUD). Imaged-guided
Therapy in Urology, Melbourne, Australia
Co-Chair, Renal Tumor Biopsy: Indications, Techniques, Safety and Impact on Treatment
Decision Making. Society of International Urology International Consortium of Urologic
Diseases Consultation. Imaged-guided Therapy in Urology, Melbourne, Australia
Panelist, W.H.O. Classification of Genitourinary Malignancies. Zurich, Switzerland
Co-Organizer, International Society of Urological Pathology (ISUP)
Consensus Conference on Gleason Grading of Prostate Cancer. Derived the 2014 ISUP revised
criteria for Gleason Grading. Chicago, IL
Editor-in-Chief, American Joint Committee on Cancer, Cancer Staging Manual, 8th Edition
Lead Organizer, Consensus Statement with Recommendations Supported by
The College of American Pathologists, International Society of Urological Pathology,
Association of Directors of Anatomic and Surgical Pathology, The New Zealand Society of
Pathologists and The Prostate Cancer Foundation for Prostate Cancer Patients Determining
Eligibility for Active Surveillance as a Management Option in Patients with Prostate Cancer
Co-Organizer, Best Practices Recommendations in the Application of Immunohistochemistry
in Urologic Cancer - Report from the International Society of Urologic Pathology Consensus
Conference. Baltimore, MD
Co-Chairperson, Pathology Consensus Guidelines by the Pathology of Bladder Cancer
Workgroup, 2nd International Consortium on Bladder Cancer, Vienna, Austria
Panelist, Genitourinary Task Force and Lead Member, American Joint Commission on
Cancer (AJCC) staging system of Prostate Cancer, 7th edition
Co-Organizer, The 2005 International Society of Urological Pathologists
(ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. San Antonio,TX
Faculty, Long Course, 93rd & 97th United States and Canadian Academy of
Pathology Meeting, Pathology of the Gonads and Tumor and Tumor-like lesions of the Bladder
and Kidney. Vancouver, B.C., Canada & San Diego, CA
Invited Panelist & Rapporteur, W.H.O. 2004 International Consultation on
Prediction of Patient Outcome in Prostate Cancer, Stockholm, Sweden.Team leader for needle
biopsy prognostic and predictive factors
Panelist, W.H.O. Classification of Genitourinary Malignancies. Lyon, France
Co-Author, Third Series Fascicle, Armed Forces Institute of Pathology,
Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra, and Penis
Co-Author, Third Series Fascicle, Armed Forces Institute of Pathology, Tumors of the Testis,
Adnexa, Spermatic Cord, and Scrotum
Co-Organizer, International Society of Urological Pathologists (ISUP) Consensus Classification
Conference Committee on Bladder Cancer. Boston, MA
Invited Participant, Expert Multidisciplinary Group. 1997 Workshop on Diagnosis and
Prognosis of Renal Cell Carcinoma: Sponsored by the World Health Organization in
collaboration with Union Internationale Contre Le Cancer (UICC), American Joint Committee
on Cancer (AJCC), etc. Workgroup on classification of renal cell cancer. Rochester, MN
Advisor & Invited Participant, Workshop on Pathology of Cancer of the Bladder: Sponsored by
the World Health Organization and International Collaborating Center for Genitourinary Tract
Tumors. Consultation for 1999 W.H.O. classification for bladder tumors. Armed Forces
Institute of Pathology. Washington, D.C.
Consultant, Board Membership and Advisory Committees:

2013 - 2014
2013 - 2014
2011 - 2014
Pathology Advisory Board, Foundation Medicine, Boston, MA

Consultant, Amgen, Thousand Oaks, CA
Advisory Board Member, The Doctor's Company, Napa, CA
Editorial Service:
1. Editor-in-Chief: American Joint Committee on Cancer, Cancer Staging Manual, 8th Edition. 2013 - 2016.
2. Editor-in-Chief: Advances in Anatomic Pathology. Lippincott Williams & Wilkins. 2000 - present.
3. Associate Editor and Section Editor for Urologic Pathology: Archives of Pathology and Laboratory Medicine. CAP
Press. 2005 - present.
4. Section Editor: Genitourinary pathology and nephropathology section, Advances in Anatomic Pathology. Raven
Press, 1994 - 1999.
5. Editorial Boards:
- Union for International Cancer Control (UICC), TNM Staging Manual. Wiley Publications. 2014-2017.
- American Journal of Surgical Pathology. Lippincott Williams & Wilkins. 1998 - present.
- Annals of Diagnostic Pathology. WB Saunders. 2001 - present.
- Korean Journal of Pathology. Korean Society of Pathologists. 2003 - present.
- Modern Pathology. Lippincott Williams & Wilkins. 2010 present.
- Human Pathology. W.B. Saunders Co. 2010 present.
- Journal of Urologic Pathology. Humana Press, 1994 - 1999.
- CAP Today. College of American Pathologists Publication, 2001 - 2010.
6. Guest Ad Hoc Reviewer:
- American Journal of Clinical Pathology. ASCP Press.
- American Journal of Pathology. Am Society of Investigative Pathology.
- Anticancer Therapy.
- Applied Immunohistochemistry and Molecular Morphology. Lippincott Williams & Wilkins.
- Archives of International Surgery. Wolters Kluwer.
- Armed Forces Institute of Pathology Fascicle Fourth Series.
- Cancer Control. Moffitt Cancer Center.
- Cancer Research. American Association for Cancer Research.
- Cancer. John Wiley & Sons, Inc.
- Clincal Cancer Research. HighWire Press.
- Critical Reviews in Oncology/Hematology. Elsevier Inc.
- Histopathology. Wiley
- International Journal of Cancer. Wiley-Liss Inc.
- International Journal of Surgical Pathology. Westminster Publications.
- International Journal of Urology. Wiley-Blackwell.
- Journal of Clinical Oncology. Lippincott Williams & Wilkins.
- Journal of Clinical Pathology. BMJ Publishing Group.
- Journal of Registry Management. National Cancer Registrars Association Publication.
- Journal of Urology. American Urology Association.
- Urology. Elsevier Science Inc.
- Virchows Archiv. Springer
7. Guest Editor: Seminars in Diagnostic Pathology. Issue Contemporary immunohistochemical approach to the
surgical pathology of the Genitourinary Systems. (Co Editor: Robert H. Young) - 2005.
8. Guest Editor: Seminars in Diagnostic Pathology. Issue - Update on pathology of the urinary bladder and urethra.
(Co Editor: Robert H. Young) - 1997.
9. Abstract Review Board: U.S. and Canadian Academy of Pathology National Meeting Program - 1996-2002; 20122014.
HONORS, SPECIAL AWARDS & PRESTIGIOUS APPOINTMENTS:

Professional:
2010
2010
2013
2011-14
2008
2005, 2007-08,
2010-11
2005
2002 - 2014
2001
In Training:
1992
1992
1991
1990
1990
1989
1988
Lansky Award of the College of American Pathologists Foundation, presented at CAP10 Annual
meeting, Chicago, IL - Award recognizes a practicing pathologist who exemplifies distinguished
commitment to excellence, leadership, and the advancement of pathology education and science.
Distinguished Service Award of the College of American Pathologists, Presented at CAP10 Annual
meeting, Chicago, IL - Awarded for services as Chair of the Cancer Committee of the CAP award
recognizes conspicuous performance in which results enhanced the prestige of the CAP on a national
scale and which aided in furthering its national polices.
Los Angeles "Top Doctors"
Best Doctors" US News and World Report
Americas Top Doctors for Consumers Research Council of America
Americas Top Doctors for Cancer, Genitourinary Pathology Castle Connelly
Guide Listing, 3rd and 4th Edition listing
Best Doctors in Atlanta listing. Atlanta Magazine
Best Doctors of America listing
Arthur Purdy Stout Society Young Investigator Award. U.S. and Canadian Academy of
Pathologists meeting, Atlanta, GA
Pathologist-In-Training Award, Gastrointestinal Pathology Society, U.S. and Canadian
Academy of Pathology, Atlanta, GA (81st Annual Meeting): Prognostic Value of PCNA Index in Gastric
Stromal Tumors: Correlation with Mitotic Count and Clinical Outcome
Outstanding Resident Award: Best Resident award from Henry Ford Hospital and
Medical Group, Detroit, MI
Best Paper (first prize), Michigan Society of Pathology Residents Poster Competition,
Ann Arbor, MI: Computerized Static DNA Ploidy Analysis of Prostatic Intraepithelial Neoplasia
Stowell Orbison Award, Certificate of Merit, U.S. and Canadian Academy of Pathology,
Boston, MA (79th Annual Meeting): Duodenal Pathology of Canine Allografts with
Pancreaticoduodenocystostomy
Best paper, Anatomic Pathology, Residents Competition - American Society of Clinical
Pathology, Fall Meeting, Dallas, TX: Detection of Pneumocystis Carinii - Comparative Study of
Monoclonal Antibody Versus Silver Staining
Prize, Michigan Society of Pathology, Spring Seminar: Megakaryoblastic Termination of
Myeloproliferative Disorders
Diplomate with Highest Honors (Gold medal), Pathology Boards, University of Bombay
Course Faculty Member:

2007 - 2011
Cedars-Sinai Medical Center. Whats New in Anatomic and Clinical Pathology
2004 - 2010
College of American Pathologists. Annual Meetings
2004 - 2014
Urologic Pathology for Urologists. University of Chicago. Continuing Medical Education Course
2002 - 2004
American Urology Association. Genitourinary Pathology Review Course
2000 - 2004
American Urology Association. Post-graduate course. Annual meetings
1998 - 2005
Emory University School of Medicine. Diagnostic Problems in Anatomic Pathology.
Co-course Director
1997 - 2011
Harvard Med School. Urologic Surgical Pathology for the Practicing Pathologist
1996 U.S. and Canadian Academy of Pathology Annual meetings; 5 separate courses
1994 -2003
Osler Institute of Pathology. Pathology Board review course. Urologic Pathology
1994 - 1999;
2015
American Society of Clinical Pathologists. Spring and/or Fall meetings
1990 - 1992
American Urology Association. Genitourinary Pathology course. Instructor
RESEARCH GRANTS AND FELLOWSHIPS RECEIVED:

Grants and Grant Support - Current:
1. NIH IG20RR030860
S. Melmed (PI); M. Amin (Faculty)
2010 - 2015
Cedars-Sinai Biobank and Translational Research Core Facility

Goal is to build a centralized human Tissue Repository research core facility at Cedars-Sinai Medical Center, Total
amount: $9,552,872
Grants and Grant Support - Past:
1. 1. NIH R21
Philip Santangelo (PI)
2011-2014
Characterizing gene regulation with single molecule sensitive probes (Total: $500,000)
Goal is to quantify mRNA number and mRNA-protein interactions in prostate cancer cellular models and tissue
tumor samples using single molecule sensitive probes, a modified proximity ligation assay and rolling circle
amplification.
Role: Co-Investigator (Effort only)
2. NIH/1 P01 CA98912
Chung (PI); Amin (Co-Investigator)
2009 - 2014
Prostate Cancer Bone Metastasis: Biology and Targeting
The major goal of this project is to elucidate the biology and molecular pathways involved in the interaction
between stromal cells of the bone or the prostate and malignant prostate cancer cells.
3. Prostate Cancer Foundation M. Amin
2010 2013
Active surveillance for Prostate Cancer, $5,000,000 total.
Effort and Salary support: pending assignment of budget
A biorepository of patients on active surveillance (biopsies, blood samples and clinical information) is enabled to
develop a resource that will allow investigation of new biomarkers for the prediction of patients at risk for
progression.
4. NCI/RTOG
M. Amin
2006 2013
Radiation Therapy Oncology Group. National Institutes for Health (NIH) 2U10 CA 02 21661-29 (Curran). Pathology
Committee (total) $13,798,229 (01/01/08-12/31/13)
Effort and Salary support: Pathology Chair for protocols RTOG 9408, 9910, 415, 232, 521, 526, 534, 126, 612. Fee
for service retrospective and prospective review of prostate cancer cases
5. Synergy Consortium Targeting New Therapeutics for Lethal Phenotype of Prostate Cancer. Department of Defense
(DOD) Consortium Award PCRP-02 (J. Simons, Principal Investigator) $10,000,000 (total). (Funding period 4/1/03
3/31/06; no cost extension until 3/31/08)
a) Project I: Development of a Molecular Gleason Classification to Predict Lethal Phenotype of Prostate
Cancer Using Gene Expression Profiling. Principal Investigator (Team Captain) (total) $1,129,798 5%
effort and salary support.
b) Project J: Genome-wide DNA Profiling to Define Chromosomal Alterations Associated with Lethal
Phenotype of Prostate Cancer and Pathogenomics Core. Principal Investigator (Team Captain) (total)
$1,432,749 10% effort and salary support.
6. Radiation Therapy Oncology Group. National Institutes for Health (NIH) 2U10 CA 02 21661-29 (Curran).
Chairman, Pathology Committee (total) $13,798,229 (01/01/02-12/31/07) - 5% effort and salary support. Support
ended 2008.
7. Nanotechnology Linking Biomarkers with Cancer Behavior. National Institutes of Health (NIH) 1 RO1 CA108468
(Nie).$7,094,005 (total) (9/15/04 - 8/31/09). Co-Investigator - 10% effort and salary support. Support ended April
2006.
8. Developmental Transcription Factors in Prostate Cancer.National Cancer Institute (NIH) R01CA106826-01A1
(Moreno). 2/1/05 - 1/31/09. Co-Investigator - 10% effort and salary support. Support ended April 2006.
9. A VA Population Study of Disease Progression in Prostate Cancer Patients. Idea Development Award, Department
of Defense PC040315 (Zhou).1/1/2005-12/31/2007. Co-Investigator - 0.5% effort and salary support. Support
ended April 2006.
10. Disease Progression in Patients with 8p Allelic Imbalance Prostate Tumors. American Cancer Society RSG CCE108980 (Zhou). Co-Investigator - 2.25% effort and salary support. Support ended April 2006.
11. Prostate Cancer Bone Metastasis: Biology and Targeting. National Institutes of Health (NIH) Program Project 1
PO1 CA098912-01. PI: Chung (total) $8,958,411; 6/1/03 5/31/08. Director, Pathology and Laboratory Support
Core C (Amin) (total) $1,298,642 15% effort and salary support. Support ended April 2006.
12. Winship Cancer Institute, Emory University, P20 CA 103735-01, Cancer Center Planning Grant. PI: Simons (total)
$2,017,472. 4/1/03 - 3/1/08. Cancer Biology Program (Amin) - 10% effort and salary support. Support ended April
2006.
13. Molecular Dissection of 13q 14 in Prostate Cancer. National Institutes of Health (NIH) R01 CA 85560 (Dong).
4/1/00 3/31/05. Co-Investigator (total) $180,000 (4/1/00 3/31/05) 5% effort and salary support.
14. Phage Display and Prostate Neoplasia Progression. National Institutes of Health (NIH) 4 R33 CA091435-03. PI:
Parkos (total) $682,853 (04/01/01-03/31/05). Co-Principal Investigator - 10% effort and salary support.
15. Cancer Center Initiation Award: Prostate Cancer Research Center Core Facility. Department of Defense Grant. PI:
Petros; $2,400,000 (total). Pathology Core Principal Investigator (total) $692,288 (2000 2003). - 10% effort and
salary support.
16. Development Program in Prostate Cancer Research. National Cancer Institute (NIH) grant R21 CA 69764-04
(Petros). $1,168,000 (total) - $30,000 Prostate cancer Pathology program development. Investigator. (2000
2003)
17. MR evaluation of soft tissue infection and osteomyelitis in the diabetic foot. Henry Ford Hospital Small Projects
Grant, $10,000. Participant Investigator.
18. Computerized measurement and image analysis of DNA content in prostatic
intraepithelial
neoplasia
and
cancer. Henry Ford Hospital award $5,000. Co-Investigator.
19. Evaluation of new prognostic markers in transitional cell carcinoma of the urinary bladder: Correlation with
pathologic features and survival. Graduate Medical Education, Henry Ford Hospital award $5,000. Senior Staff
Advisor.
20. Determining prognosis of clinically localized prostate cancer using PCR to detect p53 mutations. Graduate Medical
Education, Henry Ford Hospital, $5,000. Senior Staff Advisor.
21. International Union Against Cancer fellowship. Bladder Cancer Study with Tata Cancer Hospital and Cancer
Research Institute, Mumbai India ICRETT #974, 1998. Geneva Switzerland. Project Chairman.
22. International Union Against Cancer fellowship. Prostate Cancer Study with Lilavati Hospital and Research Center.
Mumbai, India. ICRETT #262, 2000. Geneva, Switzerland. Project Chairman.
COOPERATIVE GROUPS CLINICAL TRIALS:

1994 - 2001
1999 - 2002
1999 - 2004
2002 - 2007
2002 - 2012
2006 - 2009
2006 - 2009
2006 - 2012
2007 -
2008 -
Pathology Chairman: RTOG Protocol 94-08: A Phase III Trial of the Study of Endocrine Therapy
Used as a Cytoreductive and Cytostatic Agent Prior to Radiation Therapy in Good Prognosis
Locally Confined Adenocarcinoma of the Prostate.
Pathology Chairman: Eastern Cooperative Oncology Group (ECOG). A Prospective
Randomized Phase III Study Comparing Radical Surgery to Elective Kidney Sparing Surgery for Low
Stage Renal Cell Carcinoma: An Intergroup Study. Participating Groups: EORTC (group protocol
30904), ECOG (group protocol 30904), SWOG, CUOG, SOG, AUO.
Pathology Chairman: Radiation Therapy Oncology Group (RTOG), RTOG Protocol
99-10: A Phase III Trial to Evaluate the Duration of Neoadjuvant Total Androgen Suppression and
Radiation Therapy in Intermediate Risk Prostatic Cancer.
Pathology Chairman: RTOG Protocol 0126: A Phase III Randomized Study of High
Dose 3D-CRT versus Standard Dose 3D-CRT in Patients Treated for Localized
Prostate Cancer.
Pathology Chairman: RTOG Protocol 0232: A Phase III Study Comparing External
Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone for
Selected Patients with Intermediate Risk Prostate Cancer.
Pathology Chairman: RTOG Protocol 0415: A Phase III Randomized Study of
Hypofractionated 3D-CRT/LMRT versus Conventionally Fractionated 3D-CRT/LMRT in Patients with
Favorable-Risk Prostate Cancer.
Pathology Chairman: RTOG Protocol 0521: A Phase III Protocol of Androgen
Suppression (AS) and 3D-CRT/LMRT vs AS and 3D-CRT/LMRT Followed by Chemotherapy with
Docetaxel and Prednisone.
Pathology Co-Chairman: RTOG Protocol 0612: Investigating Markers of Radiation
Outcome in Patients with Intermediate-Risk Prostate Cancer Using DNA Microarray Analysis: An Rtog
Pilot Study.
Pathology Chairman: RTOG Protocol 0526: A Prospective Phase II Trial of
Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma
Following External Beam Radiotherapy.
Pathology Chairman: RTOG Protocol 0534: A Phase III Trial of Short Term
Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy in Prostate Cancer
Patients with a Rising PSA after Radical Prostatectomy.
INVITED LECTURES AND PRESENTATIONS:

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
"Round cell tumors of bone. Department of Orthopedics, Henry Ford Hospital, Detroit, MI, December 17, 1993.
"Precursor lesions of the prostate carcinoma. Urology Grand Rounds, Department of Pathology, Henry Ford
Hospital, Detroit, MI, January 22, 1994.
"Prostatic intraepithelial neoplasia - relationship to adenocarcinoma of prostate." M.D. Anderson Cancer Center
Alumni Meeting, Houston, TX, April 28, 1994.
Osler Institute of Pathology, Pathology Board Review Course - Genitourinary Pathology session, Cincinnati, OH,
May 26, 1994.
"Pathology of transitional cell carcinoma. In: "Contemporary Management of Bladder Cancer", Dearborn, MI,
August 5, 1994.
"Preneoplastic lesions of the prostate. Korean Society of Pathologists, and Mokdong Hospital College of
Medicine Ewha Womens University, Seoul, Korea, October 17, 1994.
"Therapy-oriented approach to testicular germ cell neoplasms." Lake Superior Pathology Society, Duluth, MN,
November 9, 1994.
Precursor lesions of prostatic adenocarcinoma. Physicians Association of Baroda, Baroda, India, November 24,
1994.
Approach to the diagnosis of adenocarcinoma of the prostate in needle biopsy specimens. Seth G.S. Medical
College and King Edward Memorial Hospital. Bombay, India, December 16, 1994.
Pathology of renal cell carcinoma, newer classification systems. Department of Urology, Henry Ford Hospital,
Detroit, MI, March 22, 1995.
Recently described topics in testicular pathology. Department Pathologie der Universitat, Institut fur Klinische
Pathologie, Universitatsspital, Zurich, Switzerland, July 18, 1995.
Invasion and early invasion in urothelial neoplasia. Case presentation and discussion in evening specialty
conference. U.S. and Canadian Academy of Pathology, Washington, D.C., March 26,1996.
Osler Institute of Pathology, Pathology Board Review Course - Genitourinary Pathology session, Chicago, IL, May
14, 1996.
Contemporary classification of adult renal epithelial neoplasms. In: Advances in management of renal cell
carcinoma, Dearborn, MI, August 3, 1996.
Approach to the diagnosis of prostatic carcinoma and its differential diagnoses. 1996
Annual Meeting of American Osteopathic Association and American Osteopathic College of Pathologists, Las
Vegas, NV, October 10, 1996.
Classification of adult renal epithelial neoplasms. 1996 Annual Meeting of American Osteopathic Association
and American Osteopathic College of Pathologists, Las Vegas, NV, October 10, 1996.
Contemporary classification of renal tumors. Pathology Grand Rounds, Massachusetts General Hospital,
Boston, MA, November 18, 1996.
Intraepithelial lesions of the urinary bladder. Pathology Grand Rounds, Indiana University, Indianapolis, IN,
December 12, 1996.
Precursor lesions of bladder cancer and recognition of early invasion. Michigan Society of Pathologists, Ann
Arbor, MI, May 10, 1997.
Osler Institute of Pathology, Pathology Board Review Course - Genitourinary Pathology session, Indianapolis, IN,
June 2, 1997.
"Interpretation of bladder biopsies" - Urologic Pathology Update - International Society of Urological Pathology
Companion Meeting at American Society of Clinical Pathologists Meeting, Philadelphia, PA, September 20, 1997.
"Renal oncocytoma. Birth, rebirth... and growing pains" - National Cancer Institute and National Institute of
Health (NIH), Bethesda, MD, November 14, 1997.
"Clinical relevance of histologic variants of adenocarcinoma of prostate. El Colegio Mexicano De Urologia,
Monterrey, Mexico, March 20, 1998.
"Contemporary classification of adult renal epithelial neoplasms." Monterrey N.L. Association Pathologists,
"Morphologic spectrum and differential diagnosis of "granular" adult renal epithelial neoplasms. University of
Tromso, Tromso, Norway, April 21, 1998.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
Osler Institute of Pathology, Pathology Board Review Course - Genitourinary Pathology session, Toledo, OH, May
19, 1998.
Classification of bladder neoplasia - Update. COGMET Meeting, Metropolitan Hospital, Grand Rapids, MI, May
27, 1998.
Diagnostic Problems in Surgical Pathology 1998. Emory University School of Medicine and Department of
Pathology and Laboratory Medicine; Continuing Medical Education Program. Case Presentations. October 1,
1998.
Histologic diversity of carcinomas of the urinary bladder Clinical relevance and diagnostic implications.
Pathology Ground Rounds, Memorial Sloan-Kettering Cancer Center, October 29, 1998.
Contemporary classifications of renal and urinary bladder carcinomas. Department of Pathology, Hospital de
Oncologia del CMN, I.M.S.S. Mexico City, Mexico, November 20, 1998.
Flat lesions of the bladder: A historical perspective with discussion of the WHO/ISUP consensus classification
system. International Society of Urological Pathology, Comparison Meeting, U.S. and Canadian Academy of
Pathology meeting, March 20, 1999.
The WHO/ISUP classification of bladder neoplasia. Western New York Pathology Society, Buffalo NY, April 21,
1999.
Benign lesions of the genitourinary tract that mimic malignancy and vice versa. Slide session, Department of
Pathology, Roswell Park Cancer Center and University of Buffalo, Buffalo NY, April 21, 1999.
International Society of Urologic Pathologists Companion Meeting. Case presentation: Renal tumors. American
Urology Association Annual Meeting, Dallas TX, May 2, 1999.
Approach to the diagnosis of small acinar carcinoma of prostate and update on prostatic intraepithelial
neoplasia. Instituto de Patologia y Investigacion, Asuncion, Paraguay, May 13, 1999.
Contemporary classifications of bladder and renal neoplasms and topics in prostatic pathology. Sao Paulo State
Medical Society, Araraquara, Brazil, May 15, 1999.
Osler Institute of Pathology, Pathology Board Review Course - Genitourinary Pathology session, Tampa FL, June
1, 1999.
Contemporary classification of bladder and renal neoplasms. Joint Urology and Pathology Forum Pusan, Korea,
August 21, 1999.
Approach to the diagnosis of small acinar carcinoma of prostate. Tata Memorial Hospital and Cancer Center,
Mumbai, India, August 24, 1999.
Dagnostic Problems in Surgical Pathology. Emory University School of Medicine and Department of Pathology
and Laboratory Medicine; Continuing Medical Education Program. Case Presentations. September 18, 1999.
International Society of Urologic Pathologists Companion Meeting. Case Presentation: Kidney tumors.
American Urology Association Meeting, Atlanta, GA, April 30, 2000.
Classification of Renal Tumors. Mexican Congress of International Academy of Pathology, Torreon, Mexico, May
25, 2000.
Tumors of the penis. Mexican Congress of International Academy of Pathology, Torreon, Mexico, May 26, 2000.
Osler Institute of Pathology, Pathology Board Review Course Genitourinary Pathology Session. Tampa, FL, May
29, 2000.
Ault Renal Epithelial Neoplasms: From H and E to GenE the story unfolds Fifth Annual Matthews Lecture.
Department of Pathology and Laboratory Medicine, Atlanta, GA, October 4, 2000.
2000.
XXIII International Congress of the International Academy of Pathology. International Society of Urologic
Classification Companion Meeting. WHO Classification of Genitourinary Neoplasms. Nagoya, Japan, October 18,
2000.
XXIII International Congress of the International Academy of Pathology. Endocrine Pathology. Invited case
discussant Slide Seminar Small cell carcinoma of the urinary bladder. Nagoya, Japan, October 18, 2000.
XXIII International Congress of the International Academy of Pathology. Genitourinary Pathology. Invited case
discussant Slide Seminar Renal Angiomyolipoma expanding morphologic diversity. Nagoya, Japan, October
19, 2000.
WHO/ISUP Classification of Bladder Tumors. Pathology Grand Rounds. University of Massachusetts, Worcester,
MA, November 15, 2000.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
Renal Cell Carcinoma: From Morphology to the Genes. A journey begun at Henry Ford Health system.Henry
Ford Hospital Residents Day. Detroit, MI, February 23, 2001.
Differential Diagnosis of Adult Renal Epithelial Neoplasms with Granular Cytoplasm. Department of Pathology,
University of Texas MD Anderson Cancer Center, Houston, TX, April 27, 2001.
The new WHO/ISUP classification of bladder tumors. Houston Society of Pathologists. Houston, TX, April 28,
2001.
Grading of Prostate Cancer and Bladder Cancer. Mexican Congress of International Academy of Pathology,
Acapulco, Mexico, May 1-5, 2001.
29, 2001.
International Society of Urologic Pathologists Companion Meeting. Case Presentation: Kidney tumors.
American Urology Association Meeting, Anaheim, CA, June 2-7, 2001.
2001.
Pathology of Sex Cord-Stromal Tumors of the Testis. Allegheny General Hospital Pathology Grand Rounds,
Pittsburgh, PA, October 24, 2001.
Contemporary Classification of Adult Renal Epithelial Neoplasms. Pittsburgh Pathology Society, October 24,
2001.
Renal Cell Carcinoma from H&E to GenE. King Edward Memorial Hospital and G.S. Medical College, Mumbai,
India, November 26, 2001.
Histologic Grading of Genitourinary Malignancies. Twin Cities Pathology Society, Minneapolis, MN, January 29,
2002.
Renal Cell Carcinoma Classification: From Clinical to Pathologic to Molecularand the Journey Continues.
Pathology Grand Rounds, University of Minnesota, Minneapolis, MN, January 30, 2002.
Flat Intraepithelial Lesions of the Bladder: With Approach to the Diagnosis of Carcinoma in Situ. The University
of Texas Southwestern Medical Center continuing medical education course, Current Issues in Surgical
Pathology. Dallas, TX, May 18, 2002.
Histologic Variants of Bladder Cancer: Diagnostic and Prognostic Implications. The University of Texas
Southwestern Medical Center continuing medical education course, Current Issues in Surgical Pathology. Dallas,
TX, May 18, 2002.
29, 2002.
Gleason Grading System: Overview. University of Wales NHS Hospital. Cardiff, Wales, United Kingdom,
September 17, 2002.
Gleason Grading System: Diagnostic and Management Implications. Prostate 2002. Molecular Mechanisms as
Targets in Prostatic Disease. Liverpool, United Kingdom, September 19, 2002.
Renal Epithelial Neoplasms from the Morphology to the Genes. Yale University, Department of Pathology
Grand Rounds, Hartford, CT, October 17, 2002.
Pathology and Laboratory Medicine; Continuing Medical Education Program. Case Presentations. October 1920, 2002.
Gleason Grading of Prostate Cancer. Department of Pathology, University of Wisconsin School of Medicine,
November 2, 2002.
Contemporary Classification of Adult Renal Epithelial Neoplasms: from H&E to the GenE. Brigham and Womens
Hospital and Harvard Medical School, Boston, MA, February 28, 2003.
1998 WHO/ISUP Classification of Bladder Tumors. Histologic and cytologic characterization of human tumors:
new basic discoveries and frontiers in diagnosis. Ischia, Italy, May 1, 2003.
Prostate Cancer Grading. Gleason System. Histologic and cytologic characterization of human tumors: new basic
discoveries and frontiers in diagnosis. Ischia, Italy, May 1, 2003.
Stanford University and University of California at San Francisco Pathology Course: Differential diagnosis of
oxyphilic renal neoplasms and current status of classification of urothelial neoplasms. San Francisco, CA, May
2003.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
27, 2003.
Grading and Staging of Bladder Cancer. Controversies in Anatomic Pathology Workshop. American Society of
Clinical Pathologists Annual Meeting, New Orleans, LA, September 20, 2003.
Diagnostic Problems in Anatomic and Clinical Pathology. Emory University School of Medicine and Department
of Pathology and Laboratory Medicine; Continuing Medical Education Program. Case Presentations. October 1819, 2003.
Renal Epithelial Neoplasms-the New and Not So New. University of Texas Southwestern Medical School, Dallas,
TX, October 28, 2003.
Gleason Grading of Prostate Cancer. Criteria and pitfalls. Baylor University Medical Center, Dallas, TX, October
29, 2003.
Prostate Biopsy Interpretation and Gleason Grading. Hellenic Society of Pathology, Athens, Greece, December
22, 2003.
Kidney Tumor Classification. General Hospital of Athens, Athens, Greece, December 29, 2003.
Gleason Score and Other Prognostic Factors of Prostate Cancer in Needle Biopsies: Associacio Catalana
dAnatomia Patologia. Barcelona, Spain, January 22, 2004.
Selected Other Problematic Testicular and Paratesticular Lesions. Long Course. United States and Canadian
Academy of Pathology meeting. Vancouver, BC, March 2004.
Approach to the Diagnosis of Prostate Cancer. Institute of Pathology, University of Regensburg. Regensburg,
Germany, April 13-14, 2004.
Urologic Pathology for Urologists. University of Chicago. Continuing Medical Education Course. Chicago, IL, April
24, 2004.
The WHO (2004)/ISUP Classification of Bladder Neoplasia: Nomenclature, Criteria and Rationale for
Implementation. Hospital Pathology Associates, PA. St. Paul, MN, May 5, 2004.
Advances in Uropathology. Society of Pathological Anatomy and Histopathology, Polytechnic University of the
Marche Region. Ancona, Italy, June 18, 2004.
Prognostic Factors of Prostate Cancer in Needle Biopsy Specimens. WHO 2004 International Consultation on
Prediction of Patient Outcome in Prostate Cancer. Stockholm, Sweden, September 10, 2004.
Gleason Grading and Bladder Cancer Grading.13th Annual University of Iowa Anatomic Pathology Course. Cedar
Rapids, IA, September 26, 2004.
Gleason Grading, 1966-2004: Current Applications from What Have We Learned. Grand Rounds. Department of
Pathology, Mayo Clinic, Rochester, MN, November 4, 2004.
Gleason Grading, 1966-2004: Current Applications from What Have We Learned.Bell Symposium. University of
Minnesota, Minneapolis, MN, November 5, 2004.
WHO (2004)/ISUP Grading of Bladder Cancer. California Society of Pathologists, San Francisco, CA, December 1,
2004.
Prostate Cancer Reporting: Advances in Urology, 2004. Emory University, Department of Urology, Atlanta, GA,
December 4, 2004.
Genitourinary Pathology Slide Seminar: TNM Hospital and BYL Medical College, Mumbai, India, December 27,
2004.
WHO 2004 Classification of Renal Tumors: Update.Grand Rounds. Department of Pathology, Medical College of
Virginia, Richmond, VA, February 4, 2005.
Glandular Lesions of the Urinary Bladder.Companion Meeting.International Society of Urologic Pathologists.U.S.
and Canadian Academy of Pathology meeting, San Antonio, TX, February 26, 2005.
Alveolar Soft Part Sarcoma of the Urinary Bladder.Surgical Pathology Specialty Conference.U.S. and Canadian
Academy of Pathology meeting, San Antonio, TX, March 1, 2005.
Urologic Pathology for Urologists. University of Chicago. Continuing Medical Education Course. Chicago, IL, April
17, 2005.
WHO Classification of Bladder Tumors. Turkish Society of Pathology, Istanbul, Turkey, May 31, 2005.
Renal Tumors and Testicular Tumors Update. Aegean Pathology Society, Izmir, Turkey, June 3, 2005.
Gleason Grading of Prostate Cancer: Past, Present and Future..Grand Rounds. Department of Pathology and
Laboratory Medicine, University of Michigan, Ann Arbor, MI, July 16, 2005.
Reporting of Prostate Needle Biopsies: Oklahoma Pathology Society. October 15, 2005.
104. Histologic Variants of Bladder Cancer and Clinically Relevant Pathologic Features in Testicular tumors. University
of Toronto Continuing Medical Education. November 5, 2005.
105. Testicular Tumors: An Update. Tata Memorial Hospital, Mumbai, India. December 26, 2005.
106. WHO/ISUP Classification of Bladder Tumors and Adult Renal Tumors. University of Colorado Continuing Medical
Education program, Aspen, CO, February 17, 2006.
107. Grand Rounds, Cedars-Sinai Medical Center, Department of Pathology, Gleason Grading of Prostate Cancer: Past,
Present and Future. Los Angeles, CA, March 7, 2006.
108. Reporting of Cancer in Resections for Cancer. Key note speaker. American Joint Commission on Cancer Meeting.
George Washington University, Washington DC, April 7, 2006.
109. Molecular Gleason Grading. German Society of Pathology, Key note speaker for Congress, Berlin, Germany, April
20, 2006.
110. Urologic Pathology for Urologists. University of Chicago. Continuing Medical Education Course. Chicago, IL, April
27, 2006.
111. Grand Rounds, University of Pittsburgh. Adult Renal Epithelial Neoplasia: "A journey
from
traditional
histopathology to the molecular era", Pittsburgh, PA, June 21, 2006.
112. Evaluation of the Radical Prostatectomy Specimen. Cornell Urology Symposium, Weill Medical College of Cornell
University, New York, New York, August 5, 2006.
113. Gleason Grading of Prostate Cancer. Long Course. The Pathology of Prostate Cancer: From the Population Studies
to the Molecule. XXVI International Congress of the International Academy of Pathology, Montreal, Canada,
September 18, 2006.
114. Germ Cell Tumors of the Testis Pathological Features that Really Matter and 3 Hour Slide Seminar on Urologic
Lesions. Key note speaker. Pacific Northwest Society of Pathologists Fall Meeting, Victoria, British Columbia,
September 30-October 1, 2006.
115. The Role of Immunohistochemistry in Diagnostic Renal and Prostatic Pathology. Pacific Northwest Society of
Pathologists Fall Meeting, Victoria, British Columbia, September 30, 2006.
116. Grand Rounds, Cedars-Sinai Medical Center, Department of Hematology/Oncology. Histologic Classification of
Adult Renal Epithelial Neoplasms: Prognostic and Predictive Management Implications, Los Angeles, CA, October
24, 2006.
117. Grand Rounds, University of Southern California, Department of Pathology. Adult Renal Epithelial Neoplasia:
From the H and E to the GenE, Los Angeles, CA, Dec 5, 2006
118. Current Issues in Bladder and Prostate Pathology. American Hospital of Dubai. Dubai, UAE, December 21, 2006.
119. The Approach to the Diagnosis of Oxyphilic Renal Neoplasm and Histologic Variants of Bladder Cancer. Surgical
Pathology Update. Harvard Medical School Continuing Medical Education. Scottsdale, AZ, January 15-16, 2007.
120. Classification of Renal Tumors and Gleason Grading of Prostate Cancer. Los Angeles Society of Pathologists,
Spring Seminar, Los Angeles, CA, January 20, 2007.
121. Role of Immunohistochemistry in the Diagnosis of Urologic Malignancies. First International Course on Applied
immunohistochemistry and Molecular Morphology. Duck Key, FL, January 23, 2007.
122. Best Practices in Pathology. Role of Immunohistochemistry in the Diagnosis of Prostate Cancer. CAP Companion
Meeting of United States and Canadian Academy of Pathology meeting. San Diego, CA, March 24, 2007.
123. Urologic Pathology for Urologists. University of Chicago. Continuing Medical Education Course. Chicago, IL, May
4, 2007.
124. The WHO Classification of Renal Tumors and Testicular Tumors: Clinically Relevant Pathologic Features.
University of Cairo School of Medicine. Cairo, Egypt. June 17, 2007.
125. Evaluation of the Radical Prostatectomy Specimen. Cornell Urology Symposium, Weill Medical College of Cornell
University, New York, New York, July 2007.
126. Cancer Nomenclature: From Inception to Implementation. International Agency of Research on Cancer (IARC),
Lyon, France. September 25, 2007.
127. Update on Bladder Neoplasia. Las Vegas, NV, Quest Diagnostics, October 9, 2007.
128. Prostatic Carcinoma Diagnosis: An Approach. Walnut Creek, CA, Kaiser Permanente, October 24, 2007.
129. Prostate Cancer Needle Biopsy: An Update Sharp Medical Center, San Diego, January 2008.
130. Immunohistochemistry in the Diagnosis of Genitourinary Tract Malignancies Second International Course on
Applied immunohistochemistry and Molecular Morphology, Santa Barbara, CA, January 2008.
131. An Approach to the Diagnosis of Bladder Lesions in Biopsy and transurethral Resection Specimens. USCAP
Practical Pathology Seminars, Clearwater, FL, April 2008.
132. Urologic Pathology for Urologists. University of Chicago Continuing Medical Education Course. Chicago, IL,
May 2008.
133. WHOs WHO of Adult Renal Epithelial Neoplasia - Testicular Germ Cell Tumors: Features that really matter 27th
Annual Current Issues in Surgical Pathology Symposium, UT Southwestern Medical Center, Dallas, TX, May 2008.
134. Role of the Surgical Pathologist in the Era of Personalized Medicine. Tata Memorial Cancer Center, Mumbai,
India, June 2008.
135. Molecular Diagnosis: From Curative Medicine to Prospective Care. Presentation to the Cedars-Sinai Medical
Center Board of Directors and Life Trustees, Los Angeles, CA, June 2008.
136. Approach to the Diagnosis of Oncocytic Renal Tumors and Prostate Biopsy Reporting Update. Arizona Society
of Pathologists, Scottsdale, AZ, November 2008.
137. Tumors and Tumor-like lesions of the urinary bladder: California Society of Pathology, Los Angeles, CA,
December 2008.
138. Approach to the Diagnosis of Eosinophilic Tumors of the Kidney. PhenoPath Laboratories Educational Program
Presentation. Seattle, WA, February 2009.
139. Role of Immunohistochemistry in Urologic Pathology Selected Topics Pathology/IHC Conference
Presentation. PhenoPath Laboratories, Seattle, WA, February 2009.
140. Diagnostic pitfalls in pathologic staging of selected urologic malignancies. ISUP Companion Meeting. U.S. and
Canadian Academy of Pathology Meeting. Boston, MA, March 2009.
141. The role of the anatomic pathologist in the era of personalized medicine: potential impact of enabling
technologies that will empower our specialty. BioImagene Special Lecture. U.S. and Canadian Academy of
Pathology Meeting. Boston, MA, March 2009.
142. Specialty Conference. Genitourinary Pathology, Bone & Soft Tissue Mesenchymal Tumors and Their Mimics of
the Viscera. U.S. and Canadian Academy of Pathology Meeting. Boston, MA, March 2009.
143. The W.H.O. (2004)/I.S.U.P. Classification of Urothelial Tumors: Clinical Relevance and Application in Surgical
Pathology; Contemporary Issues in Prostatic Pathology. A Pattern-Based Approach with Integration of
Immunohistochemistry in the Diagnostic Algorithm; Handling and reporting of radical prostatectomy
specimens; Application of the Gleason Grading System in Needle Biopsies & Radical Prostatectomies.
Urologic Surgical Pathology Update Course. Udine, Italy, March 30-31, 2009.
144. Staging of Prostate Cancer: Update with new CAP Recommendatios and AJCC Staging System. Invited Lecturer,
Department of Pathology, University of Verona, Italy, April 2009.
145. Specialty Review in Urology. University of Chicago Continuing Medical Education Course. Chicago, IL, April 8,
2009.
146. Reshaping Tertiary Center Pathology and Lab Services for Personalized Medicine. Executive War College. New
Orleans, LA, April 29, 2009.
147. Immunohistochemical Panels in the Surgical Pathology of Renal and urothelial Tumors and Tumor-like
Conditions. The New York Pathological Society. Lennox Hill Hospital. New York, NY, May 2, 2009.
148. Bladder Pathology. Sixteenth Annual Seminar in Pathology. Pittsburgh, PA, May 3, 2009.
149. The role of the anatomic pathologist in the era of personalized medicine: potential impact of enabling
technologies that will empower our specialty. Hinduja Medical Center and Research Institute, Mumbai, India,
June 2009.
150. Risk Stratification in Genitourinary Neoplasia: Role of the Surgical Pathologist. Sixth Asia Pacific IAP Congress.
Kochi, Kerala, India, August 20, 2009.
151. Grand Rounds, Cedars-Sinai Medical Center, Urology Center of Excellence, Role of the Surgical Pathologist in the
Diagnosis, Prognosis and Prediction of Genitourinary Cancers. Los Angeles, CA, September 17, 2009.
152. The Who's W.H.O. in Renal Epithelial Tumors and Beyond and Role of Immunohistochemistry in Prostatic
Needle Biopsies. Keynote speaker, Annual Pathology Update, University of Toronto, Canada, November 20,
2009.
153. The Whos W.H.O. of Adults Renal Epithelial Neoplasms and Beyond: A discussion on the clinico-pathologic
significance of histologic subtypes of renal tumors in the 2004 WHO classification. Visiting Professor, University
of Erlangen, Germany, December 17-19, 2009.
154. Carcinoma In Situ and Early Invasion in Urinary Bladder Carcinoma: Diagnostic Criteria and Pitfalls. Kaiser
Foundation Hospital, Downey, CA January 5, 2010.
155. Specialty Conference. Genitourinary Pathology, Large Atypical Glandular Proliferations of the Prostate. U.S.
and Canadian Academy of Pathology Meeting. March 25, 2010.
156. Pathology for Urologists: Prostate Cancer Diagnosis and Gleason Grading; Bladder Cancer Grading and Staging.
Multiple Presentations at the Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India. January 12-13, 2010.
157. Histologic Variant of Bladder Cancer: Clinical, pathologic and prognostic significance. Department of Pathology
and Laboratory Medicine, Baylor College of Medicine, Houston, TX April 9, 2010.
158. Update on Renal Tumors. Houston Society of Clinical Pathology, Houston, TX. April 10, 2010.
2010.
160. The Role of the Surgical Pathologist in Evaluation and Management of Germ Cell Tumors of the Testis. Los
Angeles Society of Pathologists Scientific Program. Los Angeles, CA, February 2011.
161. International Consortium for Urologic Diseases European Association Of Urology International Consultation
On Bladder Cancer 2011: Consensus Guidelines By The Pathology Of Bladder Cancer Work Group. European
Association of Urology, Vienna, Austria, March 18, 2011.
2011.
163. Flat and Papillary Lesions of the Urinary Bladder: Diagnostic Criteria, Grading and Clinical Significance.
Geisinger Medical Center, Department of Pathology, Danville, PA, September 17, 2011.
164. Personalized Medicine: Empowering Light Microscopy & the Pathologist. 62nd Annual Puerto Rico Urological
Association, San Juan, Puerto Rico, September 30, 2011.
165. Personalized Medicine: Empowering Light Microscopy & the Pathologist. Grand Rounds, Kaiser Permanente
West Los Angeles, Department of Pathology, Los Angeles, CA, October 18, 2011.
166. Personalized Medicine: Empowering Light Microscopy & the Pathologist. PathVysions 2011 Conference, San
Diego, CA, October 31, 2011.
167. "The Whos WHO in Adult Renal Epithelial Tumors." Grand Rounds, University of California, Irvine Medical
Center, Irvine, CA, November 17, 2011.
168. "Pathologic Staging of Bladder Cancer and Problems in the Assessment of Urothelial Neoplasms in Bladder and
Transurethral Resections." Henry Ford, Detroit, MI, December 2, 2011.
169. "Flat and Papillary Lesions of the Urinary Bladder: Diagnostic Criteria, Grading and Clinical Significance."
University of Michigan Society of Pathologists, Detroit, MI, December 3, 2011.
170. "How I Diagnose Bladder Tumors: Practical Issues We all Struggle With and An Approach to Resolve Them."
University of Miami, Miami, FL, January 18, 2012.
171. "Approach to the Diagnosis of Adult Renal Tumors with Clear and Oxyphilic Cytoplasm and Those with Papillary
Architecture: A Clearer Picture Emerges." North Texas Society of Pathology, UT Southwestern Medical Center,
Dallas, TX, March 6, 2012.
172. "Classification of Renal Cell Carcinoma." University of Sienna, Italy, March 26, 2012.
173. "Role of the Surgical Pathologist in Personalized Medicine." University of Florence, Italy, March 29, 2012.
174. Contemporary issues in the Diagnosis of Prostate Cancer. Grand Rounds, Kaiser Permanente West Los Angeles,
Department of Pathology, Los Angeles, CA, April 3, 2012.
175. "Clear Cell-Papillary Renal Cell Carcinoma: Diagnosis Criteria and What Have We Learned in the 6 Years Since its
First Description". Los Angeles Society of Pathologists Scientific Program. Los Angeles, CA, April 10, 2012.
2012.
177. "Challenging Urologic, Endocrine and Head & Neck Lesions: Surgical Pathologic and Cytopathologic Diagnosis."
Scientific Symposium International Course. Maui, HI, July 2-5, 2012.
178. "Approach to the Diagnosis of Prostate Cancer in Needle Biopsies." Lecture on Prostate Pathology. Visiting
Professor, Beijing University School of Medicine. Beijing, China, August 8, 2012.
179. "The Perfect Surgical Pathology Report." Quality Assurance Symposium. International Academy of Pathology
2012 Congress, Cape Town, South Africa, October 1, 2012.
180. "Immunohistochemistry in Urologic Cancer." Immunohistochemistry Symposium. International Academy of
Pathology 2012 Congress, Cape Town, South Africa, October 1, 2012.
181. "Histologic Variants of Bladder Cancer." Uropathology Symposium - Bladder Cancer: An Update. International
Academy of Pathology 2012 Congress, Cape Town, South Africa, October 3, 2012.
182. "Translocation Associated Carcinoma of the Kidney." Open Slide Seminar. International Academy of Pathology
2012 Congress, Cape Town, South Africa, October 4, 2012.
183. "Selected Diagnostic Pitfalls and Contemporary Issues in Bladder Pathology." Featured Speaker, Oregon
Pathologists Association Annual Meeting, Portland, OR, December 1, 2012.
184. "Controversies and Hot Topics in Urological Pathology: A Dialogue with the Experts" Companion Meeting International Society of Urological Pathology, Baltimore, MD, March 2, 2013.
185. "2013 International Society of Urologic Pathology Conference on Best Practices Recommendations in the
Application of Immunohistochemistry in Diagnostic Urologic Pathology." Moderator, Baltimore, MD, March 3,
2013.
186. Genitourinary Pathology Proffered Papers Session, Moderator, U.S. and Canadian Academy of Pathology
Meeting. Baltimore, MD, March 5, 2013.
187. "Recently Described and Unusual Adult Renal Neoplasms." Grand Rounds, Kaiser Permanente West Los Angeles,
Department of Pathology, Los Angeles, CA, March 19, 2013.
188. "Risk Stratification in Prostate Cancer." Prostate Cancer Update, Cedars-Sinai Medical Center, Department of
Surgery, Los Angeles, CA, April 13, 2013.
189. "Update on Needle Biopsy Diagnosis of Prostate Cancer with Emphasis on Recently Described Morphologic
Patterns and Best Practices in Adjunctive Immunohistochemical Diagnosis." Grand Rounds, Veterans
Administration Medical Center, Westwood, CA, April 18, 2013.
2013.
191. "Dialogue in Uro-oncology: Uropathology Summit." Uropathology Course (5 lectures), Nadiad, India, May 31-June
1, 2013.
192. Basel Seminars in Pathology Postgraduate Course, Kidney and Urinary Tract (5 lectures & slides seminars), Guest
Lecturer, Basel, Switzerland, June 7, 2013.
193. "Neuroendocrine Prostate Cancer Pathology Current Concepts: A working classification of neuroendocrine
neoplasm of the prostate." Prostate Cancer Foundation Pathology Workshop for t-NEPC, Weill Cornell Medical
College, New York, NY, July 31, 2013.
194. "Approach to the diagnosis of adult renal tumors with clear and oxyphilic cytoplasm and those with papillary
architecture." Spain Hospital Clinic in Madrid, Hospital German Trias y Pujol in Barcelona & University Hospital
Virgen Macarena in Seville - Spain, August 2013.
195. "How I diagnose bladder tumors: Practical issues we all struggle with and an approach to resolve them." Spain
Hospital Clinic in Madrid, Hospital German Trias y Pujol in Barcelona & University Hospital Virgen Macarena in
Seville - Spain, August 2013.
196. "The Bridge from a "Population Based" to a "More Personalized" Approach." AJCC General Board Meeting
Lecturer, AJCC Annual Meeting, Chicago, IL, September 12, 2013.
197. "The Wide Histologic Spectrum of Bladder Cancer: Clinico-pathologic Implications of its Appreciation." Genital
Tract Pathology, The Royal College of Pathologists, London, UK, October 14, 2013.
198. "Challenging Urologic Pathology cases from which I have learned tremendously." Genital Tract Pathology, The
Royal College of Pathologists, London, UK, October 15, 2013.
199. "Nomenclature of Human Neoplasia A 2013 approach. Integrating extent of disease (TNM stage), histological
classification and molecular markers to enable precision and targeted oncology." Plenary Session, Indian Cancer
Congress, New Delhi, India, November 23, 2013.
200. "Role of immunohistochemistry in the diagnosis of genitourinary tract pathology." Educational Symposium,
Indian Cancer Congress, New Delhi, India, November 23, 2013.
201. "The Critical Role of the Pathologist in the Multidisciplinary Team Management Approach to Prostate Cancer."
Symposium on Pathology of Prostate Cancer, Hinduja Hospital, Mumbai, India, December 27, 2013.
202. "ISUP Vancouver Classification of Renal Neoplasia." Anatomic Pathology Didactics Lecture, Department of
Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, January 13, 2014.
203. The Spectrum of Neuroendocrine Differentiation in Prostate Cancer: Proposed Unifying Terminology for
Histologic Classification in Light of Recent Molecular and Treatment Advances. Grand Rounds, MD Anderson
Cancer Center, Houston, TX, January 17, 2014.
204. "Best Practices in the Application of Immunohistochemistry to Diagnostic Urologic Pathology: Lessons from uses
and abuses." Vernie A. Stembridge, MD Lectureship, 93rd Annual Meeting of the Texas Society of Pathologists,
Houston, TX, January 17, 2014.
205. "Best Practices in the Application of IHC to Diagnostic Urologic Pathology: Lessons from Uses and Abuses."
Division of Pathological Anatomy, University of Florence, Italy, January 22, 2014.
206. "ISUP Vancouver Classification of Renal Neoplasia", "Stromal Neoplasms of the Kidney", "Germ Cell Tumors of
the Testis" and "Prostate Neuroendocrine Tumors." Faculty Lecturer, 2nd Milan Conference on Urologic Tumors,
Milan, Italy, January 23-24, 2014.
207. Specialty Review in Urology. University of Chicago Continuing Medical Education Course. Chicago, IL, May 1,
2014.
208. "Epithelioid Angiomyolipoma." Faculty Lecturer, 3rd Urogenital Pathology Meeting, Mikulov, Czech Republic, June
14, 2014.
209. "Histologic classification of adult renal epithelial tumours", "WHO/ISUP grading and diagnosis of urothelial
neoplasms" and "Selected problems in the diagnosis of renal tumours with focus on issues related to
immunohistochemistry and staging." Faculty Lecturer, London Uropathology Conference 2014, London, UK, June
18-19, 2014.
210. "Subtle patterns and common pitfalls in the diagnosis of prostate cancer", "Pseudoneoplastic lesions of the
urinary bladder: diagnostic criteria and implications of misdiagnosis", "Challenging tumors of the urinary bladder:
diagnostic, prognostic and therapeutic significance of appropriate classification", "The most common clinically
significant misdiagnoses in renal neoplasia and how to avoid them" and "Pitfalls in the application of
immunohistochemistry as a diagnostic tool in urologic pathology". Faculty Lecturer, Scientific Symposiums
International Surgical Pathology of Difficult to Diagnose Genitourinary, Breast, Pancreatic and Gastrointestinal
Lesions Conference, Maui, HI, July 9-10, 2014.
211. "The Bridge from a "Population Based" to a More "Personalized" Approach." AJCC General Board Meeting
Lecturer, AJCC Annual Meeting, Chicago, IL, September 11, 2014.
212. Debate-Prostate FT: Pathologic Basis: "It's Building Up." Faculty Lecturer, 7th Annual International Symposium on
Focal Therapy and Imaging in Prostate & Kidney Cancer. Pasadena, CA, Aug 23, 2014.
213. "Use of Immunohistochemistry in Bladder Pathology - An Update from the ISUP Consensus Meeting",
International Association of Pathologists 2014 Meeting, Bangkok, Thailand, Oct 5-10, 2014.
214. "Molecular & Genetic Aspects." Small Renal Mass 360o: An AUA Surgical Summit. American Urological
Association Consensus Conference on the Small Renal Mass, University of Southern California, Los Angeles, CA,
Oct 23, 2014.
215. "Update on Grading of Urologic Malignancies." Department of Pathology, William Beaumont Hospital, Royal Oak,
MI, Nov 26, 2014.
216. "Evolving cancer nomenclature, molecular diagnosis and staging" and "Update on diagnostic issues in bladder
cancer." Nagalotimath Memorial Oration and Invited Lecturer, 20th AIPNA-ICP International CME 2015,
Hyderabad, India, Jan 30, 2015.
217. "Gleason grading: where we are and where we are going", "Renal cancer classification-recommendations and
newer entities with importance of IHC and molecular work up", "Bladder tumor-grading, staging and issues in
pathology reporting" and "Nomenclature of human neoplasia - A 2015 approach. Integrating extent of disease
(TNM stage), histological classification and molecular markers to enable precision and targeted oncology."
Featured Speaker, CME on Uro-Oncopathology, Tata Memorial Hospital, Mumbai, India, Feb 3, 2015.
218. Lectures on Kidney, Bladder & Testis Tumors (5 Lectures). Faculty, International CME in Pathology Histopathology & Cytopathology, Goa, India, Feb 5-7, 2015.
219. "The Spectrum of neuroendocrine differentiation in prostate cancer: proposed unifying terminology for
histologic classification in light of recent molecular and treatment advances", "Stromal Neoplasms of the Kidney:
An Update" and "Papillary Lesions of the Urinary Bladder: Problems Associated with Recognition and Grading of
Exophytic, Endophytic and Treated Lesions." Faculty, XVIII Pathology Meeting of the EPOAHT Uropathology
Course, Sao Paulo, Brazil, Mar 5-7, 2015.
220. "High-grade distal nephron-related carcinomas of the kidney: emerging spectrum based on evolving clinicopathologic experience". Faculty, Symposium on recent advances in Pathology & Genetics of Urologic Tumors,
Zurich, Switzerland, Mar 14, 2015.
221. "Interesting Surgical Pathology Cases." Surgical Pathology Evening Specialty Conference Panelist, U.S. and
Canadian Academy of Pathology Meeting, Boston, MA, March 24, 2015.
222. "Grading and staging of bladder cancer and conventional prognostic factors essential for reporting" and
"Histologic variants of bladder cancer, diagnostic, prognostic and therapeutic significance." Faculty, Urinary tract
neoplasms: how to make a correct and clinically useful histological & cytological report, Catholic University,
Agostino Gemelli Hospital, Rome, Italy, Apr 24, 2015.
223. "Renal cell carcinoma after Vancouver", "Variants of urothelial carcinoma", "Role of IHC & molecular pathology
in UC diagnosis & prognosis", "Gleason grading system after the ISUP Consensus Conf" and "Germ Cell Tumors".
Faculty, Milan Uropathology Course: morphologic & molecular backgrounds for personalized therapies in
genitourinary cancers, Milan, Italy, Apr 27-28, 2015.
WORKSHOPS, COURSES AND SLIDE SEMINARS:

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
Genitourinary Pathology Course, American Urology Association - Instructor, February 1990, 1991, 1992.
Ro JY, Ayala AG, Amin MB. Workshop: "Testicular Tumors. A Practical Approach To Assessing Clinically Relevant
Pathologic Findings. American Society of Clinical Pathologists Spring Meeting, April 2, 1994.
Amin MB. Workshop "Surgical Pathology of the Prostate Gland: An Update and Review. Michigan Society of
Pathologists, Lansing Michigan, September 10, 1994.
Ayala AG, Srigley J, Amin MB, Ro JY, Han WS. Slide Seminar: "Pathology of the Male Genital System. 20th
International Congress of the International Academy of Pathology and the 11th World Congress of Academic and
Environmental Pathology, Hong Kong, October 13, 1994.
Amin MB, Ro JY, Ayala AG. Short Course: "Testicular Tumors. 20th International Congress of the International
Academy of Pathology and the 11th World Congress of Academic and Environmental Pathology, Hong Kong,
October 14, 1994.
Ro JY, Ayala AG, Amin MB. Workshop: "Testicular tumors. A Practical Approach To Assessing Clinically Relevant
Pathologic Findings. American Society of Clinical Pathologists Spring Meeting, Orlando, FL, April 25, 1995.
Ro JY, Ayala AG, Amin MB. Workshop: "Testicular tumors. A Practical Approach To Assessing Clinically Relevant
Pathologic Findings. American Society of Clinical Pathologists. Weekends in Pathology: Anatomic Pathology
Seminars, New York, NY, June 23, 1995.
Amin MB, Jones EC. Workshop: Common problems and Controversial Issues in Urologic pathology. American
Society of Clinical Pathologists, Fall Meeting, New Orleans, LA, September 20, 1995.
Ro JY, Amin MB, Cohen RJ. Workshop. Surgical Pathology of Prostate Gland: World Congress of Anatomic and
Clinical Pathologists, Annual Scientific Meeting of the Royal College of Pathologists of Australia and New Zealand
Society of Pathologists, Auckland, New Zealand, October 13, 1995.
Amin MB, Jones EC, Srigley JR. Short Course: Recently Described Topics in Urologic Pathology. U.S. and
Canadian Academy of Pathology, Washington, DC, March 28, 1996.
Ro JY, Ayala AG, Amin MB. Workshop: "Testicular Tumors. A Practical Approach To Assessing Clinically Relevant
Pathologic Findings. American Society of Clinical Pathologists Spring Meeting, Boston, MA, April 23, 1996.
Amin MB, Jones EC. Workshop: Common Problems and Controversial Issues in Urologic Pathology. American
Society of Clinical Pathologists, Weekends in Pathology: Anatomic Pathology Seminars. Washington DC, June 29,
1996.
Ayala AG, Amin MB, Grignon D, Srigley J, Ro JY. Slide Seminar. Controversies and Diagnostic Dilemmas in
Tumors and Pseudo Tumorous Lesions of the Male Genitourinary Tract. XXI International Congress of The
International Academy of Pathology & 12th World Congress of Academic and Environmental Pathology,
Budapest, Hungary, October 25, 1996.
Ro JY, Amin MB, Mickuz G, Ayala AG. Short Course Therapy Oriented Approach to Pathologic Features of
Testicular Tumors. XXI International Congress of the International Academy of Pathology & 12th World
Congress of Academic and Environmental Pathology, Budapest, Hungary, October 22,1996.
Ro JY, Ayala AG, Amin MB. Workshop: "Testicular tumors. A Practical Approach to Assessing Clinically Relevant
Pathologic Findings. American Society of Clinical Pathologists Spring Meeting, Chicago, IL, April 6, 1997.
Society of Clinical Pathologists Spring Meeting, Chicago, IL, April 7, 1997.
Young RH, Scully RE, Amin MB, Bostwick DG, Eble JN. 3-Day Weekend Course: Urologic Surgical Pathology for
the Practicing Pathologist. Harvard Medical School, Dept. of Continuing Education, May 16-18, Boston, MA,
1997.
Canadian Academy of Pathology, Boston, MA, March 6, 1998.
Pathologic Findings. American Society of Clinical Pathologists Spring Meeting, Los Angeles, CA, April 4, 1998.
Amin MB. Slide Seminar. "Topics in Urologic Pathology. Monterrey N.L. Association of Pathologists.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
the Practicing Pathologist. Harvard Medical School, Dept. of Continuing Education, Boston, MA, May 1-3, 1998.
Amin MB. Topics in genitourinary pathology; Seminar. Utah Society of Pathologists. Salt Lake City, UT November 14, 1998.
Amin MB. Slide Seminar. XIV Course of Surgical Urinary, Gynecology and Breast Pathology. Department of
Oncology, Hospital of National Medical Center of Social Security, Mexico City, Mexico, November 21, 1998.
the Practicing Pathologist. Harvard Medical School, Dept. of Continuing Education, San Diego, CA, January 1618,1999.
Canadian Academy of Pathology. San Francisco, CA. March 16, 1999.
Pathologic Findings. American Society of Clinical Pathologists Spring Meeting, Orlando, FL, April 12, 1999.
Amin MB. Microscopic Tutorial: Pathology of Urinary Bladder and Prostate. American Society of Clinical
Pathologist Spring Meeting, Orlando, FL, April 13, 1999.
the Practicing Pathologist. Harvard Medical School, Department of Continuing Education, Boston MA, May 7-9,
1999.
Pathologic Findings. American Society of Clinical Pathologists Spring Meeting, New Orleans, LA, September 27,
1999.
Society of Clinical Pathologists Spring Meeting, New Orleans, LA, September 28, 1999.
Amin MB. Microscopic Tutorial: Pathology of Urinary Bladder and Prostate. American Society of Clinical
Pathologist Spring Meeting, New Orleans, LA, September 29, 1999.
Amin MB, Eble JN. Workshop. Tumors of the Kidney and Urinary Bladder. Thirtieth Annual Seminar of the
Nassau and Suffolk County Societies of Pathologists. New York, NY, October 2, 1999.
Amin MB. Transurethral Resectate Pathology of the Urinary Bladder and Prostate A Practical Approach for the
Practicing Pathologist. Atlanta Society of Pathologists. Atlanta, GA, November 14, 1999.
Canadian Academy of Pathology. New Orleans, LA, March 31, 2000.
Amin MB, Reuter VE. Postgraduate course: Contemporary Classifications of Neoplasms of the Genitourinary
Tract: A Comprehensive Review of Clinically Significant Features. American Urology Association Annual
Meeting; Atlanta, GA, May 3, 2000.
Srigley JR, Amin MB, Humphrey PA. Contemporary Issues in Prostatic and Urinary Tract Pathology: An
interactive seminar, U.S. and Canadian Academy of Pathology Meeting, Atlanta, GA, March 8, 2001.
Young RH, Scully RE, Amin MB, Epstein JI, Eble JN. 3-Day Weekend Course: Urologic Surgical Pathology for the
Practicing Pathologist. Sanibel Island, FL, March 24-26, 2001.
Amin MB, Reuter VE. Postgraduate Course: Contemporary Classifications of Neoplasms of the Genitourinary
Meeting; Los Angeles, CA, June 2-7, 2001.
Young RH, Amin MB, Epstein JI, Eble JN. 3-Day Weekend Course: Urologic Surgical Pathology for the Practicing
Pathologist. Scottsdale, AZ, January 19-21, 2002.
interactive seminar, U.S. and Canadian Academy of Pathology Meeting; Chicago, IL, February 28, 2002.
Epstein JI, Amin MB. Genitourinary Pathology (Urinary Bladder). Long Course: Michigan Society of Pathologists;
Livonia, MI, April 27, 2002.
Meeting, Orlando, FL, May 29, 2002.
Weiss MA, Grignon DG, Srigley JR, Amin MB. 3-day course: 22nd Annual American Urology Association Course.
Genitourinary Pathology and Radiology. Dallas, TX, June 19-23, 2002.
Amin MB. 3-hour workshop: Bladder biopsy interpretation. Wisconsin Society of Pathologists; Waukesha, WI,
November 2, 2002.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
Amin MB, Eble JE, Srigley JR, Grignon DG. 3-day course: Genitourinary Pathology. Tata Memorial Hospital
National Pathology Course. Mumbai, India, January 10-12, 2003.
interactive seminar, U.S. and Canadian Academy of Pathology meeting; Washington DC, March 2003.
Pathologist. Costa Mesa, CA, April 4-7, 2003.
Meeting; Chicago, IL, April 27, 2003.
Weiss MA, Grignon DG, Srigley JR, Amin MB. 3-day course: 23rd Annual American Urology Association Course.
Genitourinary Pathology and Radiology. Chicago, IL, August 6-8, 2003.
Amin MB, Humphrey PA, Oliva E, Srigley JR. 3-day course: Genitourinary Pathology. Hospital del Mar, Barcelona,
Spain, January 21-23, 2004.
interactive seminar. U.S. and Canadian Academy of Pathology meeting; Vancouver, BC, March 2004.
Srigley JR, Weiss MA, Grignon DG, Amin MB. 3-day course: 24th Annual American Urology Association Course.
Genitourinary Pathology and Radiology. Chicago, IL, July 30-August 2, 2004.
Amin MB. 2-day workshop: Update on Surgical Pathology of the Prostate Gland and Urinary Bladder. Sardinia,
Italy, September 2-3, 2004.
Amin MB. Bladder Biopsy Interpretation.Short Course. College of American Pathologists Annual Meeting (CAP
'04); Phoenix, AZ, September 20, 2004.
Young RH, Amin MB, Srigley JR, Eble JN. 3-Day Weekend Course: Urologic Surgical Pathology for the Practicing
Pathologist. Sanibel Island, FL, October 31 - November 1, 2004.
Amin MB.Minneapolis Society of Pathologists.1-Day Slide Seminar. Minneapolis, MN, November 6, 2004.
Amin MB, McKenney JK.An Approach to the Diagnosis of Bladder Lesions in Biopsy and Transurethral Resection
Specimens.Short Course.U.S. and Canadian Academy of Pathology meeting. San Antonio, TX, March 2, 2005.
'05); Chicago, September 2005.
Amin MB. Approach to the Diagnosis of Adult Renal Epithelial Tumors including Renal Biopsy specimens. (CAP
'05); Chicago, September 2005.
Amin MB, McKenney JK. An Approach to the Diagnosis of Bladder Lesions in Biopsy and Transurethral Resection
Specimens.Short Course.U.S. and Canadian Academy of Pathology meeting. Atlanta, GA. March 2006.
Pathologist. Boston MA. May 2006.
'06); San Diego, September 2006.
Amin MB. Approach to the Diagnosis of Adult Renal Epithelial Tumors including Renal Core Biopsy specimens
performed for mass lesions (CAP '06); San Diego, September 2006.
Amin MB. 1st Annual Whats New in Anatomic and Laboratory Medicine Symposium, Contemporary Gleason
Grading and Reporting of Prostate Cancer in Needle Biopsies. Cedars-Sinai Medical Center, Department of
Pathology & Laboratory Medicine, Los Angeles, CA, February 2007.
Amin MB. 1st Annual Whats New in Anatomic and Laboratory Medicine Symposium, Problems in the
Diagnosis of Prostate Biopsies Workshop Cedars-Sinai Medical Center, Department of Pathology & Laboratory
Medicine, Los Angeles, CA, February 2007.
Amin MB, McKenney JK. Short Course: An Approach to the Diagnosis of Bladder Lesions in Biopsy and
Transurethral Resection Specimens. U.S. and Canadian Academy of Pathology meeting. San Diego, CA, March
2007.
Young RH, Amin MB, Humphrey PA, Eble JN. 3-Day Weekend Course: Urologic Surgical Pathology for the
Practicing Pathologist. Fort Meyers, FL, May 2007.
Amin MB, Montgomery E, Folpe A, Ronnett B, Wenig B. Day Long Course: Gray zone lesions and precursor
lesions in diagnositc surgical pathology: Approach with integration of molecular techniques. (CAP 07): Chicago,
IL, September 2007.
Amin MB. Approach to the Diagnosis of Adult Renal Epithelial Tumors including Renal Core Biopsy specimens
performed for mass lesions (CAP 07): Chicago, IL, September 2007.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
Amin MB. 2ND Annual Whats New in Anatomic and Laboratory Medicine Symposium, Histologic Variants of
Bladder Cancer: Diagnostic, Prognostic and Therapeutic Ramifications. Cedars-Sinai Medical Center,
Department of Pathology & Laboratory Medicine, Los Angeles, CA, February 2008.
Amin MB. Long Course: Histologic Variants of Bladder Cancer: Diagnostic, Therapeutic and Prognostic
Implications. United States and Canadian Academy of Pathology meeting, Denver, CO, March 2008.
Amin MB, McKenney JK. An Approach to the Diagnosis of Bladder Lesions in Biopsy and Transurethral Resection
Specimens. Short Course.U.S. and Canadian Academy of Pathology meeting. Denver, CO, March 2008.
Practicing Pathologist. Harvard Medical School, Massachusetts General Hospital Annual CME Course. Tucson, AZ,
May 2008.
Amin MB. Short Course: Gray zone lesions and precursor lesions of the genitourinary tract: Approach with
integration of molecular techniques. (CAP 08): Phoenix, AZ, September 2008.
Hansel DE, Amin MB. Short Course: Histopathologic Considerations Integrated with Contemporary Diagnostic
Modalities in Bladder Neoplasia. U.S. and Canadian Academy of Pathology Meeting. Boston, MA, March 2009.
Practicing Pathologist. Harvard Medical School, Massachusetts General Hospital Annual CME Course. Newport
Beach, CA, April 2009.
Amin MB. Short Course: Gray areas in contemporary urologic surgical pathology: Incipient neoploasia and
tumors of borderline malignancy an integrative morphological, immunohistochemical and molecular approach.
(CAP 09): Washington, DC, October 2009.
Amin MB. Video Microscopy Course: Histologic spectrum of adult renal epithelial tumors. (CAP09): Washginton,
DC, October 2009.
Modalities in Bladder Neoplasia. U.S. and Canadian Academy of Pathology Meeting. Washington, DC, March
2010.
Young RH, Amin MB, Humphrey PA, Eble JN. 4-Day Course: Urologic Surgical Pathology for the Practicing
Pathologist. Harvard Medical School, Massachusetts General Hospital Annual CME Course. Naples, FL, April 2010.
Amin MB. Whats New in Anatomic and Laboratory Medicine Symposium, Approach to the Diagnosis of
Atypical Large Glandular Proliferation In Prostatic Needle Biopsies. Cedars-Sinai Medical Center, Department of
Pathology & Laboratory Medicine, Los Angeles, CA, May 1, 2010.
Amin MB. Short Course: Gray Areas in Contemporary Urologic Surgical Pathology: Incipient Neoplasia and
Tumors of Borderline MalignancyAn Integrative Morphological, Immunohistochemical, and Molecular
Approach. (CAP10): Chicago, IL, September 2010.
Amin MB. Video Microscopy Course: Histologic spectrum of adult renal epithelial tumors. (CAP10): Chicago, IL,
September 2010.
Amin MB. Course: Update In Genitourinary Pathology: Renal Cell Carcinoma - Update In Classification with
Emphasis On Recently Described Subtypes and Problems Associated with Staging. 63rd Annual Convention,
California Society of Pathologists. San Francisco, CA, December 2010.
Amin MB. All-day Seminar: 67th Annual Seminar, San Antonio Society of Pathologists. Urologic Pathology Update:
Practical Issues in the Pathology of Kidney, Bladder, Testis and Prostate Tumor & Tumor-Like Lesions. San
Antonio, TX, January 2011.
Amin MB. Retreat. Department of Pathology & Lab Medicine 5 Year Strategic Planning Retreat. Newport Coast,
CA, January 2011.
Amin MB. Short Course: IHC Work-up in prostate pathology and IHC work-up in (non-prostate) GU pathology.
Fifth Annual Course on Applied Immunohistochemistry & Molecular Pathology. Coral Gables, FL, February 2011.
Modalities in Bladder Neoplasia. U.S. and Canadian Academy of Pathology Meeting. San Antonio, TX, March
2011.
Amin MB. Whats New in Anatomic and Laboratory Medicine Symposium, Renal Tumors with Clear and
Papilary Cytoplasm: A Clearer Picture Emerges. Cedars-Sinai Medical Center, Department of Pathology &
Laboratory Medicine, Los Angeles, CA, April 1, 2011.
Amin MB. Pratt-Thomas Symposium in Surgical Pathology. Medical University of South Carolina, Department of
Pathology & Lab Medicine, Pathology Spring Seminar. Charleston, SC, April 13, 2011.
91.
Young RH, Amin MB, Humphrey PA, Eble JN. 4-Day Course: Urologic Surgical Pathology for the Practicing
Pathologist. Harvard Medical School, Massachusetts General Hospital Annual CME Course. Boston, MA, May
2011.
92. Amin MB. Approach to the Diagnosis of Adult Renal Tumors with Clear and Oxyphilic Cytoplasm and Those with
Papillary Architecture: A Clearer Picture Emerges, Lumps and Bumps of the Urinary Bladder: An Update of
Significant Diagnostic Pitfalls of Urothelial Neoplasia, and Role of the Surgical Pathologist in the Diagnosis and
Management of Germ Cell Tumors of the Testis. USCAP Diagnostic Pathology Summer Course. Jackson Hole,
WY, July 2011.
93. Amin MB. Short Course. An Algorithmic Approach to the Diagnosis of Tumors and Tumor-Like Lesions of the
Urinary Bladder. U.S. and Canadian Academy of Pathology Meeting. Vancouver, BC, Canada, March 21, 2012.
94. Hansel DE, Amin MB. Short Course: Histopathologic Considerations Integrated with Contemporary Diagnostic
Modalities in Bladder Neoplasia. Practical Pathology Seminars. U.S. and Canadian Academy of Pathology
Meeting. Boston, MA, May 2012.
95. Amin MB, Hansel DE. Short Course: An Algorithmic Approach to the Diagnosis of Tumors and Tumor-Like Lesions
of the Urinary Bladder. U.S. and Canadian Academy of Pathology Meeting. Baltimore, MD, March 7, 2013.
96. Gill, I, Villers A, Ahmed H, Ukimura O, Amin MB. "Focal Therapy: New Approaches in the Management of Early
Prostate Cancer." Faculty, AUA Annual Meeting, San Diego, CA, May 6, 2013.
97. Amin MB, Hansel DE. Short Course: An Algorithmic Approach to the Diagnosis of Tumors and Tumor-Like Lesions
of the Urinary Bladder. U.S. and Canadian Academy of Pathology Meeting. San Diego, CA, March 7, 2014.
98. Amin MB. Slide Seminars: "Variants of bladder cancer and common pitfalls", "Grading and staging of bladder
tumours" and "Uropathological spindle cell lesions". Faculty, London Uropathology Conference 2014, London,
UK, June 18-19, 2014.
99. Amin MB. Slide Seminar on Bladder. XVIII Pathology Meeting of the EPOAHT Uropathology Course, Sao Paulo,
Brazil, Mar 5-7, 2015.
100. Amin MB, Hansel DE, Hirsch M. Short Course: Expanding the Differential Diagnosis in Urologic Pathology:
Controversies and New Entities. U.S. and Canadian Academy of Pathology Meeting, Boston, MA, March 25, 2015.
101. Amin MB, Martignoni G. Slide Seminar on Renal Tumors. Milan Uropathology Course: morphologic & molecular
backgrounds for personalized therapies in genitourinary cancers, Milan, Italy, Apr 27, 2015.
BIBLIOGRAPHY:
RESEARCH PAPERS (PEER-REVIEWED)
A.
Reseach Papers (published)

1.
Mittal BV, Amin MB, Kinare SG: Spectrum of histological lesions in 185 consecutive prostatic
specimens. J Postgrad Med 1989;35:157-161.
2.
Amin MB, Abrash MP, Mezger E, Sekerak G: Systemic dissemination of pneumocystis carinii in a
patient with Acquired Immune Deficiency Syndrome (AIDS). Henry Ford Hospital Medical Journal
1990;38:68-71.
3.
Amin MB, Mezger E, Zarbo RJ: Detection of pneumocystis carinii: Comparative study of monoclonal
antibody versus silver staining. Am J Clin Pathol 1992;98:13-18.
4.
Amin MB, Maeda K, Carey J, Babu VR, Raman BKS: Megakaryoblastic termination of myeloproliferative
disorders. Henry Ford Medical Journal 1992;40:122-126.
5.
Ma CK, Amin MB, Kintinar E, Linden MD, Zarbo RJ: Immunohistologic characterization of
gastrointestinal stromal tumors. Mod Pathol 1993;6:139-144.
6.
Bostwick D, Amin MB, Dundore P, Marsh W, Schultz DS: Architectural spectrum of high grade prostatic
intraepithelial neoplasia. Human Pathol 1993;24:298-310.
7.
Amin MB, Gottlieb C, Fitzmaurice M, Gaba AR, Lee, MW, Zarbo RJ: Fine needle aspiration cytology of
myofibroblastoma of breast: a case report on the immunohistochemical findings and ultrastructural
findings. Am J Clin Pathol 1993; 99:593-597.
8.
Amin MB, Ro, JY, Ayala, AG: Ideas in pathology. Precursor lesions of prostatic adenocarcinoma: fact
or fancy? Mod Pathol 1993;6:476-483.
9.
Schultz DS, Amin MB, Zarbo RJ: Type IV collagen basement membrane component of prostatic
intraepithelial neoplasia and associated carcinoma. Applied Immunohistochem 1993;1:123-126.
10.
Amin MB, Schultz DS, Zarbo RJ, Kubus J, Shaheen C: Computerized static DNA ploidy analysis of
prostate intraepithelial neoplasia. Arch Pathol Lab Med 1993; 117:794-798.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
Zavala-Pompa A, Ro JY, El-Naggar A, Amin MB, Ordonez NG, Pierce PD, Ayala AG: Primary carcinoid
tumor of testis. Immunohistochemical, ultrastructural and DNA flow cytometric studies of three cases
with a review of the literature. Cancer 1993; 72:1726-1732.
Amin MB, Ma CK, Linden MD, Kubus J, Zarbo RJ: Prognostic value of PCNA index in gastric stromal
tumors: correlation with mitotic count and outcome. Am J Clin Pathol 1993;100:428-432.
Jimenez-Quintero L, Ro JY, Zavala-Pompa A, Amin MB, Ordonez NG, Ayala AG: Granulosa cell tumor of
the adult testis: A clinicopathologic study of seven cases and a review of literature. Human Pathol
1993;24:1120-1126.
Amin MB, Ro JY, Ayala AG: The clinical relevance of histologic variants of prostate cancer. The Cancer
Bulletin 1993;45:403-410.
Raslan W, Ro JY, Ordonez NG, Amin MB, Ayala AG: Carcinoid tumor of the kidney. An
immunohistochemical and ultrastructural study of five patients. Cancer 1993; 72:2660-2666.
Ro JY, El-Naggar A, Amin MB, Ordonez NG, Sahin AS, Ayala AG: Pseudosarcomatous fibromyxoid tumor
of bladder and prostate: An immunohistochemical and flow cytometric analysis of 9 cases. Human
Pathol 1993; 24:1203-1210.
Amin MB, Schultz DS, Zarbo RJ: Analysis of cribriform morphology in prostate neoplasia using antibody
to high molecular weight cytokeratins. Arch Pathol Lab Med 1994;118:260-264.
Amin MB, Ro JY, Lee KM, Ordonez NG, Dinney CP, Gulley ML, Ayala AG: Lymphoepithelioma-like
carcinoma of the urinary bladder. Am J Surg Pathol 1994; 18:466-473.
Malpica A, Ro JY, Troncoso P, Ordonez NG, Amin MB, Ayala AG: Nephrogenic adenoma of prostatic
urethra involving the prostate gland. Human Pathol 1994;25:390-395.
Zavala-Pompa A, Ro JY, El-Naggar A, Amin MB, Ordonez NG, Ayala AG: Tubular seminoma:
Immunohistochemical and DNA flow cytometric study of four cases: Am J Clin Pathol 1994;102:397401.
Amin MB, Ro JY, El-Sharkawy T, Lee KM, Troncoso P, Silva EG, Ordonez NG, Ayala AG: Micropapillary
variant of transitional cell carcinoma of the urinary bladder. A histologic pattern resembling ovarian
papillary serous carcinoma. Am J Surg Pathol 1994;18:1224-1232.
de Peralta MN, Amin MB, Schultz DS, Keoleian C, Kubus J, Linden MD: Papillary renal cell carcinoma: A
Clinico-pathologic study of 28 cases with assessment of proliferative activity using PCNA and MIB-1 (Ki67). Appl Immunohistochemistry 1994;2:241-247.
Amin MB, Ro JY, Ayala AG: Prostatic intraepithelial neoplasia - its relationship to prostate
adenocarcinoma. In: Pathology Annual 1994 (Part II). Editors - Rosen PP, Fechner RE. Appleton Lange.
Norfolk, CT, pages 1-30.
Zbar B, Glenn G, Lubensky J, Choyke P, Magnusson G, Bergerheim U, Pettersson S, Amin MB, Hurley K,
Linehan WM: Hereditary papillary renal cell carcinoma: Clinical studies in 10 families. J Urol
1995;153:907-912.
Shin H, Ro JY, Sella A, Amin MB, Ordonez NG, Ayala, AG: Histologic characteristics of residual renal cell
carcinoma following interferon-alpha based therapy: Correlation with clinical parameters. Int J
Oncology 1995;7:679-684.
Gulley ML, Amin MB, Banks PM, Ayala AG, Srigley JR, Eagan PA, Ro JY: Epstein-Barr virus is detected in
nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the bladder. Human Pathol
1995;26:1207-1214.
Corless CL, Aburantani H, Fletcher JA, Housman D, Amin MB, Weinberg DS. Papillary Renal Cell
Carcinoma: Quantitation of chromosome 7 and 17 by FISH, Analysis of 3 p for LOH and DNA ploidy.
Diag Mol Pathol 1996;5:53-64.
Amin MB, Murphy WM, Reuter VE, Weiss MA, Ro JY, Ayala AG, Eble JN, Young RH: Controversies in
the Pathology of Transitional Cell Carcinoma of the Urinary Bladder. Part I, Chapter 1. In: Reviews of
Pathology, 1996, Vol. 1. Editors: Rosen PP, Fechner RE. ASCP Press, Chicago, pages 1-39.
Stricker HJ, Jay JK, Linden MD, Tamboli P, Amin MB: Determining prognosis of clinically localized
prostate cancer by immunohistochemical detection of mutant p53. Urology 1996;47:366-369.
Amin MB, Grignon D, Bostwick D, Reuter V, Troncoso P, Ro JY, Ayala AG (ad hoc committee):
Recommendation for the reporting of resected prostate carcinomas. Association of Directors of
Anatomic and Surgical Pathology. Hum Pathol 1996; 27:321-323, Mod Pathol 1996; 9:453-456, Am J
Clin Pathol 1996;105:667-670.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
Amin MB, Bostwick DG: Pigment in prostatic epithelium and adenocarcinoma: A potential source of
diagnostic confusion with seminal vesicular epithelium. Mod Path 1996; 9:791-795.
Durham JR, Keohane ME, Amin MB: Chromophobe renal cell carcinoma of kidney. Adv Anat Pathol
1996;3:336-342.
Tamboli P, Amin MB, Schultz DS, Linden MD, Kubus J: Comparative analysis of nuclear proliferative
index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia and prostatic carcinoma. Mod
Pathol 1996;9:1015-1019.
Amin MB, Crotty TB, Tickoo SK, Farrow GM: Renal oncocytoma: A reappraisal of morphologic features
with clinicopathologic findings in 80 cases. Am J Surg Pathol 1997; 21:1-11.
Amin MB, Varma M, Tickoo SK, Ro JY. Collecting Duct Carcinoma of Kidney - A review. Adv Anat Pathol
1997;4:85-94.
Hailemariam S, Engeler DS, Bannwart F, Amin MB. Primary mediastinal germ cell tumor with
intratubular germ cell neoplasia - Further support for germ cell origin of these tumors - A case report.
Cancer 1997; 79:1031-1036.
Amin MB, Young RH: Primary carcinoma of the urethra. Semin Diag Pathol 1997;14:147-160.
Amin MB, Young, RH: Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis
of bladder neoplasia. Sem Diag Pathol 1997;14:84-97.
Craig JG, Amin MB, Wu K, Eyler WR, van Holsbeeck MT, Bouffard JA, Shirazi K: Osteomyelitis of the
diabetic foot: MR-pathologic correlation. Radiology 1997;203:849-855.
Randolph T, Amin MB, Ro JY, Ayala AG. Histologic variants of prostatic adenocarcinoma. Histologic
criteria and clinical significance. Mod Pathol 1997;10:612-629.
Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS: Papillary (chromophil) renal cell
carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic
parameters in 62 cases. Am J Surg Pathol 1997; 21:621-635.
Tickoo SK, Amin MB, Linden MD, Lee MW, Zarbo RJ: Utility of antimitochondrial antibody (113-1) in
the differential diagnosis of granular renal cell tumors. Am J Surg Pathol 1997;21:922-930.
Ro JY, Lapham R, Amin MB. Deceptively bland transitional cell carcinoma of the urinary bladder further characterization of subtle and diagnostically treacherous patterns of invasion in urothelial
neoplasia. Adv Anat Pathol 1997;4:244-251.
Amin MB, Gomez JA, Young RH. Urothelial transitional cell carcinoma with endophytic growth
patterns: A discussion of patterns of invasion and problems associated with assessment of invasion in
18 cases. Am J Surg Pathol 1997;21:1057-1068.
Strkel S, Eble JN, Adlakha K, Amin MB, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K.
Classification of renal cell carcinoma. Workgroup I. Cancer 1997;80:987-989.
Eble JN, Amin MB, Young RH. Epithelioid angiomyolipoma of the kidney: A report of five cases with a
prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol
1997;1:1123-1130.
Amin MB, Murphy WM, Reuter VE, Weiss MA, Ro JY, Ayala AG, Eble JN, Young RH: Controversies in
the pathology of transitional cell carcinoma of the urinary bladder. Part II, Chapter 5. In: Reviews of
Pathology, 1997, Vol. 2. Editors: Rosen PP, Fechner RE. ASCP Press, Chicago, pages 71-110.
Ma CK, de Peralta M, Amin MB, Linden MD, Dekovich AA, Kubus J, Zarbo RJ. Small intestinal stromal
tumors: A clinicopathologic study of 20 cases with immunohistochemical assessment of cell
differentiation and the prognostic role of proliferation antigens. Am J Clin Pathol 1997;108:641651.
Tamboli P, Amin MB, Xu HJ, Linden, MD. Immunohistochemical expression of retinoblastoma and p53
tumor suppressor genes in prostatic intraepithelial neoplasia (PIN): comparison with prostatic
adenocarcinoma and benign prostate. Mod Pathol 1998;11:247-252.
Tickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms including
chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. Am J Surg Pathol
1998;22:419-424.
Mohsin SK, Lee MW, Amin MB, Stoler MH, Eyzaguirre E, Ma CK, Zarbo RJ. Cutaneous verruciform
xanthoma: A report of five cases investigating the etiology and nature of xanthomatous cells. Am J
Surg Pathol 1998;22:479-487.
Gulley ML, Burton MP, Allred DG, Nicholls JM, Amin MB, Ro JY, Schneider BG. Epstein-Barr Virus
infection is associated with p53 accumulation in nasopharyngeal carcinoma. Human Pathol 1998;
29:252-259.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
Gulley ML, Nicholls JM, Schneider BG, Amin MB, Ro JY, Geradts J. Nasopharyngeal carcinomas
frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma
gene product. Am J Pathol 1998; 152:865-869.
Shah VI, Ro JY, Amin MB, Mullick S, Nazeer T, Ayala AG. Histologic variations in the epididymis Findings in 167 orchiectomy specimens. Am J Surg Pathol 1998;22:990-996.
Weirich G, Glenn G, Junker K, Merino M, Strkel S, Lubensky I, Choyke P, Pack S, Amin MB, Walther
MM, Linehan WM, Zbar B. Familial renal oncocytoma: Clinicopathological study of 5 families. J Urol
1998;160:335-340.
Hailemariam S, Gaspert A, Komminoth P, Tamboli P, Amin MB. Primary, pure, large- cell
neuroendocrine carcinoma of the urinary bladder: Report of a unique case. Mod Pathol 1998;11:10161020.
Maas E, Craig J, Swisher P, Amin MB, Marcus N Fluid levels in a simple bone cyst on MRI. Australas
Radiol 1998; 42:267-270.
Bostwick DG, Iczkowski KA, Amin MB, Discigel G, Osborne B. Malignant lymphoma involving the
prostate: Report of 62 cases. Cancer 1998;83:732-738.
Varma M, Stone CH, Mozes MF, Tickoo SK, Mohindra H, Amin MB. Chromophobe renal cell carcinoma
arising in a renal allograft. A case report with review of literature. J Urol Pathol 1998;9:163-170.
Tickoo SK, Amin MB. Discriminant nuclear features of renal oncocytoma and chromophobe renal cell
carcinoma. Analysis of their potential utility in the differential diagnosis. Am J Clin Pathol
1998;110:782-787.
Lin T-Y B, Brynes RK, Gelb AB, McCourty A, Amin MB, Medeiros J. Cyclin D1 expression in renal
carcinomas and oncocytomas: An immunohistochemical study. Mod Pathol 1998;11:1075-1081.
Tickoo SK, Amin MB, Linden MD, Zarbo RJ. The MIB-1 tumor proliferation index in adult renal epithelial
tumors with granular cytoplasm: Biologic implications and differential diagnostic potential. Mod
Pathol 1998;11:1115-1121.
Epstein JI, Amin MB, Reuter VR, Mostofi FK and the Bladder Consensus Conference Committee. The
World Health Organization/International Society of Urological Pathology Consensus classification of
urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435-1448.
Amin MB, Grignon DJ, Bostwick DG, Epstein JI, Reuter VE, Troncoso P, Ro JY, Ayala AG.
Recommendations for reporting resected prostatic carcinomas. Path Case Reviews 1998;3:223-232.
Farrow G, Amin MB. Protocol for the examination of specimens from patients with carcinomas of renal
tubular origin, exclusive of Wilms tumor and tumors of urothelial origin: A basis for checklists. Arch
Pathol Lab Med 1999;123:23-27.
Kurman RJ, Amin MB. Protocol for the examination of specimens from patients with carcinomas of the
cervix: A basis for checklists. Arch Pathol Lab Med 1999;123:55-61.
Ligato S, Ro JY, Tamboli PT, Amin MB, Ayala AG. Benign tumors and tumor-like lesions of the adult
kidney. Part I: Benign renal epithelial neoplasms. Adv Anat Pathol 1999; 6:1-11.
Gomez JA, Amin MB, Ro JY, Linden MD, Lee MW, Zarbo RJ. Immunohistochemical profile of myogenin
and MyoD1 does not support skeletal muscle lineage in alveolar soft part sarcoma: A study of 19
tumors. Arch Pathol Lab Med 1999;123:503-507.
Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval techniques on
antibody 34E12 immunostaining of prostatic tissues. Mod Pathol 1999;12:472-478.
Amin M, Tickoo SK, Schultz DS, Amin MB. Myelolipoma of renal sinus: An unusual site for a rare extraadrenal lesion. Arch Pathol Lab Med 1999;123:631-634.
Amin MB, Tamboli P, Varma M, Srigley JR. Postatrophic hyperplasia of prostate: A detailed analysis of
its morphology in needle biopsy specimens. Am J Surg Pathol 1999;23:925-931.
Tran TA, Ayala AG, Amin MB, Nazeer T, Ro JY, Ross JS, Jennings TA. Utility of high-molecular weight
cytokeratin 34E12 in atypical small acinar proliferations in prostatic needle biopsies. Appl Immuno
1999;7:186-192.
Tickoo SK, Reuter VE, Amin MB, Srigley JR, Epstein JI, Min KW, Rubin MA, Ro JY. Renal oncocytosis:
Morphologic spectrum and morphogenetic considerations; A study of 14 cases. Am J Surg Pathol
1999;23:1094-1101.
Javidan J, Stricker HJ, Tamboli P, Amin M, Peabody JO, Deshpande A, Menon M, Amin MB. Prognostic
significance of the 1997 TNM classification for renal cell carcinoma. J Urol 1999;162:1277-1281.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
Haussler O, Epstein JI, Amin MB, Heitz PU, Hailemariam S. Cell proliferation, apoptosis, oncogene, and
tumor supressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic
intraepithelial neoplasia, and cancer. Hum Pathol 1999;30:1077-1086.
Amin MB, de Peralta-Venturina MN, Ro JY, El-Naggar A, Mackay B, Ordonez N, Mani A, Ayala A. Clear
cell sarcoma of kidney in an adolescent and in young adults. A report of four cases with ultrastructural,
immunohistochemical and DNA flow cytometric analysis. Am J Surg Pathol 1999;23:1455- 463.
Reuter VR, Epstein JI, Amin MB, Mostofi FK and the Bladder Consensus Conference Committee. A
Newly Illustrated Synopsis of The World Health Organization/ International Society of Urological
Pathology (WHO/ISUP) consensus classification of urothelial (transitional cell) neoplasms of the urinary
bladder. A review. J Urol Pathol 1999;11:1-27.
Amin MB, Advances in Anatomic PathologyContinuing the journey into the new millenium. Adv
Anat Pathol 2000; 7:1.
Jimenez RE, Keane TE, Hardy HT, Amin MB. pT1 Urothelial carcinoma of the bladder: criteria for
diagnosis, pitfalls, and clinical implications. Adv Anat Pathol 2000;7:13-25.
Tamboli PT, Ligato S, Ro JY, Amin MB, Ayala AG. Benign tumors and tumor-like conditions of the adult
kidney. Part II: Benign mesenchymal and mixed neoplasms and tumor-like lesions. Adv Anat Pathol
2000;7:47-66.
Agoff SN, Lamps LW, Philip AT, Amin MB, Schmidt RA, True LD, Folpe AL. Thyroid transcription factor-1
is expressed in extrapulmonary small cell carcinomas, but not in other extrapulmonary neuroendocrine
tumors. Mod Pathol 2000;13:238-242.
Prasad AR, Amin MB, Randolph TL, Lee CS, Ma CK. Retrorectal cystic hamartoma: Report of five cases
with malignancy arising in two. Arch Pathol Lab Med 2000;124:725-729.
Oliva E, Quinn TR, Amin MB, Eble JN, Epstein JI, Srigley JR, Young RH. Primary malignant melanoma of
the urethra. A Clinicopathologic analysis of 15 cases. Am J Surg Pathol 2000;24:785-796.
Engeler DS, Hsli PO, John H, Banwart F, Sulser T, Hedinger CE, Amin MB, Heitz PH, Hailemariam S.
Early orchidopexy-prepubertal intratubular germ cell neoplasia and fertility outcome. Urology
2000;56:144-148.
Bostwick DG, Grignon DJ, Hammond EH, Amin MB, Cohen M, Crawford D, Gospadarowicz M, Kaplan
RS, Miller DS, Montironi R, Pajak TF, Pollack A, Srigley JR, Yarbro JW. Prognostic factors in prostate
cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med
2000;124:995-1000.
Srigley JR, Amin MB, Bostwick DG, Grignon DJ, Hammond EH, for Members of the Cancer Committee,
College of American Pathologists. Updated Protocol for the Examination of Specimens From Patients
With Carcinomas of the Prostate Gland. Arch Pathol Lab Med 2000;124:1034-1039.
Brinker DA, Amin, MB, dePeralta-Venturina M, Reuter V, Chan DY, Epstein JI. Extensively necrotic cystic
renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal
cancers. Am J Surg Pathol 2000;24:988-995.
Alvarado-Cabrero I, Folpe AL, Srigley JR, Gaudin P, Philip AT, Reuter VE, Amin MB. Intrarenal
Schwannoma: A report of four cases including three cellular variants and review of literature. Mod
Pathol 2000;13:851-856.
Moch H, Gasser TH, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently
recommended histologic classification and revised TNM staging system of renal cell carcinoma A
Swiss experience with 588 tumors. Cancer 2000;89:604-614.
Philip AT, Amin MB, Tamboli P, Lee TJ, Hill CE, Ro JY. Intravesical adipose tissue: a quantitative study of
its presence and location with implications for therapy and prognosis. Am J Surg Pathol 2000;24:12861290.
Tickoo SK, Lee MW, Amin M, Eble JN, Christopherson T, Zarbo RJ, Amin MB. Ultrastructural
observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell
carcinoma and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol
2000;24:1247-1256.
Kommoss F, Oliva E, Bittinger F, Kirkpatrick CJ, Amin MB, Bhan A, Young RH, Scully RE. Inhibin-, CD99,
HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen
insensitivity syndrome. Hum Pathol 2000;31:1055-1061.
Jimenez RE, Fischer AH, Petros JA, Amin MB. Glutathione S-Transferase Pi Gene Methylation: The
Search for a Molecular Marker of Prostatic Adenocarcinoma. Advances Anat Pathol 2000;7:382-389.
94.
Desai S, Lim SD, Jimenez RE, Young RH, Chun T, McKenney JK, Zavala-Pompa A, Cohen C, Keane T, Amin
MB. Relationship of Cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in superficial
papillary urothelial neoplasms. Mod Pathol 2000;13:1315-1323.
95.
Allsbrook WC, Mangold KA, Johnson MH, Lane RB, Lane CG, Amin MB, Bostwick DG, Humphrey PA,
Jones EC, Reuter VE, Sakr W, Sesterhenn IA, Troncoso P, Wheeler TM, Epstein JI. Interobserver
reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Human Pathol
2001;32:74-80.
Shah RB, Lee MW, Giraldo AA, Amin MB. Histologic and histochemical characterization of seminal
vesicle intraluminal secretions: Particular emphasis on their crystalloid morphology. Arch Pathol Lab
Med 2001;125:141-145.
Zavala-Pompa A, Folpe AL, Jimenez RE, Lim SD, Cohen C, Eble JN, Amin MB. Immunohistochemical
study of micropthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell
carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic
markers. Am J Surg Pathol 2001;25:65-70.
de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H,
Ro JY, Amin MB. Sarcomatoid dedifferentiation in renal cell carcinoma: A study of 101 cases. Am J
Surg Pathol 2001;25:275-284.
McKenney JK, Gomez JA, Desai S, Lee MW, Amin MB. Morphologic expressions of urothelial
carcinoma in situ: A detailed evaluation of its histologic patterns with emphasis on carcinoma in situ
with microinvasion. Am J Surg Pathol 2001;25:356-362.
Jimenez RE, Eble JN, Reuter VE, Epstein JI, Folpe AL, de Peralta-Venturina M, Tamboli P, Ansell ID,
Grignon DJ, Young RH, Amin MB. Concurrent angiomyolipoma and renal cell neoplasia: A study of 36
cases. Mod Pathol 2001;14:157-163.
Fischer AH, Philips A, Taysavang P, McKenney JK, Amin MB. Method for procuring specific populations
of viable human prostate cells for research. Lab Invest 2001; 81:501-7.
Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS. Expression
profiling of renal epithelial neoplasms: A method of tumor classification and discovery of diagnostic
molecular markers. Am J Pathol 2001;158:1639-51.
Stone CH, Lee MW, Amin MB, Yaziji H, Gown AM, Ro JY, Ttu B, Paraf F, Zarbo RJ. Renal
angiomyolipoma: Further immunophenotypic characterization of an expanding morphologic spectrum.
Arch Pathol Lab Med 2001; 125:751-758.
McKenney JK, Desai S, Cohen C, Amin MB. Discriminatory immunohistochemical staining of urothelial
carcinoma in situ and non-neoplastic urothelium: An analysis of cytokeratin 20, p53, and CD44
antigens. Am J Surg Pathol 2001; 25:1074-1078.
Arbiser JL, Yeung R, Weiss SW, Arbiser ZK, Amin MB, Cohen C, Frank D, Mahajan S, Herron GS, Yang J,
Onda H, Zhang HB, Bai X, Uhlmann E, Loehr A, Northrup H, Au P, Davis I, Fisher DE, Gutmann DH. The
generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: Use of
telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol 2001; 159:483491.
Nevalainen TJ, Shah VI, de Peralta-Venturina M, Amin MB. Absence of group II phospholipase A2, a
Paneth cell marker, from the epididymis. APMIS 2001; 109:295-298.
Wu GJ, Varma VA, Wu MW, Wang SW,Qu P, Petros JA, Lim SD, Amin MB. Expression of a human cell
adhesion molecule, MUC18, in prostate cancer cell lines and tissues. Prostate 2001; 48:305-315.
Wu GJ, Wu MW, Wang SW, Lui Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin
MB. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of
MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. Gene
2001; 279:17-31.
Grignon D, Amin M, Brat D, El-Nagaar A, Hammond E, Lucas D, Nelson J, Petito C, Scott C, Sheahan DG,
Sneige N, True L, Yesner R. Radiation Therapy Oncology Group. Research Plan 2002-2006. Pathology
Committee. Int J Radiation Oncology, Biol, Phys 2001: 51(3 Suppl 2):110-112.
Donald CD, Laddu A, Chandham P, Lim SD, Cohen C, Amin MB, Gerton GL, Marshall FF, Petros JA.
Expression of progranulin and the epithelin/granulin precursor acrogranin correlates with neoplastic
state in renal epithelium. Anticancer Res 2001; 21:3739-3742.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
Oliva E, Amin MB, Jimenez RE, Young RH. Clear cell carcinoma of the urinary bladder. A report and
comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of
histogenesis and diagnostic problems. Am J Surg Pathol 2002: 26:190-197.
Amin MB, Amin M, Tamboli P, Javidan J, Stricker H, Venturina MD, Deshpande A, Menon M. Prognostic
impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J
Surg Pathol 2002; 26:281-291.
Jiminez RE, Folpe AL, Lapham RL, Ro JY, OShea PA, Weiss SW, Amin MB. Primary Ewings
sarcoma/primitive neuroectodermal tumor of the kidney:
a clinicopathologic and
immunohistochemical analysis of 11 cases. Am J Surg Pathol 2002; 26:320-327.
Oliva E, Young RH, Amin MB, Clement PB. An immunohistochemical analysis of endometrial stromal
and smooth muscle tumors of the uterus. A study of 54 cases emphasizing the importance of using a
panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 2002; 26:403412.
Copeland JN, Amin MB, Humphrey PA, Tamboli P, Ro JY, Gal AA. The morphologic spectrum of
metastatic prostatic adenocarcinoma to the lung: special emphasis on overlapping histology with other
pulmonary neoplasms. Am J Clin Pathol 2002; 117:552-557.
Varma M, Lee MW, Tamboli P, Zarbo RJ, Jimenez RE, Salles PGO, Amin MB. Morphologic criteria for
the diagnosis of prostatic adenocarcinoma in needle biopsies: a study of 250 consecutive cases in a
routine surgical pathology practice. Arch Pathol Lab Med 2002; 126:554-561.
Barnabas N, Amin M, Pindolia K, Nanavati R, Amin MB, Worsham MJ. Mutations in the von HippelLindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma. J Surg Oncol 2002;
80:52-60.
Amin MB, McKenney JK. An approach to the diagnosis of flat intraepithelial lesions of the urinary
bladder using the World Health Organization/ International Society of Urological Pathology (WHO/ISUP)
consensus classification system. Adv Anat Pathol 2002; 9:222-232.
Varma M, Morgan M, Jasani B, Tamboli P, Amin MB. Polyclonal anti-PSA is more sensitive but less
specific than monoclonal anti-PSA: implications for diagnostic prostatic pathology. Am J Clin Pathol
2002; 118:202-207.
Tamboli P, Mohsin SK, Hailemariam S, Amin MB. Colonic adenocarcinoma metastatic to the urinary
tract versus primary tumors of the urinary tract with glandular differentiation. Arch Pathol Lab Med
2002; 126:1057-1063.
Arbiser JL, Govindarajan B, Bai X, Onda H, Kazlauskas A, Lim SD, Amin MB, Claesson-Welsh L.
Functional tyrosine kinase inhibitor profiling: A generally applicable method points to a novel role of
platelet-derived growth factor receptor-beta in tuberous sclerosis. Am J Pathol 2002; 161:781-786.
Beach R, Gown AH, dePeralta-Venturina MN, Folpe AL, Yazizi H, Salles P, Grignon D, Fanger G, Amin
MB. P504S immunohistochemical expression in 405 prostatic specimens including 376 18-gauge
needle biopsies. Am J Surg Pathol 2002; 26:1588-1596.
Parker DC, Folpe AL, Bell J, Oliva E, Cohen C, Amin MB. Potential utility of uroplakin III,
thrombomodulin, high molecular weight cytokeratin and cytokeratin 20 in invasive, metastatic, and
non-invasive urothelial (transitional) carcinomas. Am J Surg Pathol 2003; 27:1-10.
Young AN, Salles PGO, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS, Amin MB. Beta defensin-1,
parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors
derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol 2003;
27:199-205.
Varma M, Morgan M, Amin MB, Wozniak S, Jasani B. High molecular weight cytokeratin antibody
(clone 34E12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from
prostate cancer. Histopathol 2003; 42:167-172.
Logani SL, Cabrera RA, Amin MB. Embryonal rhabdomyosarcoma of the adult prostate: differential
diagnostic considerations. Path Case Reviews 2003: 82:82-86.
Kubo H, Gardner TA, Wada Y, Koeneman KS, Gotoh A, Yang L, Kao C, Lim SD, Amin MB, Yang H, Black
ME, Matsubara S, Nakagawa M, Gillenwater JY, Zhau HE, Chung LWK. Phase I dose escalation clinical
trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase
in localized and metastatic hormone-refractory prostate cancer. Hum Gene Ther 2003: 14:227-241.
Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA.
Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest 2003: 83:501-505.
129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
Amin MB, Tamboli P. Impact of histologic subtyping of renal epithelial neoplasms. Am J Surg Pathol
2003; 27:1021-1024.
Junker K, Weirich G, Amin MB, Moravek P. Genetic subtyping of renal cell carcinoma by comparative
genomic hybridization. Recent Results Cancer Res 2003; 162:169-175.
McKenney JK, Amin MB, Young RH. Urothelial (transitional cell) papilloma of the urinary bladder: a
clinicopathologic study of 26 cases. Mod Pathol 2003; 16:623-629.
Schraml P, Hergovitz A, Hatz F, Amin MB, Lim SD, Krek W, Mihatsch MJ, Moch H. Relevance of nuclear
and cytoplasmic von hippel lindau protein expression for renal carcinoma progression. Am J Pathol
2003; 163:1013-1020.
Amin MB, Srigley JR, Grignon DJ, Reuter VE, Humphrey PA, Cohen MB, Hammond ME. Updated
Protocol for the examination of specimens from urinary bladder, ureter, and renal pelvis. Arch Pathol
Lab Med 2003; 127:1263-1279.
Qualman SJ, Bowen J, Amin MB, Srigley JR, Grundy, PE, Perlman EJ. Protocol for the examination of
specimens from patients with Wilms tumor (nephroblastoma) or other renal tumors of childhood.
Arch Pathol Lab Med 2003;127:1280-1289.
Logani S, Oliva E, Amin MB, Folpe AL, Cohen C, Young RH. Immunoprofile of ovarian tumors of putative
transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic
implications. Am J Surg Pathol 2003; 27:1434-1441.
Varma M, Morgan M, Amin MB, Wozniak S, Jasani B. High-molecular-weight cytokeratin antibody
(clone 34betaE12) as a urothelial marker: a note of caution. Histopathol 2004; 44:189-190.
Jiang Z, Wu CL, Woda BA, Iczkowski KA, Chu PG, Tretiakova MS, Young RH, Weiss LM, Blute RD Jr,
Brendler CB, Krausz T, Xu JC, Rock KL, Amin MB, Yang XJ. Alpha-methylacyl-CoA racemase/P504S: a
multi-institutional study of a new prostate cancer marker. Histopathology 2004; 45:218-225.
Wang R, Xu J, Saramki O, Visakorpi T, Sutherland WM, Zhou J, Sen B, Lim SD, Mabjeesh N, Amin MB,
Dong JT, Petros JA, Nelson PS, Marshall FF, Zhau HE, Chung LW. PrLZ, a novel prostate-specific and
androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in
human prostate cancer. Cancer Res 2004; 64:1589-94.
Skinnider BF, Oliva E, Young RH, Amin MB. Expression of alpha-methylacyl-CoA racemase (P504S) in
nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential
diagnosis with prostatic adenocarcinoma. Am J Surg Pathol 2004; 28:701-5.
Zhou W, Goodman M, Lyles RH, Lim SD, Williams TY, Rusthoven KE, Mandel JS, Amin MB, Petros JA.
Surgical margin and Gleason score as predictors of postoperative recurrence in prostate cancer with or
without chromosome 8p allelic imbalance. Prostate 2004; 61:81-91.
Parast MM, Eudy G, Gow KW, Amin MB, Shehata B. A unique case of renal carcinoma with Xp11.2
translocations/TFE3 gene fusions in a 3-year-old child, with co-existent von Hippel-Lindau gene
mutation. Pediatr Dev Pathol 2004, 7:403-406.
Salama ME, Azam M, Ma CK, Ormsby A, Zarbo RJ, Amin MB, Lee MW. Chondroid syringoma:
cytokeratin 20 (CK20) immunolocalization of Merkel cells and reappraisal of apocrine folliculosebaceous differentiation. Arch Pathol Lab Med 2004, 128:986-990.
McKenney JK, Amin MB, Srigley JR, Jimenez RE, Ro JY, Grignon DJ, Young RH. Basal cell proliferations of
the prostate other than usual basal cell hyperplasia: a clinicopatholgic study of 23 cases, including four
carcinomas, with a proposed classification. Am J Surg Pathol 2004, 28:1289-1290.
Lim SD, Sun C, Lambeth JD, Marshall F, Amin MB, Chung L, Petros JA, Arnold RS. Increased Nox1 and
hydrogen peroxide in prostate cancer. Prostate 2005, 62:200-207.
Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini
SH, Marshall FF, Wallace DC. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl
Acad Sci U S A. 2005;102:719-724.
Ramachandran S, Liu P, Young AN, Yin-Goen Q, Lim SD, Laycock N, Amin MB, Carney JK, Marshall FF,
Petros JA, Moreno CS. Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Oncogene.
2005;24:188-198.
Went PT, Dirnhofer S, Salvisberg T, Amin MB, Lim SD, Diener PA, Moch H. Expression of epithelial cell
adhesion molecule (EpCam) in renal epithelial tumors. Am J Surg Pathol 2005;29:83-88.
Logani S, Oliva E, Arnell PM, Amin MB, Young RH. Use of novel immunohistochemical markers
expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal
carcinoma. Mod Pathol 2005;18:19-25.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
Amin MB. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and
pseudotumors, mesothelial lesions and secondary tumors. Mod Pathol 2005;18:5131-5145.
Nassar A, Amin MB, Sexton DG, Cohen C. Utility of -methylacyl coenzyme A racemase (P504S
antibody) as a diagnostic immunohistochemcial marker for cancer. Appl Immunohistochem Mol
Morphol 2005;13: 252-255.
Skinnider BF, Folpe AL, Hennigar RA, Lim SD, Cohen C, Tamboli P, Young A, dePeralta-Venturina M,
Amin MB. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue:
potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg
Pathol 2005;29:747-754.
Amin MB, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, Newling D, Nilsson S, Sakr W,
Srigley JR, Wheeler TM, Montironi R. Prognostic and predictive factors and reporting of prostate
carcinoma in prostate needle biopsy specimens. Scand J Urology and Nephrology 2005; (Suppl.)
216:20-33.
Srigley JR, Amin MB, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, Newling D, Nilsson
S, Sakr W, Wheeler TM, Montironi R. Prognostic and predictive factors in prostate cancer: historical
perspectives and recent international consensus initiatives. Scand J Urology and Nephrology 2005;
(Suppl.) 216:8-19.
Epstein JI, Amin MB, Boccon-Gibod L, Egevad L, Humphrey PA, Mikuz G, Newling D, Nilsson S, Sakr W,
Srigley JR, Wheeler TM, Montironi R. Prognostic factors and reporting of prostate carcinoma in radical
prostatectomy and pelvic lymphadenectomy specimens. Scand J Urology and Nephrology 2005;(Suppl.)
216:34-63.
Salama ME, Guru K, Stricker H, Peterson E, Peabody J, Menon M, Amin MB, de Peralta-Venturina M.
pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant
renal epithelial tumors. J Urol 2005;173:1492-1495.
Schuetz AN, Yin-Goen Q, Amin MB, Moreno CS, Cohen C, Hornsby CD, Petros JA, Issa MM, Pattaras JG,
Ogan K, Marshall FF, Young AN. Molecular classification of renal tumors by gene expression profiling. J
Mol Diagnostics 2005;7:206-218.
Epstein JI, Allsbrook WC, Amin MB, Egevad LL & the ISUP Grading Committee. The 2005 International
Society of Urologic Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma.
Am J Surg Pathol 2005;29:1228-42.
Amin MB, Young RH. Contemporary Immunohistochemical Approach to the Surgical Pathology of the
Genitourinary Systems. Introduction. 2005;22;1-2.
Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal
tumors. Semin Diag Pathol 2005;22: 51-68.
McKenney JK, Amin MB. The role of immunohistochemistry in the diagnosis of urinary
bladder
neoplasms. Semin Diag Pathol 2005;22: 69-87.
Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI. Urothelial neoplasms in patients 20 years or
younger: a clinicopathologic analysis using World Health Organisation 2004 bladder consensus
classification. J Urol 2005;174:1976-80.
Baydar D, Amin MB, Epstein JI. Osteoclast-rich undifferentiated carcinomas of the urinary tract. Mod
Pathol 2006;19:161-71.
Yin-Goen O, Dale J, Yang WL, Phan J, Moffitt R, Petros J, Datta M, Amin MB, Wang MD, Young AN.
Advances in molecular classification of renal neoplasms. Histol Histopathol 2006;21:325-39.
Paner PP, Srigley JR, Radhakrishnan A, Cohen C, Skinnider BF, Tickoo SK, Young AN, Amin MB.
Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell
carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Am J Surg
Pathol 2006;30:13-19.
Tickoo SK, Deperalta-Venturina MN, Salama M, Harik LR, Worcester HD, Moch H, Amin MB. Spectrum
of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with
emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol
2006;30:141-153.
Booker LM, Habermacher GM, Jessie BC, Sun QC, Baumann AK, Amin MB, Lim SD, Fernandez-Golarz C,
Lyles RH, Brown MD, Marshall FF, Petros JA. North American white mitochondrial haplogroups in
prostate and renal cancer. J Urol 2006;175:468-473.
167.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
178.
179.
180.
181.
182.
183.
184.
Harik LR, Merino C, Coindre J-M, Amin MB, Pedeutour F, Weiss SW. Pseudosarcomatous
myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol
2006;30: 787-794.
Amin MB. (Editorial). Key Issues in Reporting Common Cancer Specimans Using the College of
American Pathologists Cancer protocols. Arch Pathol Lab Med 2006;30: 284-285.
Argani P, Lae M, Ballard ET, Rodriguez M, Amin MB, Manivel C, Hutchinson B, Reuter VE, Ladanyi M.
Translocation carcinomas of the kidney as chemotherapy-induced secondary malignancies. J Clin Oncol
2006;24:1529-1534.
Amin MB, Patel RM, Oliveira P, Cabrera R, Carniero V, Preto M, Balzer B, Folpe AL. Alveolar soft part
sarcoma of the urinary bladder with urethral recurrence: a unique case with emphasis on differential
diagnoses and diagnostic utility of an immunohistochemical panel including TFE3. Am J Surg Pathol
2006;30:1322-1335.
Epstein JI, Allsbrook WC, Amin MB, Egevad LL. Update on the Gleason Grading System for Prostate
Cancer. Results of an international consensus conference of urologic pathologists. Adv Anat Pathol
2006;13:57-59.
Srigley JR, Amin MB, Epstein JI, Grignon DJ, Renshaw AA, Wheeler TM. Updated protocol for the
examination of specimens from patients with carcinomas of the prostate gland. Arch. Pathol Lab Med
2006;130:936-46.
Young AN, Master VA, Amin MB. Current Trends in the Molecular Classification of Renal Neoplasms.
Scientific World Journal 2006;6:2505-18.
Young AN, Dale J, Yin-Geon Q, Harris WB, Petros JA, Datta MW, Wang MD, Marshall FF, Amin MB.
Current trends in molecular classification of adult renal tumors. Urology 2006; 67:873-80.
Giedl J, Wild PJ, Stoehr R, Junker K, Boehm S, van Oers JM, Zwarthoff EC, Blaszyk H, Fine SW, Humphrey
PA, Dehner LP, Amin MB, Epstein JI, Hartmann A. Urothelial neoplasms in individuals younger than 20
years show very few genetic alterations and have a favourable clinical outcome. Verh Dtsch Ges Pathol
2006;90:253-63.
Wild P, Giedl J, Stoehr R, Junker K, Boehm S. van Oers J, Zwarthoff E, Blaszyk H, Fine S, Humphrey P,
Dehner L, Amin MB, Epstein J, Hartmann A. Genomic aberrations are rare in urothelial neoplasms of
patients 19 years or younger. J Pathol 2007; 211:18-25.
Turbiner J, Amin MB, Humphrey PA, Srigley JR, De Leval L, Radhakrishnan A, Oliva E. Cystic nephroma
and mixed epithelial and stromal tumor of kidney: a detailed clinicopathological analysis of 34 cases
and proposal for renal epithelial and stromal tumor (REST) as a unifying term. Am J Surg Pathol
2007;31:489-500.
Ulbright TM, Amin MB, Young RH. Intratubular large cell hyalinizing sertoli cell neoplasia of the testis: a
report of 8 cases of a distinctive lesion of the Peutz-Jeghers Syndrome. Am J Surg Pathol 2007;31:827835.
Lim SD, Stallcup W, Lefkove B, Govindarajan B, Au KS, Northrup H, Lang D, Fisher DE, Patel A, Amin
MB, Arbiser JL. Expression of the Neural Stem Cell Markers NG2 and L1 in Human Angiomyolipoma: Are
Angiomyolipomas Neoplasms of Stem Cells? Mol Med. 2007; 13:160165.
Paner GP, Ro JY, Datta MW, Venkataraman G, Wojcik EM, Amin MB. Further characterization of the
muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications
for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 2007;31:1420-9.
Hornsby C, Cohen C, Amin MB, Picken MM, Lawson D, Yin Goen Q, Young AN. Claudin-7
immunohistochemistry in Renal Tumors: A Candidate Marker for Chromophobe Renal Cell Carcinoma
Identified by Gene Expression Profiling. Archives Pathol Lab Med 2007;131:1541-6.
Kuehn A, Paner GP, Skinnider B, Cohen C, Radhakrishnan A, Shehata B, MW Datta, Young AN, Hennigar
R, Srigley JR, Amin MB. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional
and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Am J Surg
Pathol 2007;31:1528-1533.
Datta MW, True LD, Nelson PS, Amin MB.The role of tissue microarrays in prostate cancer biomarker
discovery. Adv Anat Pathol. 2007;14:408-18.
Lim SD, Young AN, Paner GP, Cohen C, Amin MB. Prognostic role of CD44 cell adhesion molecule
expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 164 cases.
Virchows Arch 2008;452:49-55.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
198.
199.
200.
201.
202.
Chang SS, Amin MB. Utilizing the TNM staging for prostate cancer: The Sixth Edition, 2002. CA Cancer J
Clin 2008;58:54-59.
Young AN, Master VA, Paner GP, Wang MD, Amin MB. Renal epithelial neoplasms: Diagnostic
applications of gene expression profiling. Adv Anat Pathol 2008;15:28-38.
Ingold B, Wild PJ, Nocito A, Amin MB, Storz M, Heppner FL, Moch H.Renal cell carcinoma marker
reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell
carcinoma. Histopathology 2008;52:674-81.
Gupta R, Paner GP, Amin MB. Neoplasms of the upper urinary tract: A review with focus on urothelial
carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat
Pathol 2008;15:127-139.
Nigwekar N, Amin MB. The many faces of urothelial carcinoma: An update with an emphasis on
recently describe variants. Adv Anat Pathol 2008;15:218-233.
Paner GP, McKenney JK, Epstein JI, Amin MB. Rhabdomyosarcoma of the urinary bladder in adults:
predilection for anaplasia and alveolar morphology and significant histologic overlap with small cell
carcinoma. Am J Surg Pathol 2008:1022-1028.
Evans AJ, Henry PC, Van der Kwast T, Tkachuk D, Watson K, Lockwood G, Fleshner NE, Cheung C,
Belanger E, Amin MB, Bocon-Gibod L, Bostwick DG, Egevad L, Epstein JI, Grignon D, Jones E, Montironi
R, Moussa M, Sweet JM, Trypkov K, Wheeler T, Srigley JR. Interobserver variability between expert
urological pathologists for extraprostatic extension and surgical margin status in radical prostatectomy
specimens. Am J Surg Pathol 2008;32:1503-1512.
Latour M, Amin MB, Billis A, Egevad L, Grignon DJ, Humphrey PA, Reuter VE, Sakr WA, Srigley JR,
Wheeler TM, Yang XJ, Epstein JI. Grading of invasive cribriform carcinoma on prostate needle biopsy:
an interobserver study among experts in genitourinary pathology. Am J Surg Pathol 2008;32:1532-39.
Paner GP, Luthringer D, Amin MB. Best practices in immunohistochemistry. Prostate carcinoma and its
mimics in prostate needle biopsy. Arch Pathol Lab Med 2008;132:1388-96.
Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker H, Lyles R, Datta MW, Moch H.
Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional
pathologic parameters Am J Surg Pathol 2008;32:1822-1834.
Viswanathan S, Desai SB, Prabhu SR, Amin MB. Squamous differentiation in a sarcomatoid
chromophobe renal cell carcinoma: An unusual case report with review of literature. Arch of Pathol Lab
Med 2008;132:1672-1674.
Sung SY, Hseh CL, Law A, Zhau HE, Pathak S, Multani AS, Lim S, Coleman IM, Wu LC, Figg WD, Dahut WL,
Nelson P, Lee JK, Amin MB, Lyles R, Johnstone PA, Marshall FF, Chung LW. Coevolution of prostate
cancer and bone stroma in 3 dimensional coculture: implications for cancer growth and metastasis.
Cancer Res 2008;68:9996-10003.
Paner GP, Shen SS, Lapetino S, Venkataraman G, Barkan G, Quek ML, Ro JY, Amin MB. Diagnostic utility
of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosa of the
urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am
J Surg Pathol 2009;33:71-98.
Osunkoya AO, Cohen C, Lawson D, Picken MM, Amin MB, Young AN. Claudin-7 and Claudin-8:
Immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and
renal oncocytoma. Hum Pathol 2009;40:206-10.
Dhillon J, Paner GP, Turi G, Amin MB, Reuter VE. Mucinous tubular and spindle cell carcinoma with
sarcomatoid change. A report of 2 cases. Am J Surg Pathol 2009;33:44-9.
Gupta R, Balzer B, Picken M, Osunkoya A, Shet T, Alsabeh R, Luthringer D, Paner GP, Amin MB.
Diagnostic implications of transcription factor Pax 2 protein & transmemebrane enzyme complex
carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am J Surg Pathol
2009;33:241-7.
Westfall D, Folpe AL, Paner GP, Oliva E, Goldstein LC, Alsabeh R, Gown AM, Amin MB. Utility of a
comprehensive immunohistochemical (IHC) panel in the differential diagnosis of spindle cell lesions of
the urinary bladder. Am J Surg Pathol 2009;33:99-105.
Sukov WR, Cheville JC, Amin MB, Gupta R, Folpe AL. Perivascular epithelioid cell tumor PEComa of the
urinary bladder: report of three cases and review of the literature Am J Surg Pathol 2009;33:304-8.
203.
204.
205.
206.
207.
208.
209.
210.
211.
212.
213.
214.
215.
216.
217.
218.
219.
220.
221.
Amin MB, MacLennan GT, Gupta R, Grignon DJ, Paraf F, Vieillefond A, Paner GP, Stovsky M, Young AN,
Srigley JR, Cheville JC. Tubulocystic carcinoma of the kidney: Clinicopathologic analysis of 31 cases of a
distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 2009;33:384-92.
Nigwekar P, Tamboli P, Amin M, Osunkoya AO, Ben-Dor D, Amin MB. Plasmacytoid Urothelial
Carcinoma - Detailed Analysis of Morphology with Clinicopathologic Correlation in 17 Cases. Am J Surg
Pathol 2009;33:417-24.
Amin MB, Gupta R, Ondrej H, McKenney JK, Michal M, Young AN, Paner GP, Junker K, Epstein JI.
Primary Thyroid-like Follicular Carcinoma of the Kidney: Report of 6 Cases of a Histologically Distinctive
Adult Renal Epithelial Neoplasm. Am J Surg Pathol 2009;33:393-400.
Nese N, Paner GP, Ritchie J, Stewart A, Amin MB. Renal cell carcinoma: Assessment of key pathologic
prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base.
Ann Diagn Pathol 2009;13:1-8.
Lester SC, Connolly JL, Amin MB. College of American Pathologists protocol for the reporting of ductal
carcinoma in situ. Arch Pathol Lab Med. 2009;133:13-4.
Dadmanesh F, Fan X, Dastane A, Amin MB, Bose S. Comparative analysis of size estimation by mapping
and counting number of blocks with ductal carcinoma in situ in breast excision specimens. Arch Pathol
Lab Med. 2009;133:26-30.
Nese N, Gupta R, Bui MH, Amin MB. Carcinoma in situ of the urinary bladder: review of
clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic
techniques and prognosis. J Natl Compr Canc Netw. 2009;7:48-57.
Gupta R, Howell RS, Amin MB. Paratesticular Paraganglioma: A rare cause of an intrascrotal mass. Arch
Pathol Lab Med. 2009;133:811-3.
Amin MB. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic
implications. Mod Pathol. 2009;Suppl 2:S96-S118.
Yee DS, Navneet N, Amin MB, Skarecky DW, Ahlering TE. Robot-Assisted Radical Prostatectomy:
Current Evaluation of Surgical Margins in Clinically Low, Intermediate and High Risk Prostate Cancer. J
Endourol. 2009;23:1-5.
Rao P, Pinheiro N Jr, Franco M, Ra S, Costa H, Manzano J, Paner GP, Silva EG, Amin MB. Psudomyxoma
peritonei associated with primary mucinous borderline tumor of the renal pelvicalyceal system. Arch
Pathol Lab Med. 2009;133:1472-76.
Srigley JR, Humphrey PA, Amin MB, Chang SS, Egevad L, Epstein JI, Grignon DJ, McKiernan JM,
Montironi R, Renshaw AA, Reuter VE, Wheeler TM; Members of the Cancer Committee, College of
American Pathologists. Protocol for the examination of specimens from patients with carcinoma of the
prostate gland. Arch Pathol Lab Med. 2009;133:1568-76.
Wang HL, Lopategui J, Amin MB, Patterson SD. KRAS mutation testing in human cancers: The
pathologist's role in the era of personalized medicine. Adv Anat Pathol. 2010;17:23-32.
Lopez-Beltran A, Amin MB, Oliveira PS, Montironi R, Algaba F, McKenney JK, de Torres I, Mazerolles C,
Wang M, Cheng L. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and
LOH analysis. Am J Surg Pathol. 2010;34:371376.
Amin MB. The 2009 Version of the Cancer Protocols of the College of American Pathologists: A
Continuing Journey from Guidelines for Pathologists to Standards for Multidisciplinary
Comprehensive Cancer Care. Arch Pathol Lab Med. 2010;134:326-30.
McKenney JK, Amin MB, Epstein JI, Grignon DJ, Oliva E, Reuter VE, Srigley JR, Humphrey PA. Protocol
for the examination of specimens from patients with carcinoma of the urethra. Arch Pathol Lab Med.
2010;134:345-50.
Srigley JR, Amin MB, Delahunt B, Campbell SC, Chang A, Grignon DJ, Humphrey PA, Leibovich BC,
Montironi R, Renshaw AA, Reuter VE Members of the Cancer Committee, College of American
Pathologists. Protocol for the examination of specimens from patients with invasive carcinoma of renal
tubular origin. Arch Pathol Lab Med. 2010;134:e25-30.
Tewari AK, Patel ND, Leung RA, Yadav R, Vaughan ED, El-Douaihy Y, Tu JJ, Amin MB, Akhtar M, Burns
M, Kreaden U, Rubin MA, Takenaka A, Shevchuk MM. Visual cues as a surrogate for tactile feedback
during robotic-assisted laparoscopic prostatectomy: posterolateral margin rates in 1340 consecutive
patients. BJU Int. 2010;106:528-536.
Tewari A, Patel N, Yadav R, Vaughan ED, El-Douaihy Y, Tu JJ, Amin MB, Akhtar M, Leung RA, Burns M,
Kreaden U, Rubin MA, Takenaka A, Shevchuk MM. Anatomical retro-apical technique of synchronous
222.
223.
224.
225.
226.
227.
228.
229.
230.
231.
232.
233.
234.
235.
236.
237.
238.
(posterior and anterior) urethral transection: a novel approach for ameliorating apical margin positivity
during robotic radical prostatectomy. BJU Int. 2010;106:1364-73.
Paner GP, Brown JG, Lapetino S, Nese N, Gupta R, Shen SS, Hansel DE, Amin MB. Diagnostic utility of
antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary
bladder tumor (TURBT) specimens. Am J Surg Pathol. 2010;34:792-79
Brown JG, Folpe AL, Rao P, Lazar AJ, Paner GP, Gupta R, Parakh R, Cheville JC, Amin MB. Primary
Vascular Tumors and Tumor-like Lesions of the Kidney: A Clinicopathologic Analysis of 25 Cases. Am J
Surg Pathol. 2010;34:942-9.
Velazquez EF, Amin MB, Epstein JI, Grignon DJ, Humphrey PA, Pettaway CA, Renshaw AA, Reuter VE,
Srigley JR, Cubilla AL; Members of the Cancer Committee, College of American Pathologists. Arch Pathol
Lab Med. Protocol for the examination of specimens from patients with carcinoma of the penis.
2010;134:923-9.
Paner GP, Amin MB, Alvarado-Cabrero I, Young AN, Stricker HJ, Moch H, Lyles RH. A novel tumor
grading scheme for chromophobe renal cell carcinoma: Prognostic utility and comparison with
Fuhrman nuclear grade. Am J Surg Pathol. 2010;34:1233-40.
Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, Lopez-Beltran A, Oliva E,
Paner GP, Reuter VE, Ro JY, Shah RB, Shen SS, Tamboli P, McKenney JK. Interobserver Reproducibility in
the Diagnosis of Invasive Micropapillary Carcinoma of the Urinary Tract Among Urologic Pathologists.
Am J Surg Pathol. 2010;34:1367-76
Owen HC, Giedl J, Wild PJ, Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI, Blaszyk H, Hughes
D, Hartmann A, Stoehr R, Catto JW. Low frequency of epigenetic events in urothelial tumors in young
patients. J Urol. 2010;184:459-63.
Nese N, Martignoni G, Fletcher CD, Gupta R, Pan C, Kim H, Ro JY, Hwang IS, Sato K, Bonetti F, Pea M,
Amin M, Hes O, Svec A, Kida M, Vankalakunti M, Berel D, Rogatko A, Gown A, Amin MB. Pure
Epithelioid PEComas (so called epithelioid angiomyolipoma) of the Kidney: A Clinico-pathologic study of
41 cases: Detailed Assessment of Morphology and Risk Stratification. Am J Surg Pathol. 2011;35:16176.
Paner GP, Kristiansen G, McKenney JK, Amin MB. Rete Testis-Associated Nodular Steroid Cell Nests:
Description of Putative Pluripotential Testicular Hilus Steroid Cells. Am J Surg Pathol. 2011; 35:505-11.
van der Kwast TH, Amin MB, Billis A, Epstein JI, Griffiths D, Humphrey PA, Montironi R, Wheeler TM,
Srigley JR, Egevad L, Delahunt B; ISUP Prostate Cancer Group. International Society of Urological
Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens.
Working group 2: T2 substaging and prostate cancer volume. Mod Pathol. 2011;24:16-25.
Chaux A, Philip A, Amin MB, Cubilla AL, Young RH. Metastatic tumors to the penis: A report of 17 cases
and review of the literature. Int J Surg Pathol. 2011;19:597-606.
Jones CU, Hunt D, McGowan DG, Amin MB, Chetner MP, Bruner DW, Leibenhaut MH, Husain SM,
Rotman M, Souhami L, Sandler HM, Shipley WU. Radiotherapy and short-term androgen deprivation for
localized prostate cancer. N Engl J Med. 2011;365:107-18.
Hansel DE, Paner GP, Nese N, Amin MB. Limited smoothelin expression within the muscularis mucosae:
validation in bladder diverticula. Hum Pathol. 2011;42:1770-6.
Martignoni G, Bonetti F, Chilosi M, Brunelli M, Segala D, Amin MB, Argani P, Eble JN, Gobbo S, Pea M.
Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Mod
Pathol. 2012;25:100-11.
Ching CB, Amin MB, Tubbs RR, Elson P, Platt E, Dreicer R, Fergany A, Hansel DE. HER2 gene
amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dualcolor in situ hybridization. Mod Pathol. 2011;24:1111-9.
Fine SW, Amin MB, Berney DM, Bjartell A, Egevad L, Epstein JI, Humphrey PA, Magi-Galluzzi C,
Montironi R, Stief C. A Contemporary Update on Pathology Reporting for Prostate Cancer: Biopsy and
Radical Prostatectomy Specimens. Eur Urol 2012;62:20-39.
Goodman M, Ward KC, Osunkoya AO, Datta MW, Luthringer DJ, Young AN, Marks K, Cohen V, Kennedy
JC, Haber MJ, Amin MB. Frequency and determinants of discordance in Gleason score for prostate
cancer: a population registry-based study. Prostate. 2012;72:1389-98.
Paner GP, Aron M, Hansel DE, Amin MB. Non-epithelial neoplasms of the prostate. Histopathology.
2012;60:166-86.
239.
240.
241.
242.
243.
244.
245.
246.
247.
248.
249.
250.
251.
252.
253.
Nystrom SJ, Hornberger JC, Varadhachary GR, Hornberger RJ, Gutierrez HR, Henner DW, Becker SH,
Amin MB, Wlaker MG. Clinical utility of gene-expression profiling for tumor-site origin in patients with
metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival. Oncotarget.
2012;3:620-8.
Raspollini MR, Franchi A, Rose AD, Balzer B, Brown J, Amin MB. Necrotizing palisading granuloma of the
bladder in an otherwise healthy young man. Arch Pathol Lab Med 2012;136:679-80.
Gupta R, Billis A, Shah RB, Moch H, Osunkoya AO, Jochum W, Hes O, Bacchi CE, de Castro MG, Hansel D,
Zhou Z, Vankalakunti M, Salles PG, Cabrera RA, Gown AM, Amin MB. Carcinoma of the Collecting Ducts
of Bellini and Renal Medullary Carcinoma: Clinicopathologic Analysis of 52 Cases of Rare Aggressive
Subtypes of Renal Cell Carcinoma with a Focus on their Interrelationship. Am J Surg Pathol.
2012;36:1265-78.
Gruver AM, Amin MB, Luthringer DJ, Westfall DE, Arora K, Farver CF, Osunkoya AO, McKenney JK,
Hansel DE. Selective Immunohistochemical Markers to Distinguish Between Metastatic High Grade
Urothelial Carcinoma and Primary Poorly Differentiated Invasive Squamous Cell Carcinoma of the Lung.
Arch of Pathol Lab Med. 2012;1339-46.
Gulmann C, Paner GP, Parakh RS, Hansel DE, Shen SS, Ro JY, Annaiah C, Lopez-Beltran A, Rao P, Arora K,
Cho Y, Herrera-Hernandez L, Alsabeh R, Amin MB. Immunohistochemical profile to distinguish
urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol. 2013;44:164172.
Brimo F, Montironi R, Egevad L, Erbersdobler A, Lin D, Nelson J. Rubin M, Amin MB, van der Kwast T,
Epstein JI. Contemporary Grading for Prostate Cancer: Implications for Clinical Practice. European Urol.
2013;63:892-901.
Oliva E, Pinheiro NF, Heney NM, Kaufman DS, Shipley WU, Gurski C, Spicer B, Paner GP, Gown AM,
Amin MB. Immunohistochemistry as an Adjunct in the Differential Diagnosis of Radiation-Induced
Atypia vs Urothelial Carcinoma In Situ (CIS) of the Bladder. A Study of 45 Cases. Hum Pathol.
2013;44:860-866.
Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Epstein JI, Soloway M,
Reuter VE and Members of the Pathology of Bladder Cancer Work Group. Consensus Guidelines by The
Pathology Of Bladder Cancer Work Group. European Urol. 2013;63:16-35.
Hansel, DE, Amin MB, Comperat E, Cote RJ, Knchel R, Montironi R, Reuter VE, Soloway MS, Umar SA,
Van der Kwast TH. A contemporary update on pathology standards for bladder cancer: Transurethral
resection (TUR) and radical cystectomy specimens. European Urol. 2013;63:321-32.
Verhoven B, Yan Y, Ritter M, Khor LY, Hammond E, Jones C, Amin MB, Bahary JP, Zeitzer K, Pollack A.Ki67 Is an Independent Predictor of Metastasis and Cause-Specific Mortality for Prostate Cancer
Patients Treated on Radiation Therapy Oncology Group (RTOG) 94-08. Int J Radiat Oncol Biol Phys.
2013;86:317-23.
Comperat E, Campara P, Srigley J, Delahunt B, Egevad L, ISUP Consensus Working Group, Amin MB,
Berney DM, Billis A, Cheng L, Epstein JI, Evens A, Grignon D, Humphrey P, Magi-Galuzzi C, Montironi R,
Samaratunga H, Tan PH, True L, van der Kwast T, Wheeler T. Prise en charge de la piece de
prostatectomy radicale. Resultats de la conference de consensus de la Societe internationale
d'uropathologie (ISUP). Annales de pathologie. 2013;33:155-161.
Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A, Samaratunga H, Tamboli P,
Delahunt B, Egevad L, Montironi R, Srigley JR; the members of the ISUP Renal Tumor Panel. Handling
and Staging of Renal Cell Carcinoma: The International Society of Urological Pathology Consensus (ISUP)
Conference Recommendations. Am J Surg Pathol. 2013;37:1505-1517.
Kim M, Ro JY, Amin MB, de Peralta-Venturina M, Kwon GY, Park YW, Cho YM. Urothelial eddies in
papillary urothelial neoplasms: a distinct morphologic pattern with low risk for progression. Int J Clin
Exp Pathol. 2013;15:1458-66.
Aron M, McKenney JK, Hansel DE, Luthringer DJ, Mohanty S, Balzer BL, Parakh R, Westfall DE, Amin
MB. Utility of a triple antibody cocktail Intraurothelial Neoplasm-3 (IUN3-CK20/CD44/p53) and alphaMethylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive
urothelial atypia. Am J Surg Pathol. 2013;37:1815-1823.
Comprat E, Egevad L, Lopez-Beltran A, Camparo P, Algaba F, Amin MB, Epstein JI, Hamberg H,
Hulsbergen-Van de Kaa C, Kristiansen G, Montironi R, Pan CC, Heloir F, Treurniet K), Sykes J, Van der
254.
255.
256.
257.
258.
259.
260.
261.
262.
263.
264.
265.
266.
267.
268.
Kwast TH. A Consensus Study On Invasiveness Of Bladder Cancer Using Virtual Microscopy and
Heatmaps Histopathol. 2013;63:756-66.
Ananthanarayanan V, Pan Y, Tretiakova M, Amin MB, Cheng L, Epstein JI, Grignon DJ, Hansel DE,
Jimenez RE, McKenney JK, Montironi R, Oliva E, Osunkoya AO, Rao P, Reuter VE, Ro JY, Shen SS, Srigley
JR, Tsuzuki T, Yao JL, Antic T, Haber M, Taxy JB, Paner GP. Influence of Histologic Criteria and
Confounding Factors in Staging Equivocal Cases for Microscopic Perivesical Tissue Invasion (pT3a): An
Interobserver Study Among Genitourinary Pathologists. Am J Surg Pathol. 2014;38:167-75.
Chan OT, Chiles L, Levy M, Zhai J, Yerian LM, Xu H, Xiao SY, Soffer EE, Conklin JL, Dhall D, Kahn ME,
Balzer BL, Amin MB, Wang HL. Smoothelin Expression in the Gastrointestinal Tract: Implication in
Colonic Inertia. Appl Immunohistochem Mol Morphol. 2013;21:452-9.
Arville B, O'Rourke E, Chung F, Amin MB, Bose S. Evaluation of a Triple Combination of CK20, p53 and
CD 44 for Improving Detection of Urothelial Carcinoma in Urine Cytology Specimens. Cytojournal.
2013:10;25.
Smith SC, Mohanty SK, Kunju LP, Chang E, Chung F, Carvalho JC, Paner GP, Hansel DE, Luthringer DJ,
dePeralta-Venturina M, Amin MB. Uroplakin II Outperforms Uroplakin III in Diagnostically Challenging
Settings. Histolpatol. 2014; 65:132-8.
Seipel AH, Delahunt B, Samaratunga H, Amin MB, Barton J, Berney DM, Billis A, Cheng L, Co mperat E,
Evans A, Samson WF, Grignon D, Humphrey PA, Magi-Galluzzi C, Montironi R, Sesterhenn I, Srigley JR,
Trpkov K, van der Kwast T, Varma M, Zhou M, Ahmad A, Moss S, Egevad L. Diagnostic Criteria for Ductal
Adenocarcinoma of the Prostate. Interobserver Variability among 20 Expert Uropathologists.
Histopathol. 2014;65:216-27.
Kryvenko ON, Haley SL, Smith SC, Shen SS, Paluru S, Gupta NS, Jorda M, Epstein JI, Amin MB, Truong
LD. Hemangiomas In Kidneys With End-Stage Renal Disease: A Novel Clinicopathological Association.
Histopathol. 2014;65:309-18.
Smith N, Illei P, Allaf M, Gonzalez N, Morris K, Hicks J, De Marzo A, Reuter VE, Amin MB, Epstein JI,
Netto G, Argani P. t(6;11) renal cell carcinoma (RCC): Expanded immunohistochemical profile
exphasizing novel RCC markers and report of ten new genetically-confirmed cases. Am J Surg Pathol.
2014;38:604-14.
Paner GP, Chandrakanth SA, Gulmann C, Rao P, Ro JY, Hansel DE, Shen SS, Lopez-Beltran A, Aron M,
Luthringer DJ, Cho Y, Amin MB. Immunohistochemical Evaluation of Novel and Traditional Markers
Associated with Urothelial Differentiation in a Spectrum of Variants of Urothelial Carcinoma of the
Urinary Bladder. Hum Pathol. 2014;45:1473-82.
Epstein JI, Amin MB, Beltran H, Lotan T, Mosquera JM, Reuter VE, Robinson BD, Troncoso P, Rubin, MA.
Proposed Morphologic Classification of Prostate Cancer with Neuroendocrine Differentiation. Am J Surg
Pathol. 2014;38:756-67.
Amin MB, Smith SC, Agaimy A, Argani P, Comperat EM, Delahunt B, Epstein JI, Eble JN, Grignon DJ,
Hartmann A, Hes O, Hirsch MS, Jimenez RE, Kunju LP, Martignoni G, McKenney JK, Moch H, Montironi
R, Paner GP, Rao P, Srigley JR, Tickoo SK, Reuter VE. Collecting Duct Carcinoma versus Renal Medullary
Carcinoma: An Appeal for Nosologic and Biologic Clarity. Am J Surg Pathol. 2014.38:871-4.
Seferian EG, Jamal S, Clark K, Cirricione M, Burnes-Bolton L, Amin MB, Romanoff N, Klapper E. A
multidisciplinary, multifaceted improvement initiative to eliminate mislabeled laboratory specimens at
a large tertiary care hospital. BMJ Qual Saf. 2014;23:690-97.
Amin MB, Smith SC, Eble JN, Rao P, Choi WWL, Tamboli P, Young RH. Glandular Neoplasms of the
Urachus: A Report of 55 Cases Emphasizing Mucinous Cystic Tumors with Proposed Classification. Am J
Surg Pathol. 2014;38:1033-45.
Mohanty SK, Smith SC, Chang E, Luthringer DJ, Gown AM, Aron M, Amin MB. Evaluation of
Contemporary Prostate and Urothelial Lineage Biomarkers in a Consecutive Cohort of PoorlyDifferentiated Bladder Neck Carcinomas. Am J Clin Pathol. 2014;142:173-83.
Amin MB, Epstein JI, Ulbright TM, Humphrey PA, Egevad L, Montironi R, Grignon D, Trpkov K, LopezBeltran A, Zhou M, Argani P, Delahunt B, Berney DM, Srigley JR, Tickoo SK, Reuter VE. Best Practices
Recommendations in the Application of Immunohistochemistry in Urologic Pathology - Report from the
International Society of Urologic Pathology Consensus Conference. Am J Surg Pathol. 2014;38:1017-22.
Amin MB, Trpkov K, Lopez-Beltran A, Grignon D and members of the ISUP Immunohistochemistry in
Diagnostic Urologic Pathology Group. Best Practices Recommendations in the Application of
269.
270.
271.
272.
273.
274.
275.
276.
277.
278.
B.
Immunohistochemistry in the Bladder Lesions - Report from the International Society of Urologic
Pathology Consensus Conference. Am J Surg Pathol. 2014;38:e20-34.
Amin MB, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin M, Nacey J, Carter HB, Klotz L,
Sandler H, Zietman AL, Holden S, Montironi R, Humphrey PA, Evans AJ, Epstein JI, Delahunt B,
McKenney JK, Berney D, Wheeler TM, Chinnaiyan AM, True L, Knudsen B, Hammond ME. The Critical
Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in
Patients with Prostate Cancer: Consensus Statement with Recommendations Supported by The College
of American Pathologists, International Society of Urological Pathology, Association of Directors of
Anatomic And Surgical Pathology, The New Zealand Society of Pathologists and The Prostate Cancer
Foundation. Arch Pathol Med Lab Med. 2014;138:1387-405.
Williamson SR, Eble JN, Amin MB, Gupta NS, Smith SC, Sholl LM, Montironi R, Hirsch MS, Hornick JL.
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors
defining a unique subtype of renal cell carcinoma. Mod Pathol. 2014 Jul 18 [Epub ahead of print].
Montironi R, Hammond EH, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin MA, Nacey J,
Klotz L, Sandler H, Zietman AL, Holden S, Humphrey PA, Evans AJ, Delahunt B, McKenney JK, Berney D,
Wheeler TM, Chinnaiyan A, True L, Knudsen B, Epstein JI, Amin MB. Consensus statement with
recommendations on active surveillance inclusion criteria and definition of progression in men with
localized prostate cancer: the critical role of the pathologist. Virchows Arch. 2014;465:623-628.
Kuroda N, Ohe C, Kawakami F, Mikami S, Furuya M, Matsuura K, Moriyama M, Nagashima Y, Zhou M,
Petersson F, Lpez JI, Hes O, Michal M, Amin MB. Clear Cell Papillary Renal Cell Carcinoma with Focus
on Clinical and Pathobiological Aspects. J Clin Exp Pathol. 2014;7:7312-7318.
Rioux-Leclercq N, Ferran A, Amin MB, Argani P, Billis A, Bonsib S, Cheng L, Cheville J, Eble J, Egevad L,
Epstein J, Grignon D, Hes O, Humphrey P, Magi-Galluzzi C, Martignoni G, McKenney J, Merino M, Moch
H, Montironi R, Netto G, Reuter V, Samaratunga H, Shen S, Srigley J, Tamboli P, Tan PH, Tickoo S,
Trpkov K, Zhou M, Delahunt B, Comperat E. Renal tumors: The International Society of Urologic
Pathology (ISUP) 2012 consensus conference recommendationsAnn Pathol. 2014;34:448-61.
Amin MB, Smith SC, Reuter VE, Epstein JI, Grignon DJ, Hansel DE, Lin O, McKenney JK, Montironi R,
Paner GP, Al-Ahmadie HA, Algaba F, Ali S, Alvarado-Cabrero I, Bubendorf L, Cheng L, Cheville JC,
Kristiansen G, Cote RJ, Delahunt B, Eble JN, Genega EM, Gulmann C, Hartmann A, Langner C, LopezBeltran A, Magi-Galluzzi C, Merce J, Netto GJ, Oliva E, Rao P, Ro JY, Srigley JR, Tickoo SK, Tsuzuki T,
Umar SA, Van der Kwast T, Young RH, Soloway MS. Update for the Practicing Pathologist: The
International Consultation on Urologic Disease-European Association of Urology Consultation on
Bladder Cancer. Mod Pathol. 2014 Nov 21 [Epub ahead of print].
Delahunt B, Hammond E, Egevad L, Samaratunga H, Srigley JR, Humphrey PA, Rubin M, Epstein JI, Lin
DW, Gore JL, Nacey J, Klotz L, Sandler H, Zietman AL, Holden S, Montironi R, Evans AJ, McKenney JK,
Berney D, Wheeler TM, Chinnaiyan AM, True L, Knudsen B, Amin MB. Active Surveillance for Prostate
Cancer: the Role of the Pathologist. Pathology. 2015;47:1-3.
Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA,
Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM. Duration of
Androgen Suppression before Radiotherapy for Localized Prostate Cancer Radiation Therapy
Oncology Group Randomized Clinical Trial 9910. J Clin Oncol. 2015;33:332-339.
Berney DM, Algaba F, Amin MB, Delahunt B, Comprat E, Epstein JI, Humphrey P, Idrees M, LopezBeltran A, Magi-Galluzzi C, Mikuz G, Montironi R, Oliva E, Srigley J, Reuter VE, Trpkov K, Ulbright TM,
Varma M, Verrill C, Young RH, Zhou M, Egevad L. Handling and Reporting of Orchidectomy Specimens
with Testicular Cancer: Areas of Consensus and Variation among 25 Experts and 225 European
Pathologists. Histopathology. 2015 Jan 25 [Epub ahead of print].
Bruner DW, Hunt D, Michalski JM, Bosch WR, Galvin JM, Amin MB, Xiao C, Bahary JP, Patel M, Chafe S,
Rodrigues G, Lau H, Duclos M, Baikadi M, Deshmukh S, Sandler HM. Preliminary Patient Reported
Outcomes Analysis of 3DCRT versus IMRT on the High Dose Arm of the Radiation Therapy Oncology
Group (RTOG) 0126 Prostate Cancer Trial. Cancer 2015 Apr 2 [Epub ahead of print].
Reseach Papers (In press)

279.
Aron M, Chang E, Herrera L, Hes O, Hirsch MS, Comperat E, Camparo P, Rao P, Picken M, Michal M,
Montironi R, Tamboli P, Monzon F, Amin MB. Clear cell-papillary renal cell carcinoma of the kidney not
associated with end-stage renal disease: clinicopathologic correlation with expanded
280.
C.
Published Papers with Authorship as Listed Collaborator on PubMed

281.
282.
283.
284.
285.
286.
287.
288.
289.
290.
D.
immunophenotypic and molecular characterization of a large cohort with emphasis on relationship

with renal angiomyoadenomatous tumor. Am J Surg Pathol (In press).
Hirsch M, Mehra R, Smith SC, Divatia M, Amin MB. Emerging Entities in Renal Neoplasia. Surgical
Pathology Clinics (In press).
Samaratunga H, Montironi R, True L, Epstein JI, Griffiths DF, Humphrey PA, van der Kwast T, Wheeler
TM, Srigley JR, Delahunt B, Egevad L; ISUP Prostate Cancer Group (Amin MB listed collaborator on
PubMed). International Society of Urological Pathology (ISUP) Consensus Conference on Handling and
Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol.
2011;24:6-15.
Berney DM, Wheeler TM, Grignon DJ, Epstein JI, Griffiths DF, Humphrey PA, van der Kwast T, Montironi
R, Delahunt B, Egevad L, Srigley JR; ISUP Prostate Cancer Group (Amin MB listed collaborator on
Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Mod
Pathol. 2011;24:39-47.
Magi-Galluzzi C, Evans AJ, Delahunt B, Epstein JI, Griffiths DF, van der Kwast TH, Montironi R, Wheeler
TM, Srigley JR, Egevad LL, Humphrey PA; ISUP Prostate Cancer Group (Amin MB listed collaborator on
Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension,
lymphovascular invasion and locally advanced disease. Mod Pathol. 2011;24:26-38.
Tan PH, Cheng L, Srigley JR, Griffiths D, Humphrey PA, van der Kwast TH, Montironi R, Wheeler TM,
Delahunt B, Egevad L, Epstein JI; ISUP Prostate Cancer Group (Amin MB listed collaborator on
Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Mod Pathol. 2011
Jan;24:48-57.
Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, Shen SS, Grignon DJ, Montironi R,
Egevad L, Srigley JR, Delahunt B, Moch H; ISUP Renal Tumor Panel (Amin MB, Listed Collaborator on
PubMed). Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol. 2013;37:1518-31.
Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F,
Moch H, Grignon DJ, Montironi R, Srigley JR; Members of the ISUP Renal Tumor Panel. (Amin MB,
Listed Collaborator on PubMed). The International Society of Urological Pathology 7(ISUP) grading
system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37:1490-504.
Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK,
Zhou M, Argani P; ISUP Renal Tumor Panel. (Amin MB, Listed Collaborator on PubMed). The
International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J
Surg Pathol. 2013;37:1469-89.
Epstein JI, Egevad L, Humphrey PA, Montironi R and members of the ISUP Immunohistochemistry in
Diagnostic Urologic Pathology Group (Amin MB listed collaborator on PubMed). Best Practices
Recommendations in the Application of Immunohistochemistry in the Prostate - Report from the
International Society of Urologic Pathology Consensus Conference. Am J Surg Pathol. 2014:38:e6-e19.
Reuter VE, Argani P, Zhou M, Delahunt B and members of the ISUP Immunohistochemistry in Diagnostic
Urologic Pathology Group (Amin MB listed collaborator on PubMed). Best Practices Recommendations
in the Application of Immunohistochemistry in Kidney Tumors - Report from the International Society
of Urologic Pathology Consensus Conference. Am J Surg Pathol. 2014;38:e35-e49.
Ulbright TM, Tickoo SK, Berney D, Srigley JR and members of the ISUP Immunohistochemistry in
Diagnostic Urologic Pathology Group (Amin MB listed collaborator on PubMed). Best Practices
Recommendations in the Application of Immunohistochemistry in Testicular Tumors - Report from the
International Society of Urologic Pathology Consensus Conference. Am J Surg Pathol. 2014;38:e50-9.
Letters to the Editor

291.
292.
Ro JY, El-Naggar A, Amin MB, Ayala AG. Inflammatory pseudotumor of the urinary bladder. Am J Surg
Pathol 1993;17:1193. (Letter to the Editor)
Amin MB, Gottlieb CA, Gaba AR, Lee MW, Zarbo RJ, Fitzmaurice M: Cytologic diagnosis of
myofibroblastoma of the breast: (Authors Reply) Am J Clin Pathol 1994, 101(5):674-675.
293.
294.
295.
296.
297.
298.
299.
300.
301.
302.
303.
304.
Bostwick DG, Algaba F, Amin MB, Ayala AG, Eble J, Goldstein N, Helpap B, Humphrey P, Grignon D,
Jones EC, McNeal J, Montironi R, Qian J, Ro J, Srigley J, Tetu B, Troncoso P, True L, Wheeler T, Young
RH. Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia
in place of adenosis of the prostate. Hum Pathol 1994;25:840, Am J Surg Pathol 1994;18:1069-1070.
(Letter to the Editor)
Amin MB: Florid hyperplasia of mesonephric remnants: Yet another differential diagnostic
consideration under small acinar proliferations of the prostate. (Editorial Commentary) Adv Anat
Pathol 1995;2:108-113.
Amin MB, Ro JY, Ayala AG. Papillary variant of transitional cell carcinoma (Authors Reply) Am J Surg
Pathol 1996;20:126.
Amin MB, Jones EC, Eble JN, Young RH. Interinstitutional comparison of bladder carcinoma surgical
pathology report adequacy. Arch Pathol Lab Med 1996;120:517. (Letter to the Editor)
Hailemariam S, Engeler DS, Bannwart F, Amin MB. Primary mediastinal germ cell tumor with
intratubular germ cell neoplasia of the testis - Further support for germ cell origin of these tumors.
(Author's reply). Cancer 1997;80:1008.
Renshaw AA, Amin MB, Tickoo SK, Corless CL. Nuclear grooves in renal carcinoma. (Author's reply).
Am J Surg Pathol 1998;22:1299.
Amin MB, Tickoo SK, Corless CL, Renshaw AA. Mucin secretion in papillary renal cell carcinoma.
(Authors reply). Am J Surg Pathol 1998;22:1039.
Reuter VE, Epstein JI, Amin MB, Mostofi FK and the Bladder Consensus Conference Committee. The
WHO/ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms:
Continued
Discussion. Hum Pathol 1999;30:879-880. (Letter to the Editor).
Epstein JI, Amin MB, Reuter VE, Mostofi FK. Revised classification of urothelial neoplasms: (Authors
reply). Am J Surg Pathol 2000;24:161-162.
Amin MB. Authors Reply to: Osteoclast-rich undifferentiated carcinoma of the urinary bladder: is it
really an entity? Adv Anat Pathol. 2010;17:288-9.
Amin MB, McKenney JK. Authors Reply to: An approach to the diagnosis of flat intraepithelial lesions of
the urinary bladder using the World Health Organization/ International Society of Urological Pathology
consensus classification system. Adv Anat Pathol. 2010;17:290-1.
Smith SC, Bannykh SI, Amin MB. Melanotic Sertoli Cell tumor. Am J Surg Pathol. 2014;38:1305-6.
BOOKS:
A.
Books
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Ro JY, Grignon D, Amin MB, Ayala AG: Atlas of Surgical Pathology of Male Genital Tract. 1st Edition.
W.B. Saunders Co., Philadelphia, PA, 1996.
Ulbright TM, Amin MB, Young RH: Tumors of the Testis, Adnexa, Spermatic Cord, and Scrotum. Third
Series Fascicle 25, Armed Forces Institute of Pathology, Washington, DC, 1999.
Young RH, Srigley JR, Amin MB, Ulbright TM , Cubilla AL: Tumors of the Prostate Gland, Seminal
Vesicles, Male Urethra, and Penis. Third Series Fascicle 28, Armed Forces Institute of Pathology,
Washington, DC, 2000.
Amin MB, Grignon D, Humphrey PH, Srigley JR. Gleason Grading of Prostate Cancer: A Contemporary
Approach. Lippincott Williams & Wilkins, Philadelphia, PA, 2004.
Epstein JI, Amin MB, Reuter VE. Bladder Biopsy Interpretation. Lippincott Williams & Wilkins,
Philadelphia, PA, 2004.
Epstein JI, Reuter VE, Amin MB. Biopsy Interpretation of the Bladder. 2nd Edition. Lippincott Williams &
Wilkins, Philadelphia, PA, 2010.
Amin MB, McKenney JM, Tickoo S, Paner GP, Shen S, Velazquez EF, Cubilla A, Ro J, Reuter V. Diagnostic
Pathology. Genitourinary. Amirsys, Salt Lake City, Utah, 2010.
Amin MB, Washington K. (Eds) Reporting on Cancer Specimens. College of American Pathologists,
Northfield, IL, 2010.
Amin MB, Grignon D, Srigley J, Eble J (Eds). Urological Pathology. Wolters Kluwer, Philadelphia, PA,
2014.
AJCC Cancer Staging Manual, Amin MB (Editor-in-Chief) 8th Edition. Philadelphia, PA, 2016 (In
preparation).
B.
Book Chapters
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Peabody J, Korman HJ, Amin MB: Rare urologic malignancies: miscellaneous tumors of the
genitourinary tract. Chapter 68, In: Comprehensive Textbook of Genitourinary Oncology. Eds.
Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS, Miles B. Williams and Wilkins. Baltimore, MD, 1996,
pages 1152-1158.
Bostwick DG, Amin MB: Prostate gland and seminal vesicles. Chapter 67, Vol. 2, In: Anderson's
Pathology. 10th Edition. Eds. Damjanov I, Linder J. Mosby-Year Book, Inc., St. Louis, MO, 1996, pages
2197-2230.
Ro JY, Amin MB, Ayala AG: Pathology of penis and scrotum. In: Urologic Pathology. Editors - Bostwick
DG, Eble J. Mosby Yearbook, Inc., St. Louis, MO, 1997; pages 674-723.
Srigley JR, Bullock M, Amin MB: Small glandular patterns in the prostate: the differential diagnosis of
small acinar carcinoma. Chapter 8, Vol. 34, In: Pathology of the Prostate. Major Problems in Pathology
Series. W.B. Saunders, Philadelphia, PA, 1998; pages 126-156.
Johnson TL, Amin MB: Pathology of the adrenal glands. In: Medical and Surgical Management of
Adrenal Diseases. Editor: Cerny J. Lippincott-Williams and Wilkins Publishers, Inc., Philadelphia, PA,
1999; pages 11-27.
Amin MB, Tamboli P, Ro JY: Non-transitional cell carcinoma of the bladder. Chapter 7 In: Bladder
Cancer. Editors: Syrigos KN and Skinner DG. Oxford University Press, Oxford, Great Britain, 1999;
pages 125-140.
Javidan J, Korman HJ, Amin MB, Peabody JO: Miscellaneous tumors of the genitourinary tract. In:
Comprehensive Textbook of Genitourinary Oncology. 2nd Edition, Editors: Vogelzang NJ, Scardino PT,
Shipley WU, Coffey DS, Miles BJ, Lippincott Williams & Wilkins, Philadelphia, PA, 2000; pages 11411157.
Ro JY, Amin MB, Sahin AA, Ayala AG: Tumors of the male genital tract. Chapter 14 In: Diagnostic
Histopathology of Tumors. 2nd Edition, Editor: Christopher D.M. Fletcher, Churchill Livingstone,
London, UK, 2000; pages 733-838.
Ayala AG, Ro JY, Amin MB, Czerniak B, Albores-Saavedra J: Early epithelial neoplasia of urinary bladder
(Chapter 20). In: Pathology of Incipient Neoplasia. Editors: Henson DE, Albores-Saavedra J; W.B.
Saunders Co., Philadelphia, PA 2001; pages 489-534.
Tamboli PT, Jimenez RE, Amin MB: Systemic oncology of the urinary tract. Chapter 44, Vol 1, In:
Cancer Handbook. Editor: Alison MR. Macmillan, London, UK 2001; pages 645-664.
Amin MB, Tamboli P, Ro JY: Penis and scrotum (Chapter 33). In: Modern Surgical Pathology. Editors:
Weidner N, Chan JKC, Cote RJ, Suster S, Weiss LM; W.B. Saunders Co., Philadelphia, PA 2002; pages
1197-1214.
Tickoo SK, Tamboli P, Warner N, Amin MB: Testis and paratestis including spermatic cord (Chapter 34).
In: Modern Surgical Pathology. Editors: Weidner N, Chan JKC, Cote RJ, Suster S, Weiss LM; W.B.
Saunders Co., Philadelphia, PA 2002; pages 1215-1258.
Cote RJ, Soni RA, Amin MB: Urinary bladder and urethra (Chapter 31). In: Modern Surgical Pathology.
Editors: Weidner N, Chan JKC, Cote RJ, Suster S, Weiss LM; W.B. Saunders Co., Philadelphia, PA 2002;
pages 1102-1148.
Amin MB, Srigley JR, Grignon DJ, Reuter VE, Humphrey PA, Cohen MB, Hammond ME: Urinary bladder,
ureter, and renal pelvis. In: Reporting on Cancer Specimens. Case Summaries and Background
Documentation. CAP Press, Northfield, IL, 2003.
Srigley JR, Amin MB, Humphrey PA: Prostate gland. In: Reporting on Cancer Specimens. Case
Summaries and Background Documentation. CAP Press, Northfield, IL, 2003.
Srigley JR, Amin MB: Kidney. In: Reporting on Cancer Specimens. Case Summaries and Background
Documentation. CAP Press, Northfield, IL, 2003.
Amin MB, Srigley JR, Ulbright TM: Testis. In: Reporting on Cancer Specimens. Case Summaries and
Background Documentation. CAP Press, Northfield, IL, 2003.
Martignoni G, Amin MB: Angiomyolipoma. In: World Health Organization Classification of Tumours.
Pathology and Genetic Tumors of the Urinary System and Male Genital Organs. Editors: Eble JN,
Sauter G, Epstein J, Sesterhenn I; IARC Press, Lyon, 2004; pages 65-67.
Amin MB: Epithelioid angiomyolipoma. In: World Health Organization Classification of Tumours.
Sauter G, Epstein J, Sesterhenn I; IARC Press, Lyon, 2004; pages 68-69.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
Lopez-Beltran A, Knowles, MA, Sauter G, Sidransky D, Gasser T, Cordon-Cardo C, Hartmann A, Jones PA,
Schmitz-Drager BJ, Cairns P, Helpap B, Simon R, Ayala AG, Amin MB, Tamboli P, Tyczynski JE.
Infiltrating urothelial carcinoma. In: World Health Organization Classification of Tumours. Pathology
and Genetic Tumors of the Urinary System and Male Genital Organs. Editors: Eble JN, Sauter G,
Epstein J, Sesterhenn I; IARC Press, Lyon, 2004; pages 93-109.
Sauter G, Gasser T, Algaba F, Grignon DJ, Amin MB, Hofstadter F, Busch C, Lopez-Beltran A, Cheville J,
Epstein JI. Non-invasive urothelial tumours. In: World Health Organization Classification of Tumours.
Sauter G, Epstein J, Sesterhenn I; IARC Press, Lyon, 2004; page 110.
Amin MB. Urothelial dysplasia. In: World Health Organization Classification of Tumours. Pathology
and Genetic Tumors of the Urinary System and Male Genital Organs. Editors: Eble JN, Sauter G,
Epstein J, Sesterhenn I; IARC Press, Lyon, 2004; pages 111-112.
Delahunt B, Amin MB, Hofstder F, Hartmann A:Tumors of the renal pelvis and ureters. In: World
Health Organization Classification of Tumours. Pathology and Genetic Tumors of the Urinary System
and Male Genital Organs. Editors: Eble JN, Sauter G, Epstein J, Sesterhenn I; IARC Press, Lyon, 2004;
pages 150-153.
Hofstder F, Amin MB, Delahunt B, Hartmann A: Tumors of the male and female urethra. In: World
Health Organization Classification of Tumours. Pathology and Genetic Tumors of the Urinary System
and Male Genital Organs. Editors: Eble JN, Sauter G, Epstein J, Sesterhenn I; IARC Press, Lyon, 2004;
pages 154-157.
Logani SL, Amin MB.Conventional Morphologic, Prognostic and Predictive Factors for Bladder Cancer
(Chapter 17).Pathology of the Bladder.Major Problems in Pathology Series.Saunders, Philadelphia, PA,
2005; pages 183-190.
Tickoo SK, Amin MB. Tumors and tumor-like conditions of the kidney. In: Atlas of Genitourinary
Diseases. Editor: Tannenbaum M, Madden J; Churchill Livingstone, Philadelphia, PA, 2006. Chapter 8,
pages 191-240.
Tickoo SK, Amin MB , Cramer H, , Harik, L, Ulbright TM,. The testis, paratesticular structures and male
external genitalia. In: Principles and Practice of Surgical Pathology and Cytopathology, Churchill
Livingstone, Philadelphia, PA, 2006. 4th edition Chapter 36, pages 1731-1790.
Shah RR, Amin MB, Diseases of the Penis, Urethra, and Scrotum In: Genitourinary Pathology. Editors:
Zhou M, Magi-Galluzzi C; Churchill Livingstone, Philadelphia, PA, 2007. 1st edition Chapter 8, pages 419476.
Ro JY, Amin MB, Sahin AA, Ayala AG: Tumors of the male genital tract. Chapter 14 In: Diagnostic
Histopathology of Tumors. Editor: Fletcher CDM; Churchill Livingstone, 3rd edition. London, UK, 2007;
pages 749-880.
Tickoo SK, Argani P, Amin MB: Tumors of the Kidney. Chapter 17 In: Diagnostic Renal Pathology.
Editors: Zhou XJ, Laszik Z, Nadasdy T, DAgati VD, Silva FG; Cambridge University Press, New York, NY,
2009; pages 568-602.
Cote RJ, Mitra AP, Amin MB: Urinary bladder and urethra. Chapter 31 In: Modern Surgical Pathology.
Editors: Weidner N, Chan JKC, Cote RJ, Suster S, Weiss LM; W.B. Saunders Co., 2nd edition. Philadelphia,
PA 2009, pages 1079-1120.
Tamboli P, Cubilla AL, Amin MB: Penis and Scrotum. Chapter 33 In: Modern Surgical Pathology.
Editors: Weidner N, Chan JKC, Cote RJ, Suster S, Weiss LM; W.B. Saunders Co., 2nd edition. Philadelphia,
PA 2009, pages 1181-1196.
Tickoo SK, Tamboli P, Amin MB: Testis and Paratestis Including Spermatic Cord. Chapter 34 In: Modern
Surgical Pathology. Editors: Weidner N, Chan JKC, Cote RJ, Suster S, Weiss LM; W.B. Saunders Co., 2 nd
edition. Philadelphia, PA 2009, pages 1197-1234.
Amin MB, Reuter VE, Epstein JE, Grignon DJ et al: Pathology Consensus Guidelines by the Pathology of
Bladder Cancer Work Group. Committee 2 In: Bladder Cancer. Editors: Soloway M, Khoury S; ICUD-EAU
Press, 2nd edition. Paris, France 2012, pages 63-168.
Ro JY, Kim K, Shen SS, Amin MB, Ayala AG: Tumors and tumorlike conditions of the male genital tract.
Chapter 14 In: Diagnostic Histopathology of Tumors. Editor: Fletcher CDM; Elsevier Saunders, 4th
edition. London, UK, 2013; pages 872-1030.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
Paner GP, Magi-Galluzzi CM, Amin MB, Srigley JR. Adenocarcinoma of Prostate. Chapter 9 In: Urological
Pathology. Editors: Amin, Eble, Srigley, Grignon; Wolters Kluwer, Philadelphia, PA, 2014; pages 559673.
Velazquez EF, Amin MB, Cubilla AL. Penis and Scrotum. Chapter 14 In: Urological Pathology. Editors:
Amin, Eble, Srigley, Grignon; Wolters Kluwer, Philadelphia, PA, 2014; pages 855-918.
Ro JY, Divatia M, Kim K, Amin MB, Ayala AG. Penis and Scrotum. Chapter 14 In: Urologic Surgical
Pathology. Editors: Bostwick, Cheng; Elsevier, 3rd Edition. London, UK, 2014; pages 850-900.
Sauter G, Amin MB (reviewer), Kogevinas M (reviewer). Bladder Cancer. Chapter 5.10 In: World Cancer
Report 2014. World Health Organization, IARC Press, Lyon, 2014; pages 632-644.
Smtih SC, Amin MB. Diagnosis of Invasion and Determination of the Depth of Invasion. Chapter 8 In:
Bladder Cancer: Advances in Surgical Pathology Series (In press).
Moch H, Amin MB, Delahunt B, Srigley JR, Martignoni G, Argani P, Tickoo S, Tan P. Renal Cell
Carcinoma, Classification, Staging, Grading. In: World Health Organization Classification of Tumours.
Pathology and Genetic Tumors of the Urinary System and Male Genital Organs. Editors: Moch H,
Humphrey P, Ulbright T, Reuter V; IARC Press, Lyon, 2016 (In press).
Moch H, Amin MB, Delahunt B, Srigley JR, Martignoni G, Argani P, Tickoo S, Tan P. Papillary Renal Cell
Carcinoma. In: World Health Organization Classification of Tumours. Pathology and Genetic Tumors of
the Urinary System and Male Genital Organs. Editors: Moch H, Humphrey P, Ulbright T, Reuter V; IARC
Press, Lyon, 2016 (In press).
Gill A, Amin MB, Smith SC, Trpkov K. SDH Defficient Renal Cell Carcinoma. In: World Health
Organization Classification of Tumours. Pathology and Genetic Tumors of the Urinary System and Male
Genital Organs. Editors: Moch H, Humphrey P, Ulbright T, Reuter V; IARC Press, Lyon, 2016 (In press).
Amin MB, Merino M. Renal Medullary Carcinoma. In: World Health Organization Classification of
Tumours. Pathology and Genetic Tumors of the Urinary System and Male Genital Organs. Editors:
Moch H, Humphrey P, Ulbright T, Reuter V; IARC Press, Lyon, 2016 (In press).
Fleming S, Amin MB. Collecting Duct Carcinoma. In: World Health Organization Classification of
Cheng L, Beltran-Lopez A, Amin MB. Renal Cell Carcinoma, Unclassified. In: World Health Organization
Classification of Tumours. Pathology and Genetic Tumors of the Urinary System and Male Genital
Organs. Editors: Moch H, Humphrey P, Ulbright T, Reuter V; IARC Press, Lyon, 2016 (In press).
Cubilla A, Amin MB, Young RH. Secondary Tumors of the Penis. In: World Health Organization
Classification of Tumours. Pathology and Genetic Tumors of the Urinary System and Male Genital
Organs. Editors: Moch H, Humphrey P, Ulbright T, Reuter V; IARC Press, Lyon, 2016 (In press).
Amin MB. Tumors of the Collecting Duct and Rete. In: World Health Organization Classification of
Berney D, Amin MB. Paratesticular Tumors, Mesothelioma. In: World Health Organization Classification
of Tumours. Pathology and Genetic Tumors of the Urinary System and Male Genital Organs. Editors:
Tickoo S, Amin MB, Ulbright T, et al. Prepubertal Teratoma. In: World Health Organization Classification
of Tumours. Pathology and Genetic Tumors of the Urinary System and Male Genital Organs. Editors:
Cao D, Amin MB. Inverted Papilloma of the Bladder. In: World Health Organization Classification of
Humphrey P, Fine S, Amin MB, Epstein JI, et al. Prostate Cancer, General Features. In: World Health
Organization Classification of Tumours. Pathology and Genetic Tumors of the Urinary System and Male
Genital Organs. Editors: Moch H, Humphrey P, Ulbright T, Reuter V; IARC Press, Lyon, 2016 (In press).
ABSTRACTS:
(#s 1-150 PRESENTED 1989-2000)
151.
Amin MB, Moch H, Alvarado-Cabrero I, Jimenez RE, Tamboli P, dePeralta-Venturina M, Amin M, Lim
DS, Mihatsch M, Stricker H. Chromophobe renal cell carcinoma (CH-RCC): Histopathologic and
152.
153.
154.
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
prognostic features in 116 cases. Mod Pathol 14:100A, 2001. Presented at the U.S. and Canadian
Academy of Pathology meeting, Atlanta, GA, March 2001.
Amin MB, Young RH, Scully RE. Large cell hyalinizing Sertoli cell tumor of the testis: A distinctive
estrogenic tumor of boys with Peutz-Jeghers syndrome (PHS): A report of six cases. Mod Pathol
14:100A, 2001. Presented: U.S. and Canadian Academy of Pathology meeting, Atlanta, GA, March 2001.
Lim SD, Amin M, dePeralta-Venturina M, Tamboli P, Ro J, Slaton JW, Jimenez RE, Amin MB. Patterns of
metastasis and metastatic potential of histologic subtypes of renal cell carcinoma (RCC): A study of 209
clinical cases. Mod Pathol 14:115A, 2001. Presented at the U.S. and Canadian Academy of Pathology
meeting, Atlanta, GA, March 2001.
Lim SD, Copeland JN, Cohen C, Keane TE, Amin MB. Prognostic role of CD44 cell adhesion molecule
protein expression in primary and metastatic renal cell carcinoma (RCC): A clinicopathologic study of
125 cases. Mod Pathol 14:115A, 2001. Presented at the U.S. and Canadian Academy of Pathology
meeting, Atlanta, GA, March 2001.
Copeland JN, Amin MB, Humphrey PA, Tamboli P, Ro JY, Gal AA. Morphologic patterns of prostatic
adenocarcinoma (PCa) metastatic to the lung. Mod Pathol 14:217A, 2001. Presented at the U.S. and
Canadian Academy of Pathology meeting, Atlanta, GA, March 2001.
Chen X, Amin MB, Folpe AL, Lim S, Cohen C, Neish A, Jensen P. Expression and distribution of CD74
(MHC class II invariant chain) in a wide range of epithelial neoplasia. Mod Pathol 14:104A, 2001.
Presented at the U.S. and Canadian Academy of Pathology meeting, Atlanta, GA, March 2001.
Young AN, Amin MB, Lim SD, Cohen C, Petros J, Marshall FF, Neish AS. Classification of renal epithelial
tumors by gene expression profiling. Mod Pathol 14:129A, 2001. Presented at the U.S. and Canadian
Academy of Pathology meeting, Atlanta, GA, March 2001.
Jimenez RE, Folpe AL, Lapham RL, Ro JY, Ordonez N, Ayala AG, OShea PA, Weiss SW, Amin MB.
Primary Ewings sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and
immunohistochemical analysis of 11 cases. Mod Pathol 14:112A, 2001. Presented at the U.S. and
McKenney JK, Amin MB, Srigley JR, Ro JY, Jimenez R, Grignon DJ, Young RH. Adenoid basal
proliferations of the prostate other than usual basal cell hyperplasia: A study of 23 cases with a
proposed classification. Mod Pathol 14:117A, 2001. Presented at the U.S. and Canadian Academy of
Pathology meeting, Atlanta, GA, March 2001.
Oliva E, Amin MB, Jimenez R, Young RH. Clear cell carcinoma (CCC) of the of the urinary bladder: a
report of thirteen cases with emphasis on its histogenesis. Mod Pathol 14:119A, 2001. Presented at
the U.S. and Canadian Academy of Pathology meeting, Atlanta, GA, March 2001.
Oliva E, Amin MB, Murray SK, Young RH, Scully RE. Endometrial stromal and smooth muscle tumors of
the uterus: do they have distinctive immunohistochemical profiles? Mod Pathol 14:142A, 2001.
Presented at the U.S. and Canadian Academy of Pathology meeting, Atlanta, GA, March 2001.
Sakr WA, Srigley JR, Dey J, Amin MB, Bostwick DG, Epstein JI, Grignon DJ, Humphrey PA, Jones EC,
Troncoso P, Wheeler TM, Young RH. What features do urologic pathologists emphasize in diagnosing
prostate lesions with equivocal changes of prostatic intraepithelial neoplasia (PIN)? A study of
morphologic criteria and reproducibility. Mod Pathol 14:122A, 2001. Presented at the U.S. and
Varma M, Morgan M, Jasani B, Amin MB. Immunohistochemical detection of PSA: Comparison of
monoclonal and polyclonal antibodies with implications for diagnostic pathology. Mod Pathol 14:126A,
2001. Presented at the U.S. and Canadian Academy of Pathology meeting, Atlanta, GA, March 2001.
Tamboli P, Amin MB, Eble JN, Young RH. Histologic spectrum of glandular neoplasms of the urachus
with special emphasis on low-grade tumors. Mod Pathol 14:124A, 2001. Presented at the U.S. and
Lee M, dePeralta-Venturina M, Lim S, Amin MB. Small cell carcinoma of prostate gland:
immunohistochemical assessment of relationship to adenocarcinoma of prostate. Mod Pathol
14:115A, 2001. Presented at the U.S. and Canadian Academy of Pathology meeting, Atlanta, GA, March
2001.
Sun CQ, Donald C, Chandham P, Lim SD, Cohen C, Amin MB, Marshall FF, Ganz T, Petros JA. Loss of
expression of human defensin 1 in prostate cancer suggests a possible role as tumor suppressor gene.
Proc of the Amer Assoc for Cancer Res 42:399, 2001. Presented at the 92 nd Annual Meeting of the
American Association for Cancer Research meeting, New Orleans, LA, March 2001.
167.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
178.
179.
180.
Donald C, Laddu A, Chandham P, Lim SD, Cohen C, Amin MB, Gerton G, Marshall FF, Petros JA.
Expression of acrogranin correlates with neoplastic state in breast and ovarian epithelium. Proc of the
Amer Assoc for Cancer Res 42:2180,2001. Presented at the 92nd Annual Meeting of the American
Association for Cancer Research meeting, New Orleans, LA, March 2001.
Donald CD, Laddu A, Chandham P, Lim SD, Cohen C, Amin MB, Gerton G, Marshall F, Petros J.
Increased expression of acrogranin is associated with malignant renal disease. Proc of the Amer Assoc
for Cancer Res 42:2772, 2001. Presented at the 92 nd Annual Meeting of the American Association for
Cancer Research meeting, New Orleans, LA, March 2001.
Petros JA, Sun CQ, Irons H, Donald C, Amin MB, Lim SD, Hosseini S, Marshall FF, Wallace DC.
Mitochondrial DNA point mutations are common in prostate cancer and enhance malignant phenotype.
Proc of the Amer Assoc for Cancer Res 42:2781, 2001. Presented at the 92 nd Annual Meeting of the
American Association for Cancer Research meeting, New Orleans, LA, March 2001.
Beach R, Gown AM, Folpe AL, Yaziji H, Fanger G, Amin MB. Immunohistochemical (IHC) expression of
P504S gene protein in 367 18-gauge prostatic needle biopsies: potential adjunctive marker for the
diagnosis of adenocarcinoma. Mod Pathol 15:155A, 2002. Presented at the U.S. and Canadian
Academy of Pathology meeting, Chicago, IL, February 2002.
Parker DC, Folpe AL, Bell JD, Oliva E, Cohen C, Young RH, Amin MB. Potential utility of uroplakin III,
thrombomodulin and cytokeratin 20 as a diagnostic panel for urothelial (transitional cell)
differentiation. Mod Pathol 15:176A, 2002. Presented at the U.S. and Canadian Academy of Pathology
meeting, Chicago, IL, February 2002.
McKenney JK, Amin MB, Young RH. Urothelial (transitional cell) papilloma of the urinary bladder: a
clinicopathologic study of 25 cases. Mod Pathol 15:174A, 2002. Presented at the U.S. and Canadian
Moch H, Bucher C, Nocito A, Lim SD, Amin MB, Mihatsch MJ, Sauter G. Determination of the specificity
of the renal cell carcinoma antibody by tissue microarray. Mod Pathol 15:175A, 2002. Presented at
the U.S. and Canadian Academy of Pathology meeting, Chicago, IL, February 2002.
Young AN, Salles PGO, Neish AS, Lim SD, Cohen C, Petros JA, Marshall FF, Amin MB. Beta defensin-1,
parvalbumin and vimentin expression in adult renal epithelial neoplasia:
a diagnostic
immunohistochemical panel derived from cDNA microarray studies. Mod Pathol 15:188A, 2002.
Presented at the U.S. and Canadian Academy of Pathology meeting, Chicago, IL, February 2002.
Srigley J, Kapusta L, Reuter V, Amin MB, Grignon D, Eble J, Weber A., Moch H. Phenotypic, molecular
and ultrastructural studies of a novel low grade renal epithelial neoplasm possibly related to the Loop
of Henle. Mod Pathol 15:182A, 2002. Presented at the U.S. and Canadian Academy of Pathology
meeting, Chicago, IL, February-March 2002.
Ou X, Lim SD, Cohen C, Petros JA, Keane T, Amin MB. Immunohistochemical expression of maspin
(mammary serpin) protein in 155 prostate cancers treated by radical prostatectomy. Mod Pathol
15:176A, 2002. Presented at the U.S. and Canadian Academy of Pathology meeting, Chicago, IL,
February 2002.
Logani S, Oliva E, Amin MB, Folpe AL, Cohen C, Young RH. Immunoprofile of ovarian tumors of putative
transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic
implications. Mod Pathol 15:202A, 2002. Presented at the U.S. and Canadian Academy of Pathology
meeting, Chicago, IL, February 2002.
Weirich G, Junker K, Salles PGO, Lim SD, de Peralta-Venturina MN, Alvarado-Cabrero I, Jimenez RE,
Cabras AD, Hofler H, Schubert J, Amin MB. Comparative genomic hybridization analysis of renal
oncocytomas (RO), chromophobe renal cell carcinomas (CHRCC) and tumors with hybrid histology
hybrid oncocytic tumors (HOT). Mod Pathol 15:186A, 2002. Presented at the U.S. and Canadian
Bell J, Amin MB, Parker DC, Folpe AL, Petros JA, Cohen C. Examination of uroplakin and
thrombomodulin expression in a wide spectrum of non-urothelial tissues and tumors using tissue
microarray-based high-throughput technique. Mod Pathol 15:336A, 2002. Presented at the U.S. and
Canadian Academy of Pathology meeting, Chicago, IL, February 2002.
Varma M, Morgan M, Tamboli P, Jasani B, Amin MB. Sensitivity of prostate specific antigen
immunohistochemistry in poorly differentiated prostate cancer. Mod Pathol 15:185A, 2002. Presented
at the U.S. and Canadian Academy of Pathology meeting, Chicago, IL, February 2002.
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
de Peralta-Venturina MN, Cohen C, Amin MB. Potential utility of smooth muscle myosin-heavy chain
(SMM-HC) antibody in the assessment of level of invasion in urothelial carcinomas (UCa) in
transurethral resection of bladder tumor (TURBT) specimens. Mod Pathol 15:160A, 2002. Presented at
Mendrinos SE, Angeletti C, Keane T, Petros JA, Amin MB. Identification of a novel protein profile of
urothelial carcinoma (UCa) in urine using SELDI-TOF mass spectrometry. Mod Pathol 15:174A, 2002.
Presented at the U.S. and Canadian Academy of Pathology meeting, Chicago, IL, February 2002.
Young AN, Salles PGO, Neish AS, Lim SD, Cohen C, Petros JA, Marshall FF, Amin MB. Expression
profiling of renal epithelial tumors with cDNA microarrays. Mod Pathol 15:188A, 2002. Presented at
Yang XJ, Wu C-L, Amin MB, Young R, Fanger G, Jiang Z. P504S in diagnosis of prostate cancer: a multiinstitutional analysis. Mod Pathol 15:187A, 2002. Presented at the U.S. and Canadian Academy of
Pathology meeting, Chicago, IL, February 2002.
Petros JA, Seabury C, Salles P, Young A, Neish A, Lim S, Cohen C, Marshall F, Epstein J, Amin M, Issa M.
cDNA microarray gene expression profiles of papillary renal cell carcinoma. J Urol, 167 (4, supplement):
126, 2002. Presented at the Ninety-Seventh American Urological Associations Annual Meeting, May
27, 2002.
Varma M, Morgan M, Jasani B, Tamboli P, Amin MB. Polyclonal anti-PSA is more sensitive but less
specific than monoclonal anti-PSA: implications for diagnostic prostatic pathology. Histopathol 41
(Suppl): 20A, 2002. Presented at the 24th International Congress of the International Academy of
Pathology meeting, Amsterdam, Netherlands, Oct. 2002.
Varma M, Morgan M, Amin MB, Wozniak S, Jasani B. High molecular weight cytokeratin antibody
(clone 34betaE12): a sensitive marker for differentiation of urothelial carcinoma from prostate cancer.
Histopathol 41 (Suppl): 50A, 2002. Presented at the 24th International Congress of the International
Academy of Pathology meeting, Amsterdam, Netherlands, Oct. 2002.
Amin M, Beach R, Gown AM, Yaziji H, Malhotra R, Amin MB. Use of a novel immunohistochemical
(IHC) panel (P504S, p63 and 34E12) in the diagnosis of post-radiation (PRT) prostate cancer (PCa).
Mod Pathol 16:139A, 2003. Presented at the U.S. and Canadian Academy of Pathology meeting,
Washington DC, March 2003.
Amin MB, Cabrera RA, Lim SD, Varma M. All that is micropapillary is not high-grade prostatic
intraepithelial neoplasia (HG-PIN): circumferential micropapillary perineural invasion (CMPNI) a
potential pitfall in the recognition of invasive prostatic adenocarcinoma. Mod Pathol 16:139A, 2003.
Presented at the U.S. and Canadian Academy of Pathology meeting, Washington DC, March 2003.
Gupta N, de Peralta-Venturina M, Gown A, Beach R, Salles P, Yaziji H, Amin MB. P504S antibody
expression in putative precursor lesions of prostate carcinoma (PCA) - high grade prostatic
intraepithelial neoplasia (HGPIN) and atypical adenomatous hyperplasia (AAH). Mod Pathol 16:152A,
2003. Presented at the U.S. and Canadian Academy of Pathology meeting, Washington DC, March
2003.
Harik L, Lim SD, Cui Y, Sen B, Wang R, Chung LWK, Zhau HE, Amin MB. Immunohistochemical analysis
of a novel prostate epithelial cell-specific gene PrLZ protein in prostatic epithelia in radical
prostatectomy specimens. Mod Pathol 16:153A, 2003. Presented at the U.S. and Canadian Academy
of Pathology meeting, Washington DC, March 2003.
Lim SD, Zhou W, Williams TY, Rusthoven KE, Lyles R, Benjamin M, Petros JA, Amin MB. Analysis of
allelic imbalance (AI) on chromosome (chr) 8p and 18 in prostate cancer (PCa) by a novel technique:
counting alleles to estimate loss of heterozygosity (LOH). Mod Pathol 16:159A, 2003. Presented at
the U.S. and Canadian Academy of Pathology meeting, Washington DC, March 2003.
Mendrinos SE, Amin MB, Lim SD, Nolen JDL, Cohen C. Human neutrophilic defensin (1/2/3) [HND
(1/2/3)] immunohistochemical (IHC) staining in urinary bladder cancer: validation of a novel tumor
marker discovered by urine proteomic profiling. Mod Pathol 16:162A, 2003. Presented at the U.S. and
Canadian Academy of Pathology meeting, Washington DC, March 2003.
Oliva E, Moch H, Cabrera R, Young RH, Reuter V, Amin MB. Nephrogenic adenoma (NA): an
immunohistochemical (ICH) study of 40 cases. Mod Pathol 16:164A, 2003. Presented at the U.S. and
Canadian Academy of Pathology meeting, Washington DC, March 2003.
Salama ME, de Peralta-Venturina M, Guru K, Peterson E, Stricker H, Javidan J, Peabody J, Amin M,
Tamboli P, Menon M, Amin MB. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM
196.
197.
198.
199.
200.
201.
202.
203.
204.
205.
206.
207.
208.
209.
staging modification of renal tumors. Mod Pathol 16:168A, 2003. Presented at the U.S. and Canadian
Academy of Pathology meeting, Washington DC, March 2003.
Schraml P, Hergovitz A, Hatz F, Amin MB, Lim SD, Krek W, Mihatsch MJ, Moch H. Relevance of nuclear
and cytoplasmic pVHL protein expression in renal carcinoma progression. Mod Pathol 16:169A, 2003.
Presented at the U.S. and Canadian Academy of Pathology meeting, Washington DC, March 2003.
Schuetz AN, Young AN, Yin-Goen Q, Lim SD, Petros JA, Marshall FF, Amin MB. Gene expression
fingerprinting of adult renal epithelial neoplasia (REN) correlates with traditional histopathologic
classification: fabrication of a customized tumor-specific cDNA microarray (renal chip) for molecular
classification. Mod Pathol 16:169A, 2003. Presented at the U.S. and Canadian Academy of Pathology
meeting, Washington DC, March 2003.
Shah VI, Varma M, DePeralta M, Lim SD, Amin MB. Utility of CD117 (KIT) immunoreactivity (IR) in
diagnostic histopathology of testicular germ cell tumors (TGCT). Mod Pathol 16:170A, 2003. Presented
at the U.S. and Canadian Academy of Pathology meeting, Washington DC, March 2003.
Shah VI, Varma M, DePeralta M, Lim SD, Cohen C, Amin MB. Cyclooxygenase-2 (COX-2) expression in
testicular germ cell tumors. Mod Pathol 16:170A, 2003. Presented at the U.S. and Canadian Academy
of Pathology meeting, Washington DC, March 2003.
Tickoo, SK, dePeralta-Venturina MN, Salama M, Wang Y, Moch H, Amin MB. Spectrum of epithelial
tumors in end stage renal disease (ESRD): emphasis on histologic patterns distinct from those in
sporadic adult renal neoplasia. Mod Pathol 16:173A, 2003. Presented at the U.S. and Canadian
Academy of Pathology meeting, Washington DC, March 2003.
Kyle E Rusthoven KE, Zhou W, Amin MB, Lim S, Williams TS, Lyles R, Marshall FF, Petros JA. Counting
alleles to predict recurrence in prostate cancer. J Urol 169: 154(A598), 2003. Presented at the NinetyEighth American Urological Associations Annual Meeting, Chicago IL, April 2003.
Zhau HE, Wang R, Lim SD, Cui Y, Sen B, Amin MB, Marshall FF, Chung LW. PRLZ expression in reactive
prostate stroma which could contribute to prostate carcinogenesis through an activation of tumorstroma interaction. J Urol 169:163(A631), 2003. Presented at the Ninety-Eighth American Urological
Associations Annual Meeting, Chicago IL, April 2003.
Petros JA, Issa MM, Schuetz AN, Lim SD, Amin MB, Young AN, Marshall FF. Second generation
customized cDNA renal chip accurately differentiates renal neoplasms. J Urol 169:201(776), 2003.
Presented at the Ninety-Eighth American Urological Associations Annual Meeting, Chicago IL, April
2003.
Kubo H, Gardner TA, Wada Y, Koeneman KS, Gotoh A, Ling Y, Kao C, Lim SD, Amin MB, Yang H, Black
ME, Matsubara S, Nakagawa M, Gillenwater JY, Zhau HE, Chung LW. Phase I dose-escalation clinical
trial of adenoviral osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and
metastatic hormone refractory prostate cancer. J Urol 169:243(A940), 2003. Presented at the NinetyEighth American Urological Associations Annual Meeting, Chicago IL, April 2003.
Sung S-Y, Shu J, Jin F, Lim SD, Nelson P, Amin MB, Marshall FF, Chung LW. Identification of genes
activated in tumor-associated stroma: three-dimensional co-culture cell models recapitulated gene
expression profiles in clinical prostate cancer. J Urol 169: 340(ADP9), 2003. Presented at the NinetyEighth American Urological Associations Annual Meeting, Chicago IL, April 2003.
Adsay NV, Che M, Basturk O, Tamboli P, Sakr W, Amin MB, Grignon DJ. Sarcomatous transformation in
mixed epithelial stromal tumors of the kidney (malignant MEST). Mod Pathol 17 (Suppl 1):135A-136A,
2004. Presented at the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, March 2004.
Amin MB, Michal M, Radhakrishnan A, Hes O, McKenney JK, Cheville JC. Primary thyroid-like follicular
carcinoma of the kidney: a histologically distinctive primary renal epithelial tumor. Mod Pathol 17
(Suppl 1):136A-137A, 2004. Presented at the U.S. and Canadian Academy of Pathology meeting,
Vancouver, BC, March 2004.
Amin MB, Ulbright TM, Mendrinos SE, Young RH. Utility of a comprehensive immunohistochemical
panel in the differential diagnosis of paratesticular neoplasms with tubulopapillary/glandular
architecture. Mod Pathol 17 (Suppl 1):137A, 2004. Presented at the U.S. and Canadian Academy of
Pathology meeting, Vancouver, BC, March 2004.
Amin MB, MacLennan GT, Paraf F, Cheville JC, Viellefond A, Radhakrishnan A, Che M, Srigley JR,
Grignon DJ. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 29 cases of a distinctive
rare subtype of renal cell carcinoma (RCC). Mod Pathol 17 (Suppl 1):137A, 2004. Presented at the U.S.
and Canadian Academy of Pathology meeting, Vancouver, BC, March 2004.
210.
211.
212.
213.
214.
215.
216.
217.
218.
219.
220.
221.
222.
223.
224.
Folpe AL, Skinnider BF, de Peralta-Venturina M, Amin MB. Renal oncocytomas do not express
cytokeratin 14. Mod Pathol 17 (Suppl 1):151-152A, 2004. Presented at the U.S. and Canadian Academy
of Pathology meeting, Vancouver, BC, March 2004.
Harik LR, Merino C, Coindre JM, Amin MB, Weiss SW. Pseudosarcomatous myofibroblastic
proliferation of the bladder: a clinico-pathologic study of 42 cases. Mod Pathol 17 (Suppl 1):156A, 2004.
Presented at the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, March 2004.
Hennigar RA, Skinnider BF, Lim SD, Cohen C, Folpe AL, Amin MB. Distribution of cytokeratin (CK)
isotypes and vimentin in normal human kidney. Mod Pathol 17 (Suppl 1):156A, 2004. Presented at the
U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, March 2004.
Herrera MC, Srigley JR, Lim SD, Mendrinos SE, Amin MB. Alpha-methylacyl-coenzyme A racemase
(AMACR/P504S) and MIB-1 proliferation index as objective markers of high-grade prostatic
intraepithelial neoplasia (HGPIN) in needle biopsy specimens. Mod Pathol 17 (Suppl 1):157A, 2004.
Presented at the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, March 2004.
Lim SD, Wang R, Harik L, Cui Y, Zhau HYE, Habib F, Amin MB. Immunohistochemical evaluation of a
novel prostate-specific gene PrLZ of the TPD52 family in 144 primary and hormone refractory
metastatic prostate cancer specimens. Mod Pathol 17 (Suppl 1):163-164A, 2004. Presented at the U.S.
and Canadian Academy of Pathology meeting, Vancouver, BC, March 2004.
Mendrinos SE, Amin MB, Lim SD, Herrera CM, Srigley JR. Predictive value of pathologic parameters of
high-grade prostatic intraepithelial neoplasia (HGPIN) in the initial biopsy for the subsequent detection
of prostatic carcinoma (PCa). Mod Pathol 17 (Suppl 1):168A, 2004. Presented at the U.S. and Canadian
Academy of Pathology meeting, Vancouver, BC, March 2004.
Radhakrishnan A, Lim SD, Patel A, Hennigar RA, Shehata B, Amin MB. Utility of a contemporary
immunohistochemical panel in the differential diagnosis of adult renal epithelial neoplasms: a study in
tissue microarrays to simulate experience in renal biopsy specimens. Mod Pathol 17 (Suppl 1):173A,
2004. Presented at the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, March 2004.
Schuetz AN, Young AN, Yin-Goen Q, Lim SD, Petros JA, Marshall FF, Amin MB. Novel gene expression
markers in adult renal tumors: confirmation of microarray data by quantitative reverse transcriptasepolymerase chain reaction (RT-PCR) on fixed tissue. Mod Pathol 17 (Suppl 1):176A, 2004. Presented at
the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, March 2004.
Skinnider BF, Oliva E, Young RH, Amin MB. Nephrogenic adenoma expresses a-methylacyl-CoAracemase (P504S). Mod Pathol 17 (Suppl 1):178A, 2004. Presented at the U.S. and Canadian Academy
of Pathology meeting, Vancouver, BC, March 2004.
Skinnider BF, Folpe AL, Hennigar RA, Lim SD, Cohen C, Tamboli P, dePeralta-Venturina M, Amin MB.
Adult renal epithelial neoplasms (RENs) have distinct and diagnostically useful cytokeratin (CK) profiles.
Mod Pathol 17 (Suppl 1):178A, 2004. Presented at the U.S. and Canadian Academy of Pathology
meeting, Vancouver, BC, March 2004.
Went P, Dirnhofer S, Salvisberg T, Amin MB, Lim SD, Diener PA, Moch M. EpCam adhesion molecule in
adult renal neoplasms: potential utility in the differential diagnosis of chromophobe renal cell
carcinoma and oncocytoma. Mod Pathol 17 (Suppl 1):184A, 2004. Presented at the U.S. and Canadian
Academy of Pathology meeting, Vancouver, BC, March 2004.
Logani S, Oliva E, Arnell PM, Amin MB, Young RH. Use of novel immunohistochemical markers
expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal
carcinoma. Mod Pathol 17 (Suppl 1):204A, 2004. Presented at the U.S. and Canadian Academy of
Pathology meeting, Vancouver, BC, March 2004.
Nassar A, Amin MB, Sexton D, Cohen C. Utility of a-methylacyl coenzyme A racemase (p504S antibody)
as a diagnostic immunohistochemical marker for cancer. Mod Pathol 17 (Suppl 1):359A,
2004.Presented at the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, March 2004.
Choi WWL, Amin MB, Tamboli P, Eble JN, Young RH. Glandular neoplasms of the urachus:
Clinicopathologic and immunohistochemical analysis of 43 cases with special emphasis on low-grade
mucinous cystic tumors. Mod Pathol 18 (Suppl 1):134A, 2005. Presented at the U.S. and Canadian
Academy of Pathology meeting, San Antonio, TX, February-March 2005.
Harik LR, Pashaei S, Humphrey PA, Tamboli P, Amin MB. Needle core biopsy of the kidney for mass
lesions: a clinicopathologic perspective based on 196 cases. Mod Pathol 18 (Suppl 1):144A,
2005.Presented at the U.S. and Canadian Academy of Pathology meeting, San Antonio, TX, FebruaryMarch 2005.
225.
226.
227.
228.
229.
230.
231.
232.
233.
234.
235.
236.
237.
238.
O'Reilly KC, TIckoo SK, Amin MB, Radhakrishnan A, Hill CE. Renal cell tumors arising in end-stage renal
disease (ESRD): A karyotypic study with fluorescent in-situ hybridization (FISH). Mod Pathol 18 (Suppl
1):156A, 2005.Presented at the U.S. and Canadian Academy of Pathology meeting, San Antonio, TX,
February-March 2005.
Paner GP, Srigley JR, Young AN, Radhakrishnan A, Cohen C, Tickoo SK, Skinnider BF, Amin MB.
Immunohistochemistry in the differential diagnosis of mucinous tubular and spindle cell carcinoma and
papillary renal cell carcinoma of the kidney: innovations and pitfalls. Mod Pathol 18 (Suppl 1):157A,
2005.Presented at the U.S. and Canadian Academy of Pathology meeting, San Antonio, TX, FebruaryMarch 2005.
Paner GP, A Radhakrishnan A, Yin-Goen Q, Datta MW, Young AN, Amin MB.Gene expression profiling
of renal angiomyolipoma with oligonucleotide arrays. Mod Pathol 18 (Suppl 1):160A, 2005.Presented at
the U.S. and Canadian Academy of Pathology meeting, San Antonio, TX, February-March 2005.
Worcester HD, Amin MB, Harik LR, Radhakrishnan A, Tickoo DK.
A morphologic and
immunohistochemical study of renal tumors in end-stage renal disease (ESRD): Emphasis on tumors of
unusual morphology. Mod Pathol 18 (Suppl 1):172A, 2005. Presented at the U.S. and Canadian
Academy of Pathology meeting, San Antonio,TX, February-March 2005.
Radhakrishnan A, MacLennan GT, Hennigar RA, Srigley JR, Paraf F, Cheville JC, Vieillefond A, Stovsky
MD, Che M, Grignon DJ, Amin MB. Ultrastructural and immunohistochemical (IHC) appraisal of
tubulocystic carcinoma (TCCa) of the kidney: Histogenetic and diagnostic implications. Mod Pathol 18
(Suppl 1):160A, 2005. Presented at the U.S. and Canadian Academy of Pathology meeting, San
Antonio,TX, February-March 2005.
Ertoy-Baydar D, Amin MB, Epstein JI. An immunohistochemical (IHC) study of osteoclast-like giant cell
neoplasms of the urinary tract: Extraskeletal giant cell tumor of bone or osteoclast-type giant cell
carcinoma. Mod Pathol 18 (Suppl 1):139A, 2005. Presented at the U.S. and Canadian Academy of
Pathology meeting, San Antonio,TX, February-March 2005.
Eiber M, Blaszyk H, van Oers JMM, Zwarthoff E, van der Kwast T, Stoehr R, Burger M, Cheville JC,
Sauter G, Amin MB, Hofstaedter F, Hartmann A. Molecular analysis of inverted tumors of the urinary
bladder. Mod Pathol 18 (Suppl 1):138A, 2005.Presented at the U.S. and Canadian Academy of
Pathology meeting, San Antonio, TX, February-March 2005.
Schuetz AN, Yin-Goen Q, Young AN, Moreno CS, Arnold RS, Amin MB, Petros JA. Nox gene expression in
renal cell and prostate carcinoma. Mod Pathol 18 (Suppl 1):162A,2005. Presented at the U.S. and
Canadian Academy of Pathology meeting, San Antonio, TX, February-March 2005.
Hornsby CD, Yin-Goen Q, Cohen C, Lawson D, Young AN, Amin MB. Claudin-7 expression in renal
epithelial neoplasms: A candidate Immunohistochemical marker for chromophobe renal cell carcinoma
identified by gene expression profiling. Mod Pathol 18 (Suppl 1):146A, 2005.Presented at the U.S. and
Canadian Academy of Pathology meeting, San Antonio, TX, February-March 2005.
Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI.Urothelial neoplasms in patients 20 years or
younger - a clinicopathologic analysis. Mod Pathol 18 (Suppl 1):140-141A, 2005.Presented at the U.S.
and Canadian Academy of Pathology meeting, San Antonio, TX, February-March 2005.
Turbiner J, Amin MB, Radhakrishnan A, Humphrey PA, Srigley JR, De Leval L, Oliva E. Cystic Nephroma
(CN) and Mixed Epithelial and Stromal Tumor (MEST) of the Kidney: Are They One and the Same Entity?
Mod Pathol 18 (Suppl 1):169A, 2005.Presented at the U.S. and Canadian Academy of Pathology
meeting, San Antonio, TX, February-March 2005.
Choi WWL, Datta MW, Amin MB, Edlund M. Vesicular Connexin 26 Staining Correlates with Aggressive
Grade and Stage Prostate Cancer. Mod Pathol 19 (Suppl 1): 133A, 2006. Presented at the U.S. and
Canadian Academy of Pathology meeting, Atlanta, GA, February 2006.
Kuehn A, Cohen C, Radhakrishnan A, Shehata B, Datta M, Young A, Paner G, Amin MB, Srigley JR.
Expression of Kidney-Specific Cadherin (Ksp-cad) in Rare and Unusual Renal Epithelial Neoplasms (REN).
Diagnostic and Histogenetic Implications. Mod Pathol 19 (Suppl 1): 145A, 2006. Presented at the U.S.
and Canadian Academy of Pathology meeting, Atlanta, GA, February 2006.
Paner GP, Wojcik EM, Datta, MW, Amin MB. Further Characterization of the Muscle Layers of the
Urinary Bladder by Systematic Histologic Mapping; Implications for Pathologic Staging. Mod Pathol 19
(Suppl 1): 154A, 2006. Presented at the U.S. and Canadian Academy of Pathology meeting, Atlanta, GA,
February 2006.
239.
240.
241.
242.
243.
244.
245.
246.
247.
248.
249.
250.
251.
252.
Paner GP, Alvarado-Cabrero I, Moch H, Young A, Striker H, Lyles R, Datta MW, Amin MB. A Novel
Grading Scheme for Chromophobe Renal Cell Carcinoma (ChrRCC): Prognostic Utility and Comparison
with Fuhrmans Nuclear Grade (FNG). Mod Pathol 19 (Suppl 1): 154A, 2006. Presented at the U.S. and
Paner GP, Alvarado-Cabrero I, Moch H, Young AN, Stricker H, Lyles R, Datta MW, Amin MB. Mod
Pathol 19 (Suppl 1): 154A, 2006. Presented at the U.S. and Canadian Academy of Pathology meeting,
Atlanta, GA, February 2006.
Radhakrishnan A, Datta MW, Folpe AL, Kuehn A, Amin MB. Nucleolar Pattern Telomerase Catalytic
Subunit Staining as a Selective Aid in Prostate Biopsy Diagnosis. Mod Pathol 19 (Suppl 1): 156A, 2006.
Presented at the U.S. and Canadian Academy of Pathology meeting, Atlanta, GA, February 2006.
Varma M, Jasani B, Mathews PN, Datta SN, Amin MB. Utility of Polyclonal Anti-PSA and High-Molecular
Weight Cytokeratin Immunohistochemistry in the Differentiation of Poorly Differentiated Prostatic
Carcinoma from Urothelial Carcinoma. Mod Pathol 19 (Suppl 1): 166A, 2006. Presented at the U.S. and
OReilly KC, Datta MW, Kahler AJ, Amin MB, Kajdacsy-Balla, AA. The Effect of Storage on the Antigen
Expression of Tissue Microarray Slides. Mod Pathol 19 (Suppl 1): 332A, 2006. Presented at the U.S. and
Paner GP, Ritchie J, Stewart A, Amin MB. Analysis of observed survival outcomes in histologicallyspecified renal cell carcinoma (RCC); 1993-1998 cases from the National Cancer Data Base (NCDB).
Modern Pathol 20 (Suppl 2): 168A; 2007. Presented at the U.S. and Canadian Academy of Pathology
meeting, San Diego, CA, March 2007.
Paner GP, Bae K, Grignon DJ, Pilepich M, Hanks G, Shipley W, Roach M, McGowan D, Pisansky TM,
Sandler H, Hammond E, Amin MB. Trends in Gleason grading of prostate carcinoma (Pca): Analysis of
reporting by institutional and central review pathologists in four Radiation Therapy Oncology Group
(RTOG) protocols spanning 17 years and 2094 biopsies. Modern Pathol 20 (Suppl 2): 169A; 2007.
Presented at the U.S. and Canadian Academy of Pathology meeting, San Diego, CA, March 2007.
Amin MB, Paner GP. Rete testes-associated nodular steroid rests: putative pluripotential testicular hilus
steroid cells or testicular adnexal Leydig cells. A report in 3 orchiectomies with emphasis on differential
diagnosis. Modern Pathol 20 (Suppl 2): 134A; 2007. Presented at the U.S. and Canadian Academy of
Pathology meeting, San Diego, CA, March 2007.
Young AN, Paner GP, MacLennan GT, Cheville JC, Vieillefond A, Hes O, McKenney JK, Paraf F, Grignon
DJ, Epstein JI, Srigley JR, Amin MB. Molecular profiling of the novel thyroid-like renal cell carcinoma
(RCC) and tubulocystic RCC by high-density oligonucleotide microarrays. Modern Pathol 20 (Suppl 2):
185A; 2007. Presented at the U.S. and Canadian Academy of Pathology meeting, San Diego, CA, March
2007.
Sirintrapun SJ, Paner GP, Tomaszweski J, Narula N, Lee D, Ahlering T, Tewari A, Amin MB. Histologic
landmarks that define extrprostatic extension (EPE) at the prostatic apex: characteristics of
extraprostatic tissue at the apex as dissected by robotic radical prostatectomy (RP). Modern Pathol 20
(Suppl 2): 177A; 2007. Presented at the U.S. and Canadian Academy of Pathology meeting, San Diego,
CA, March 2007.
Westfall D, Folpe AL, Paner GP, Oliva E, Goldstein LC, Gown AM, Amin MB. Utility of a comprehensive
immunohistochemical (IHC) panel in the differential diagnosis of spindle cell lesions of the urinary
bladder. Modern Pathol 20 (Suppl 2): 183A; 2007. Presented at the U.S. and Canadian Academy of
Oliva E, Kaufman DS, Shipley WU, Spicer B, Paner GP, Gown AM, Amin MB. Immunohistochemistry as
an adjunct in the differential diagnosis of radiation-induced atypia vs carcinomas in situ (CIS) of the
bladder. A study of 48 cases. Modern Pathol 20 (Suppl 2): 167A; 2007. Presented at the U.S. and
Canadian Academy of Pathology meeting, San Diego, CA, March 2007.
Datta MW, Amin MB, True L, Nelson PS. Validation of an immunohistochemical Panel of Genes for the
Prediction of Gleason Pattern 3 vs 4 Prostate Cancer. Modern Pathol 20 (Suppl 2): 142A; 2007.
Presented at the U.S. and Canadian Academy of Pathology meeting, San Diego, CA, March 2007.
Paner GP, McKenney JK, Epstein JI, Amin MB. Rhabdomyosarcoma (RMS) of the urinary bladder in
adults: predilection for anaplasia and alveolar morphology and significant histologic overlap with small
cell carcinoma. Mod Pathol 2008.21:174A. Presented at the U.S. and Canadian Academy of Pathology
meeting, Denver, CO, March 2008.
253.
254.
255.
256.
257.
258.
259.
260.
261.
262.
263.
264.
265.
266.
Lapetino S, Paner GP, Venkataraman G, Barkan G, Quek ML, Ro JY, Amin MB. Diagnostic utility of
antibody to smoothelin in the distinction of muscularis mucosa (MM) from muscularis propria (MP) of
the urinary bladder. Mod Pathol 2008.21:165A. Nominated for: Stowell-Orbison Award. Presented at
the U.S. and Canadian Academy of Pathology meeting, Denver, CO, March 2008.
Ramirez CR, Luthringer DJ, Wang S, Balzer BL, Amin MB. Clinical Significance of Atypical Small Acinar
Proliferation with and without High Grade Prostatic Intraepithelial Neoplasia. A Large Single Institution
s Contemporary Experience of 3200 Consecutive Prostate Biopsies Reviewed by a Urologic Pathology
Team, Mod Pathol 21:178A, 2008. Presented at the U.S. and Canadian Academy of Pathology meeting,
Denver, CO, March 2008.
Nigwekar P, Miick S, Rittenhouse HS, Groskopf J, Kwon GY, Tadros Y, Gupta R, Robin H, Amin MB.
Morphologic Correlates of Individual Splice Variants of TMPRSS2-ETS Prostate Cancer (PCa) Detected by
Transcription-Mediated Amplification (TMA) in Radical Prostatectomy (RP) Specimens. Mod Pathol.
21:174A, 2008. Presented at the U.S. and Canadian Academy of Pathology meeting, Denver, CO, March
2008.
Miick S, Kwon GY, Wixom C, Nigwekar P, Tadros Y, Gupta R, Robin HS, Amin MB, Rittenhouse H,
Groskopf J. Direct Detection of TMPRSS2:ETSfamily Gene Fusion mRNAs in Prostatectomy Tissue:
Prevalence and Correlation with Clinicopathologic Data. Mod Pathol. 21:171A, 2008. Presented at the
U.S. and Canadian Academy of Pathology meeting, Denver, CO, March 2008.
Nigwekar P, Kwon GY, Tomaszewski J, Narula N, Lee D, Ahlering T, Tewari A, Paner GP, Amin MB.
Reproducibility of Reporting Seminal Pathologic Parameters in Robotic Radical Prostatectomies (RP)
Specimens: Comparison of Central Versus Institutional Review Data in 173 Cases. Mod Pathol. 21:174A,
2008. Presented at the U.S. and Canadian Academy of Pathology meeting, Denver, CO, March 2008.
Nese N, Martignoni G, Fletcher CD, Gupta R, Pan CC, Kim H, Sato K, Bonetti F, Pea M, Amin M, Hes O,
Svec A, Amin MB. Renal Perivascular Epithelioid Cell Tumors [(PEComa), so Called Epithelioid
Angiomyolipoma (EAML)]: Analysis of 61 Cases Including 44 with Pure/Predominant Epithelioid (PPEComa) Morphology and Parameters Associated with Malignant Outcome. Mod Pathol. 22:186A,
2009. Presented at the U.S. and Canadian Academy of Pathology meeting, Boston, MA, March 2009.
Paner GP, Brown JG, Lapetino S, Nese N, Gupta R, Shen SS, Amin MB. Diagnostic Utility of Antibody to
Smoothelin in the Recognition of Muscularis Propria (MP) in Transurethral Resection of Urinary Bladder
Tumor (TURBT) Specimens. Mod Pathol. 22:188A, 2009. Presented at the U.S. and Canadian Academy
of Pathology meeting, Boston, MA, March 2009.
Malhotra R, Zhang PL, Bonventre JV, Gupta R, Amin MB, Rao P, Amin M. Kidney Injury Molecule-1
(KIM-1) Expression in Sarcomatoid Differentiation in Renal Cell Carcinoma (RCC): Implications for
Differential Diagnosis of Malignant Spindle Cell Lesions of the Kidney. Mod Pathol. 22:181A, 2009.
Presented at the U.S. and Canadian Academy of Pathology meeting, Boston, MA, March 2009.
Brown JG, Amin MB, Rao P, Lazar AJ, Paner GP, Gupta R, Cheville JC, Folpe AL. Primary Vascular Tumors
of the Kidney: A Clinicopathologic Analysis of 26 Cases. Mod Pathol. 22:160A, 2009. Presented at the
U.S. and Canadian Academy of Pathology meeting, Boston, MA, March 2009.
Hansel DE, Paner GP, Nese N, Amin MB. Bladder Diverticula Demonstrate Limited Diffuse Smoothelin
Expression within the Muscularis Mucosa (MM). Mod Pathol. 22:172A, 2009. Presented at the U.S. and
Canadian Academy of Pathology meeting, Boston, MA, March 2009.
Amin M, Shah RB, Vasco MW, Gupta R, Amin MB, Merchant S, Bonventre JV, Zhang PL. Utility of Kidney
Injury Molecule (KIM-1) Staining in a Wide Spectrum of Traditional and Newly Recognized Renal
Epithelial Neoplasms: Diagnostic and Histogenetic Implications. Mod Pathol. 22:156A, 2009. Presented
at the U.S. and Canadian Academy of Pathology meeting, Boston, MA, March 2009.
Chiles L, Levy M, Balzer BL, Xu H, Xiao SY, Zhai J, Soffer E, Conklin J, Dhall D, Kahn MD, Amin MB, Wang
HL. Characterization of Expression of a Novel Smooth Muscle Contractile Protein Smoothelin in
Gastrointestinal Tract: Implication in the Pathogenesis of Colonic Inertia. Mod Pathol. 22:126A, 2009.
Balzer BL, Gupta R, Lazar AJ, Rao P, Amin MB. Pseudoliposarcomatous Changes in the Perinephric
Adipose Tissue of Nephrectomy Specimens Mimicking Well Differentiated Retroperitoneal
Liposarcoma: Evaluation in 200 Nephrectomies. Mod Pathol. 22:158A, 2009. Presented at the U.S. and
Balzer BL, Gupta R, Rao P, Paner GP, Amin M, McKenney JK, Lazar AJ, Amin MB. Dedifferentiated
Liposarcoma (De-Diff LPS) Presenting as a Primary Renal Mass Resulting in a Nephrectomy: A Report of
267.
268.
269.
270.
271.
272.
273.
274.
275.
276.
277.
278.
279.
8 Cases with Discussion of Differential Diagnostic Implications. Mod Pathol. 22:158A, 2009. Presented
at the U.S. and Canadian Academy of Pathology meeting, Boston, MA, March 2009.
Amin MB, Gupta R, Osunkoya AO, Hes O, Billis A, Bacchi CE, Hansel D, Zhou M, deCastro MG, Moch H,
Salles P, Cabrera RA, Gown AM. Carcinoma of Collecting Ducts of Bellini: Analysis of 27 Distinctive Cases
of Renal Cell Carcinoma with Aggressive Clinical Behavior. Mod Pathol. 22:157A, 2009. Presented at the
U.S. and Canadian Academy of Pathology meeting, Boston, MA, March 2009.
Martignoni G, Bonetti F, Chilosi M, Brunelli M, Amin MB, Eble JN, Gobbo S, Pea M. Cathepsin -K
Expression in Both Classic and Epithelioid Angiomyolipoma of the Kidney. Mod Pathol. 22:181A, 2009.
Westfall DE, Luthringer DJ, Gown AM, Parakh RS, Vankalakunti M, Amin MB. Aberrant Staining Patterns
for Prostatic Adenocarcinoma (PCA) in Needle Biopsies Using Triple Cocktail Immunohistochemistry
(IHC): An Experience of 469 Cases with Rationale for the Selective Inclusion of Novel Cancer Specific
Nuclear Marker MYC. Mod Pathol. 23:228A 2010. Presented at the U.S. and Canadian Academy of
Pathology meeting, Washington, DC, March 2010.
Hameed O, Dailey VL, Al-Ahmadie HA, Amin MB, Bismar TA, Cheng L, Hansel DE, Humphrey PA,
McKenney JK, Netto GJ, Paner GP, Ro J, Shah RB, Shen S, Trpkov K, Zhou M. Interobserver Variability in
Determining Carcinoma Extent Based on Percentage in Radical Prostatectomy (RP) Specimens. Mod
Pathol. 23:195A 2010. Presented at the U.S. and Canadian Academy of Pathology meeting, Washington,
DC, March 2010.
Ching CB, Amin MB, Tubbs R, Hansel DE. Correlation between HER2 Gene Amplification and Protein
Expression in Micropapillary Urothelial Carcinoma (MPC). Mod Pathol. 23:185A 2010. Presented at the
U.S. and Canadian Academy of Pathology meeting, Washington, DC, March 2010.
Parakh RS, Venturina MP, Balzer B, Gown AM, Westfall DE, Vankalakunti M, Amin MB. Sensitivity and
Specificity of Novel and Contemporarily Used Immunohistochemical (IHC) Markers in the Histologic
Typing of Germ Cell Tumors (GCT) of Testis: Implications for Creating a Best Practices Panel Approach.
Mod Pathol. 23:211A, 2010. Presented at the U.S. and Canadian Academy of Pathology meeting,
Washington, DC, March 2010.
Venturina MP, Parakh RS, Balzer B, Gown AM, Westfall DE, Goldstein LC, Amin MB. Differential
Immunohistochemical (IHC) Staining in Unusual and Morphologically NonClassic Patterns of Testicular
Germ Cell Tumors (GCT): Analysis with Traditional and Contemporary Markers. Mod Pathol. 23:226A,
2010. Presented at the U.S. and Canadian Academy of Pathology meeting, Washington, DC, March
2010.
Westfall DE, Lopategui J, Venturina MP, Bose S, Wang S, Luthringer DJ, Parakh RS, Amin MB.
Inconclusive UroVysion Fluorescence In Situ Hybridization (FISH) Results: Follow Up to Determine
Clinical Implications of Diagnostic Terminology. Mod Pathol. 23:228A, 2010. Presented at the U.S. and
Canadian Academy of Pathology meeting, Washington, DC, March 2010.
Parakh RS, Brown J, Suzigan S, Martignoni G, Westfall DE, Vankalakunti M, Parwani AV, Bastacky S,
Amin MB. Spectrum of Cystic Changes in Translocation Associated Renal Cell Carcinoma (RCC): A
Report of 5 Cases with Cystic Change and Special Emphasis on Tumors with Multilocular Appearance.
Mod Pathol. 23:211A, 2010. Presented at the U.S. and Canadian Academy of Pathology meeting,
Vankalakunti M, Gown AM, Gupta R, Shah RB, Parakh RS, Westfall DE, Amin M, Luthringer DJ, Goldstein
LC, Amin MB. An Analysis of INI1 Nuclear Expression in Collecting Duct Carcinoma (CDC) and Renal
Medullary Carcinoma (RMC): Diagnostic and Pathogenetic Implications. Mod Pathol. 23:225A, 2010.
Presented at the U.S. and Canadian Academy of Pathology meeting, Washington, DC, March 2010.
Westfall DE, Luthringer DJ, Alsabeh R, Parakh RS, Vankalakunti M, Amin MB. Detailed
Immunohistochemical (IHC) Characterization of the Recently Described Clear Cell-Papillary Renal Cell
Carcinoma of the Kidney. Mod Pathol. 23:228A, 2010. Presented at the U.S. and Canadian Academy of
Rawson R, Westfall DE, Amin MB, Parakh RS, Balzer BL. Immunohistochemical (IHC) Study of Wilms'
Tumor Gene 1 (WT1) in Angiomyolipoma (AML) of the Kidney: Dual Role in Tumorigenesis? Mod
Pathol. 23:213A, 2010. Presented at the U.S. and Canadian Academy of Pathology meeting,
Vankalakunti M, Westfall DE, Parakh RS, Gupta R, Shah RB, Amin M, Gown AM, Goldstein LC, Amin MB.
Immunohistochemical (IHC) Expression of Ulex Europaeus Agglutinin-1 (UEA-1) in the Spectrum of
280.
281.
282.
283.
284.
285.
286.
287.
288.
289.
290.
291.
Adult Renal Epithelial Neoplasms - A Study of 165 Cases. Mod Pathol. 23:225A, 2010. Presented at the
U.S. and Canadian Academy of Pathology meeting, Washington, DC, March 2010.
Parakh RS, Luthringer DJ, McKenney JK, Hansel DE, Westfall DE, Vankalakunti M, Alsabeh R, Amin MB.
Utility of Triple Combination Immunohistochemical IHC) Stain Uro3 (CK20/CD44/p53) in the
Distinction of Urothelial Carcinoma in Situ (CIS) from its Mimics. Mod Pathol. 23:211A, 2010. Presented
at the U.S. and Canadian Academy of Pathology meeting, Washington, DC, March 2010.
Vankalakunti M, Nast CC, Amin MB, Cohen AC. Evaluation of Non-Neoplastic Parenchyma of
Nephrectomies with Neoplasms. Mod Pathol. 23:346A, 2010. Presented at the U.S. and Canadian
Academy of Pathology meeting, Washington, DC, March 2010.
Paner GP, Pollitt K, Stewart A, Buckner B, McKiernan J, Members of the AJCC GU Task Force, Chang SS,
Amin MB. Validation of Pathology Substaging of Deeply Invasive/Locally Aggressive Urinary Bladder
Cancers: A Data from the National Cancer Data Base (NCDB). Mod Pathol. 23:211A, 2010. Presented at
the U.S. and Canadian Academy of Pathology meeting, Washington, DC, March 2010.
Sangoi A, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, Ro JY, Lopez-Beltran A, Oliva
E, Paner GP, Reuter VE, Sha RB, Shen SS, Tamboli P, McKenney JK. Interobserver Reproducibility (IOR)
in the Diagnosis of Invasive Micropapillary Carcinoma (MPC) of the Genitourinary Tract among Expert
Urologic Pathologists. Mod Pathol. 23:216A, 2010. Presented at the U.S. and Canadian Academy of
Chandrakanth A, Balzer BL, Parakh RS, Herrera LP, Arora K, Luthringer DJ, Amin MB. Atypical Prostatic
Ductal Lesions (APDL) Presenting as Small Prostatic Urethral Polyps: A Clinicopathologic Study of 7
Cases and Documentation of a Unique form of Prostatic Ductal Neoplasia Warranting Active
Surveillance. Mod Pathol. 24:177A, 2011. Presented at the U.S. and Canadian Academy of Pathology
meeting, San Antonio, TX, March 2011.
Gruver AM, Westfall DE, Farver CF, Luthringer DJ, Osunkoya AO, McKenney JK, Amin MB, Hansel DE.
Selective Immunohistochemical Markers To Distinguish between Metastatic High Grade Urothelial
Carcinoma to the Lung and Primary Poorly Differentiated Invasive Squamous Carcinoma. Mod Pathol.
24:195A, 2011. Presented at the U.S. and Canadian Academy of Pathology meeting, San Antonio, TX,
March 2011.
Gulmann C, Paner GP, Parakh RS, Hansel DE, Shen SS, Ro JY, Chandrakanth A, Lopez-Beltran A, Rao P,
Komal A, Cho YM, Alsabeh R, Amin MB. Immunohistochemical (IHC) Profile To Distinguish Urothelial
from Squamous Differentiation in Carcinomas of Urothelial Tract. Mod Pathol. 24:195A, 2011.
Presented at the U.S. and Canadian Academy of Pathology meeting, San Antonio, TX, March 2011.
Shen SS, Guo CC, Ro JY, Anton R, Cheng L, Hameed O, Truong LD, Huang J, Weiss MA, Lin F, Srigley JR,
McKenney JK, Tamboli P, Grignon DJ, Jimenez RE, Zhou M, Paner GP, Troncoso P, Amin MB, Ayala AG
Common Diagnostic Problems in Interpretation of Early Invasive Bladder Cancer: A Consensus Study.
Mod Pathol. 24:224A, 2011. Presented at the U.S. and Canadian Academy of Pathology meeting, San
Antonio, TX, March 2011.
Chandrakanth A, Paner GP, Gulmann C, Rao P, Ro JY, Hansel DE, Shen SS, Lopez-Beltran A, Arora K,
Parakh RS, Herrera LP, Luthringer DJ, Zhai J, Cho YM, Amin MB. Detailed Immunohistochemical (IHC)
Evaluation of Novel Markers Associated with Urothelial Differentiation in a Comprehensive Spectrum of
Variants of Urothelial Carcinoma (UCa): A Study of 80 Cases. Mod Pathol. 24:178A, 2011. Presented at
the U.S. and Canadian Academy of Pathology meeting, San Antonio, TX, March 2011.
Herrera LP, Hes O, Hirsch M, Comperat E, Camparo P, Rao P, Picken M, Montironi R, Chandrakanth A,
Arora K, Tamboli P, Westfall DE, Monzon FA, Amin MB. Clear Cell-Papillary Renal Cell Carcinoma (CPRCC) Not Associated with End Stage Renal Disease: Clinicopathologic Analysis of 50 Tumors Confirming
a Novel Subtype of Renal Cell Carcinoma (RCC) Occurring in a Sporadic Setting. Mod Pathol. 24:197A,
2011. Platform Session Presented at the U.S. and Canadian Academy of Pathology meeting, San
Antonio, TX, March 2011.
Herrera LP, Amin M, Schwartz JD, Shen SS, Hansel DE, Paner GP, Tamboli P, Arora K, Chandrakanth A,
Parakh RS, Amin MB. Detailed Immunohistochemical Characterization in the Spectrum of Sex Cord
Stromal Tumors (SCST) of the Testis Using Novel and Established Immunohistochemical (IHC) Markers:
A Study of 41 Cases. Mod Pathol. 24:197A, 2011. Presented at the U.S. and Canadian Academy of
Pathology meeting, San Antonio, TX, March 2011.
Paner G, Amin MB, Ro JY, Srigley JR, Grignon DJ, Hansel DE, Schwartz JD, Jimenez RE, Amin
MB.Mesenchymal Neoplasm of the Penis: Clinicopathological Analysis of 19 Cases. Mod Pathol.
292.
293.
294.
295.
296.
297.
298.
299.
300.
301.
302.
303.
March 2011.
Behdad A, Monzon FA, Hes O, Hirsch M, Michal M, Comperat E, Camparo P, Rao P, Picken M, Montironi
R, Chandrakanth A, Herrera LP, Arora K, Westfall DE, Tamboli P, Amin MB. Relationship between
Sporadic Clear Cell-Papillary Renal Cell Carcinoma (CP-RCC) and Renal Angiomyoadenomatous Tumor
(RAT) of the Kidney: Analysis by Virtual-Karyotyping, Fluorescent In Situ Analysis and
Immunohistochemistry (IHC). Mod Pathol. 24:179A, 2011. Presented at the U.S. and Canadian
Academy of Pathology meeting, San Antonio, TX, March 2011.
Chandrakanth A, Paner GP, Gown AM, Gulmann C, Amin M, Osunkoya AO, Vankalakunti M, Herrera LP,
Gupta R, Arora K, Amin MB. Role of Immunohistochemistry (IHC) in the Differential Diagnosis of
Invasive Urothelial Carcinoma (UCa) Versus High-Grade Tumors of the Renal Collecting System
[Collecting Duct Carcinoma (CDC) and Renal Medullary Carcinoma (RMC)]. Mod Pathol. 24:178A, 2011.
Presented at the U.S. and Canadian Academy of Pathology meeting, San Antonio, TX, March 2011.
Arville B, O'Rourke E, Chung F, Amin MB, Bose S. Evaluation of a Triple Combination of CK20, p53 and
CD44 for Improving Detection of Urothelial Carcinoma in Urine Cytology Specimens. Mod Pathol.
March 2011.
Aron M, Gown AM, Balzer B, Amin M, Shen S, Hansel D, Tamboli P, Paner G, Luthringer D, Mohanty S,
Herrera LP, Amin MB. Diagnosis of Sex Cord Stromal Tumors (SCST) of the Testis. Mod Pathol. 25:190A,
2012. Presented at the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, Canada,
March 2012.
Mohanty S, Luthringer D, Gown AM, Aron M, Amin MB. Diagnostic Utility of a Comprehensive
Immunohistochemical Panel To Differentiate High Grade Urothelial Carcinoma (UCa) from Prostatics
Adenocarcinoma. Mod Pathol. 25:229A, 2012. Presented at the U.S. and Canadian Academy of
Pathology meeting, Vancouver, BC, Canada, March 2012.
Aron M, Amin M, Zhang P, DePeralta-Venturina M, Mohanty S, Wang S, Amin MB. Expression of Novel
Markers Human Kidney Injury Molecule-1(Hkim-1), S100A1 and Napsin A in the Diffential Diagnosis of
Renal Cell Carcinomas (RCC) with Clear and Papillary Features. Mod Pathol. 25:190A, 2012. Presented
at the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, Canada, March 2012.
Aron M, Luthringer D, McKenney J, Hansel D, Westfall D, Parakh R, Vankalakunti M, Mohanty S, Balzer
B, Amin MB. Expression of [alpha]-Methylacyl-CoA Racemase (AMACR) in Urothelial Carcinoma In Situ
(CIS): Comparative Utility with More Traditional markers (CK20, CS44s, p53) in the Distinction from its
Malignant Mimics. Mod Pathol. 25:190A, 2012. Presented at the U.S. and Canadian Academy of
Pathology meeting, Vancouver, BC, Canada, March 2012.
Mohanty S, Nese N, Amin M, Aron M, Rugvedita P, Gupta R, Zhang P, Luthringer D, Amin MB.
Expression of Novel Renal Tubular Associated Markers in Nephogenic Adenoma (NA) of the Urothelial
Tract: Potential Utility in Distinction from Its Malignant Mimics. Mod Pathol. 25:229A, 2012. Presented
at the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, Canada, March 2012.
Haley SL, Kryvenko ON, Aron M, Shen S, Epstein JI, Gupta NS, Amin MB, Truong LD. Hemangioma in
Kidney with End-Stage Renal Disease: A Novel Association. Mod Pathol. 25:211A, 2012. Presented at
the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC, Canada, March 2012.
Quiroga-Garza G, Ayala AG, Truong L, Amin MB, Arora K, Alvarado-Cabrero I, Cuevas-Ocampo K,
Monzon FA. Cytogenomic Molecular Profiles of Tubulocystic Carcinoma of the Kidney. Mod Pathol.
25:235A, 2012. Presented at the U.S. and Canadian Academy of Pathology meeting, Vancouver, BC,
Canada, March 2012.
Epstein J, Algaba Arrea F, Amin MB, Sykes J, Hamberg H, van der Kwast T, Egevad L, Lopez-Beltran A,
Camparo, Hulsbergen C, Kristiansen G, Montironi R, Pan CC. A Consensus Study on Invasiveness of
Bladder Cancer Using Virtual Microscopy and Heatmaps (pT1 European Network of Uropathology
(ENUP) Study). Mod Path; 26:204A, 2013. Presented at the U.S. and Canadian Academy of Pathology
meeting, Baltimore, MD, March 2013.
Ananthanarayanan V, Pan Y, Kocherginsky M, Tretiakova M, Amin MB, Cheng L, Epstein JI, Grignon DJ,
Hansel DE, Jimenez RE, McKenney JK, Montironi R, Oliva E, Osunkoya AO, Rao P, Reuter VE, Ro JY, Shen
SS, Srigley JR, Tsuzuki T, Yao JL, Antic T, Haber M, Taxy JB, Paner GP. Influence of Histologic Criteria and
Confounding Factors (CFs) in Staging Equivocal Cases for Microscopic Perivesical Tissue Invasion (MPVI
304.
305.
306.
307.
308.
309.
310.
311.
312.
313.
314.
315.
316.
or pT3a): An Interobserver Study Among Expert GU Pathologists. Mod Path; 26:194A, 2013. Presented
at the U.S. and Canadian Academy of Pathology meeting, Baltimore, MD, March 2013.
Chang EE, Luthringer DJ, de Peralta-Venturina M, Amin MB. Added Value of ERG to PIN cocktail for
Evaluation of Atypical Small Acinar Proliferations (ASAP) of Prostate. Mod Path; 26:263A, 2013.
Presented at the U.S. and Canadian Academy of Pathology meeting, Baltimore, MD, March 2013.
Chang EE, Luthringer DJ, de Peralta-Venturina M, Balzer B, Wang S, Wu, JM, Amin MB. Detailed
Histologic Evaluation of Renal Cell Carcinoma (RCC) Subtypes in 138 Metastatic Tumors with Emphasis
on Homology with Primary Site. Mod Path; 26:200A, 2013. Presented at the U.S. and Canadian
Academy of Pathology meeting, Baltimore, MD, March 2013.
Chang EE, Luthringer DJ, de Peralta-Venturina M, Barbaidorabad N, Ljubimov AV, Ljubimova JY, Amin
MB. Laminin 1 and 2 Expression in Vasculature of Clear Cell Renal Cell Carcinoma. Mod Path;
26:200A, 2013. Presented at the U.S. and Canadian Academy of Pathology meeting, Baltimore, MD,
March 2013.
McFall M, Mohanty S, Conley A, Bhele S, Yuan X, Amin MB, Knudsen B, Dhall D, Balzer B. Integration
between Immunohistochemistry (IHC) and mRNA Expression Patterns Reveals Novel Biomarkers for
Merkel Cell Carcinoma. Mod Path; 27:137A, 2014. Proffered paper presented at the U.S. and Canadian
Academy of Pathology meeting, San Diego, CA, March 2014.
Seipel AH, Delahunt B, Samaratunga H, Amin MB, Barton J, Berney DM, Billis A, Cheng L, Comperat E,
Evans A, Fine SW, Grignon D, Humphrey PA, Magi-Galluzzi C, Montironi R, Sesterhenn I, Srigley JR,
Trpkov K, van der Kwast T, Varma M, Zhou M, Ahmad A, Moss S, Egevad L. Diagnostic Criteria for Ductal
Adenocarcinoma of the Prostate. Interobserver Variability among 20 Expert Uropathologists. Mod Path;
27:260A, 2014. Proffered paper presented at the U.S. and Canadian Academy of Pathology meeting,
San Diego, CA, March 2014.
Smith SC, Mohanty SK, McDaniel AS, dePeralta-Venturina MN, Luthringer DJ, Tomlins SA, Amin MB.
Neuroendocrine Differentiation (NED) in Prostatic Adenocarcinoma (PCa): A Dual-Institutional Review
with Respects to a Newly Proposed Classification System. Mod Path; 27:261A, 2014. Stowell-Orbison
Poster presented at the U.S. and Canadian Academy of Pathology meeting, San Diego, CA, March 2014.
Williamson SR, Eble JN, Amin MB, Gupta NS, Smith SC, Sholl LM, Hirsch MS, Hornick JL. Succinate
Dehydrogenase-Deficient Renal Cell Carcinoma: Detailed Characterization of Clinicopathologic and
Immunohistochemical Features of a Distinct Morphologic Variant. Mod Path; 27:270A, 2014. Proffered
paper presented at the U.S. and Canadian Academy of Pathology meeting, San Diego, CA, March 2014.
Berney D, Algaba F, Amin MB, Camparo P, Comperat E, Lopez-Beltran A, Montironi R, Varma M, Egevad
L. Handling and Reporting of Orchiectomy Specimens with Testicular Cancer: Areas of Consensus and
Variation among 25 Experts and 225 European Pathologists. Mod Path; 27:217A, 2014. Proffered paper
presented at the U.S. and Canadian Academy of Pathology meeting, San Diego, CA, March 2014.
Comperat E, Egevad L, Lopez-Beltran A, Camparo P, Algabe F, Amin MB, Epstein JI, Hamberg H,
Hulsbergen-Van de Kaa C, Christiansen G, Montironi R, Pan CC, van der Kwaast T. Staging of Bladder
Cancer (PTA VS. PT1) among 238 European Pathologists Reporting pTa Versus pT1 on Transuretheral
Resection Specimen of the Bladder (TURB). A Survey of 238 European Pathologists. Mod Path; 27:222A,
2014. Proffered paper presented at the U.S. and Canadian Academy of Pathology meeting, San Diego,
CA, March 2014.
Mohanty SK, Liles G, Thakur S, Sahu SS, Kalra K, Amin MB, Pillai RK, Dadmanesh F. miRNA Expression
Pattern in Predicting BRCA Mutation Status in Invasive Breast Carcinoma. Mod Path; 27:68A, 2014.
Poster presented at the U.S. and Canadian Academy of Pathology meeting, San Diego, CA, March 2014.
Kryvenko ON, Haley SL, Smith SC, Shen SS, Paluru S, Gupta NS, Jorda M, EpsteIn JI, Amin MB, Truong
LD. Hemangiomas in Kidney with End-Stage Renal Disease A Novel Clinicopathological Association.
Mod Path; 27:242A, 2014. Poster presented at the U.S. and Canadian Academy of Pathology meeting,
San Diego, CA, March 2014.
Cheng C, Ma Z, Bhele S, Mohanty S, Chu YT, Luthringer D, Amin MB, Knudsen B, Gertych A. Fractal
Dimensions and Lacunarity of Nuclear Distribution Separate Benign Tissue and Cancer Grades in Radical
Prostatectomies. Mod Path; 27:396A, 2014. Poster presented at the U.S. and Canadian Academy of
Smith SC, Mohanty S, Kunju LP, Chang E, Chung F, Carvalho JC, Paner GP, Hansel DE, Luthringer DJ,
dePeralta-Ventrurina MN, Amin MB. Uroplakin II Outperforms Uroplakin III in Diagnostically
317.
318.
319.
320.
321.
322.
323.
324.
325.
326.
327.
328.
329.
Challenging Settings. Mod Path; 27:262A, 2014. Poster presented at the U.S. and Canadian Academy of
Mohanty SK, Smith SC, Kim E, Chung F, Hansel DE, dePeralta-Venturina MN, Luthringer DJ, Wang S,
Amin MB. Evaluation of the Mid/Hindgut Differentiation Marker SATB2 in Glandular Lesions of the
Urinary Bladder. Mod Path; 27:249A, 2014. Poster presented at the U.S. and Canadian Academy of
McFall MJ, Mohanty SK, Liles G, Lugo H, Chung F, Knudsen B, Yuan X, Amin MB, Dhall D, Balzer B.
Diagnostic Utility of an Expanded Panel of Novel and Well-Established Immunohistochemical (IHC)
Markers to Differentiate Merkel Cell Carcinoma from High-Grade Non-Merkel Cell Neuroendocrine
Carcinomas. Mod Path; 27:137A, 2014. Poster presented at the U.S. and Canadian Academy of
Hector L, Liles G, Smith SC, McFall MJ, Mohanty S, Amin MB, Kahn ME, Balzer BL. Diagnostic Utility of
BCL-2, CD44, and CD117 in Distinction of Well-Differentiated Neuroendocrine Tumors (WD) and High
Grade Neuroendocrine Carcinomas (HG). Mod Path; 27:153A, 2014. Poster presented at the U.S. and
Canadian Academy of Pathology meeting, San Diego, CA, March 2014.
Lugo H, McFall M, Liles G, Mohanty S, Chung F, Yuan X, Amin MB, Balzer B, Dhall D. Diagnostic Utility of
SATB2 in Determining the Site of Origin of Well-Differentiated Neuroendocrine Tumors. Mod Path;
27:155A, 2014. Poster presented at the U.S. and Canadian Academy of Pathology meeting, San Diego,
CA, March 2014.
Bhele S, Ma Z, Mohanty S, Salman S, Amin MB, Balzer B, Knudsen BS, Gertych A. A Machine Learning
Tool to Complement Gleason Grading of Prostate Carcinoma. Mod Path; 27:217A, 2014. Poster
presented at the U.S. and Canadian Academy of Pathology meeting, San Diego, CA, March 2014.
Divatia MK, Smith SC, Hes O, Epstein JI, McKenney JK, Salles PGO, Rao P, Kunju LP, Werneck da Cunha I,
Schultz L, Colecchia M, Hirsch M, Comperat E, Zampini C, de Peralta-Venturina M, Amin M, Zhang PL,
McHugh J, Mehra R, Tomlins S, Amin MB. Refining the Diagnostic Criteria and Immunophenotype of
Collecting Duct Carcinoma (CDC) in Light of Emerging Entities. Mod Path;28:216A-217A, 2015. Poster
presented at the U.S. and Canadian Academy of Pathology meeting, Boston, MA, March 2015.
Divatia MK, Smith SC, Kunju P, Hirsch M, Colecchia M, Hes O, Epstein JI, McKenney JK, Salles PGO, Rao
P, Werneck da Cunha I, Schultz L, Comperat E, Zampini C, de Peralta-Venturina M, Mehra R, Tomlins SA,
Amin MB. Renal Cell Carcinoma, Unclassified Medullary Phenotype (RCCU-MP): Findings Supporting
a Close Relationship with Renal Medullary Carcinoma (RMC). Mod Path;28:217A, 2015. Poster
presented at the U.S. and Canadian Academy of Pathology meeting, Boston, MA, March 2015.
Divatia MK, Smith SC, Colecchia M, Aron M, Amin M, Shen SS, Hansel D, Tamboli P, Paner GP, de
Peralta-Venturina M, Hererra Hernandez L, Gown AM, Amin MB. Diagnostic Utility of a Comprehensive
Immunohistochemical (IHC) Panel for Testicular Sex Cord Stromal Tumors (TSCST): A Study of 76 Cases.
Mod Path;28:216A, 2015. Poster presented at the U.S. and Canadian Academy of Pathology meeting,
Boston, MA, March 2015.
Sanz J, Divatia MK, Zampini C, Smith SC, dePeralta-Venturina M, Luthringer D, Amin MB. UrothelialAssociated Marker S100P Expression in a Multi-Tumor Cohort: Immunohistochemical (IHC) Evaluation
in a Tissue Microarray (TMA) study of 300 cases. Mod Path;28:256A-257A, 2015. Poster presented at
the U.S. and Canadian Academy of Pathology meeting, Boston, MA, March 2015.
Smith SC, Trpkov K, Mehra R, Divatia MK, Hes O, Menon S, Tripodi S, McHugh J, Brimo F, Gill A, MagiGalluzzi C, Sibony M, Williamson SR, Nesi G, Picken MM, Cheng L, Reuter VE, Epstein JI, Tickoo SK,
Tomlins SA, Chen Y, Amin MB. Is Tubulocystic Carcinoma with Dedifferentiation a form of
HLRCC/Fumarate Hydratase-deficient RCC? Mod Path;28:260A, 2015. Platform presentation at the U.S.
and Canadian Academy of Pathology meeting, Boston, MA, March 2015.
Zampini C, Divatia MK, Smith SC, dePeralta-Venturina M, Balzer B, Amin MB. Pitfalls in the Diagnostic
Application of S100A1 as a Marker of Renal Neoplasia in Metastatic Settings. Mod Path;28:270A, 2015.
Poster presented at the U.S. and Canadian Academy of Pathology meeting, Boston, MA, March 2015.
Ma Z, Xiaopu Y, Amin MB, Knudsen B, Gertych A. Fractal descriptors accurately distinguish between
growth patterns of prostate cancers. Mod Path;28:399A, 2015. Poster presented at the U.S. and
Sandler HM, Hu C, Rosenthal SA, Amin MB, et al. A phase III protocol of androgen suppression (AS) and
3DCRT/IMRT vs AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for
localized, high-risk prostate cancer (RTOG 0521). Abstract submitted for the 2015 American Society of
Clinical Oncology Annual meeting, Chicago, IL, May 2015.
Computer-Based Pathology Programs:
1.
2.
3.
Ro JY, Amin MB, Sahin A, Ayala AG: Testicular tumors. Intellipath Corp., Santa Monica, CA,1992 (Interactive
computer-based educational program with 1500 pictures and 855 kilobytes text information [approximately 280
pages of printed text] covering 56 diseases).
Amin MB, Tickoo SK. Tumors and tumor-like lesions of the kidney. Universal Multimedia, Costa Mesa, CA, 1996.
(Interactive CD-ROM based lecture program. 317 slides, 1 hour 45 minute presentation and syllabus).
Amin MB, Humphrey PA, Srigley JR and the Cancer Committee of the College of American Pathologists. 2002
Cancer Curriculum: CA-A: Prostate Carcinoma.
ADDITIONAL INFORMATION:
Post-Doctoral Dissertation:
1988
Prostatic carcinoma - a histopathological, histochemical and clinicopathological study of 60 cases. University of

Bombay, Bombay, India
Professional Society Memberships:

U.S. and Canadian Academy of Pathology
College of American Pathologists
American Society of Clinical Pathology (1989-2003)
Arthur Purdy Stout Society of Pathologists
International Society of Urologic Pathology
Association of Directors of Anatomic and Surgical Pathology (1998- 2006)
Assocation of Pathology Chairs
California Society of Pathologists
Los Angeles Society of Pathologists

Mahul Amin Academic CV 5-4-2015

Transféré par

Informations du document

Description originale:

Titre original

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

Mahul Amin Academic CV 5-4-2015

Transféré par

Droits d'auteur :

Formats disponibles

Curriculum Vitae

Chairman, Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center

Academic Affiliations present:

Hospital and Departmental Appointments - Previous:

Senior Staff Pathologist, Department of Pathology, Henry Ford Hospital, Detroit, MI

Academic Affiliations - Previous:

Visiting Instructor, Wayne State University, Detroit, MI

Clinical Assistant Professor of Pathology, Wayne State University, Detroit, MI

General Surgical Pathology with emphasis on oncologic diseases

MAHUL B. AMIN, MD Page 2

Committee Service - Local and National:

MAHUL B. AMIN, MD Page 3

2000 2000 - 2002

Organization/Participation in Major International Consensus Conferences & Meetings:

Co-Chair, Surveillance after Focal Therapy (Prostate). Society of International Urology

MAHUL B. AMIN, MD Page 4

Consultant, Board Membership and Advisory Committees:

Pathology Advisory Board, Foundation Medicine, Boston, MA

MAHUL B. AMIN, MD Page 5

HONORS, SPECIAL AWARDS & PRESTIGIOUS APPOINTMENTS:

Course Faculty Member:

RESEARCH GRANTS AND FELLOWSHIPS RECEIVED:

MAHUL B. AMIN, MD Page 6

Cedars-Sinai Biobank and Translational Research Core Facility

COOPERATIVE GROUPS CLINICAL TRIALS:

MAHUL B. AMIN, MD Page 8

INVITED LECTURES AND PRESENTATIONS:

MAHUL B. AMIN, MD Page 11

MAHUL B. AMIN, MD Page 17

WORKSHOPS, COURSES AND SLIDE SEMINARS:

MAHUL B. AMIN, MD Page 19

MAHUL B. AMIN, MD Page 20

MAHUL B. AMIN, MD Page 21

Reseach Papers (published)

MAHUL B. AMIN, MD Page 23

MAHUL B. AMIN, MD Page 25

MAHUL B. AMIN, MD Page 27

MAHUL B. AMIN, MD Page 30

MAHUL B. AMIN, MD Page 31

MAHUL B. AMIN, MD Page 32

MAHUL B. AMIN, MD Page 34

MAHUL B. AMIN, MD Page 35

MAHUL B. AMIN, MD Page 36

Reseach Papers (In press)

Published Papers with Authorship as Listed Collaborator on PubMed

immunophenotypic and molecular characterization of a large cohort with emphasis on relationship

Letters to the Editor

MAHUL B. AMIN, MD Page 41

MAHUL B. AMIN, MD Page 44

MAHUL B. AMIN, MD Page 48

MAHUL B. AMIN, MD Page 53

MAHUL B. AMIN, MD Page 55

Prostatic carcinoma - a histopathological, histochemical and clinicopathological study of 60 cases. University of

Professional Society Memberships:

MAHUL B. AMIN, MD Page 56

Vous aimerez peut-être aussi